User Image Cart Icon 0 Search Image
  • Home > Blog > Alzheimer’s, Dementia, Parkinson’s

Alzheimer’s, Dementia, Parkinson’s

Neuroprotective effects of flavonoids and polyphenols

  1. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders
  2. A bird’s-eye view of the multiple biochemical mechanisms that propel pathology of Alzheimer’s disease: recent advances and mechanistic perspectives on …
  3. A blueberry extract-supplemented diet rescues phenotypes in drosophila melanogaster models of parkinson disease
  4. A Comparative Study on the Phenolic Composition and Biological Activities of Morus alba L. Commercial Samples
  5. A Comparison of the Antioxidant Activity with the Total Phenolic and Total flavonoid contents of the Leaves and Stem-bark of Anogeissus leiocarpa (DC.) Guill& Pirr …
  6. A comprehensive database and analysis framework to incorporate multiscale data types and enable integrated analysis of bioactive polyphenols
  7. A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis
  8. A Current Understanding of Alzheimer’s Disease and the Prospects of Phytopharmacological Intervention as a Management Strategy
  9. A meta-analysis of tea drinking and risk of Parkinson’s disease
  10. A molecular approach in drug development for Alzheimer’s disease
  11. A Narrative Review of Lifestyle Factors Associated with Parkinson’s Disease Risk and Progression
  12. A Novel GSK3β Inhibitor Reduces Tau Pathology in Alzheimer’s Disease
  13. A Paradigm Shift to Prevent and Treat Alzheimer’s Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols
  14. A pharmacological appraisal of neuroprotective and neurorestorative flavonoids against Neurodegenerative diseases
  15. A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa
  16. A Review of Antioxidants and Alzheimer
  17. A review of antioxidants and Alzheimer’s disease
  18. A review of genome mutation and Alzheimer’s disease
  19. A review on cholinesterase inhibitors for Alzheimer’s disease
  20. A Review on Current Strategies and Future Perspective in Respect to Alzheimer’s Disease Treatment
  21. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
  22. A Review on Medicinal Plants for Alzheimer’s disease
  23. A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
  24. A review on potential mechanisms of Terminalia chebula in Alzheimer’s disease
  25. A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer’s disease
  26. A review on the beneficial effects of tea polyphenols on human health
  27. A review on the status of the phenolic compounds and antioxidant capacity of the flour: Effects of cereal processing
  28. A review–probable mechanism of action of curcumin for the treatment of Alzheimer disease (AD)
  29. A review: inflammatory process in Alzheimer’s disease, role of cytokines
  30. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
  31. A Study on the Role of Mimosa Pudica (Thottar Chinungi) on the Experimental Models of Parkinsonism (Nadukku Vatham)
  32. A synopsis on the linkage between age-related dementias and vascular disorders
  33. A systematic review on the role of natural products in modulating the pathways in Alzheimer’s disease
  34. Acacetin—A simple flavone exhibiting diverse pharmacological activities
  35. Accumulation of citrus flavanones in bovine milk following citrus pulp incorporation into the diet of dairy cows
  36. Acetyl-cholinesterase Inhibition by Extracts and Isolated Flavones from Linaria reflexa Desf. (Scrophulariaceae)
  37. Acetylated flavonoid Glycosides Potentiating NGF Action from Scoparia dulcis
  38. Activation of pro‐survival Akt and ERK1/2 signalling pathways underlie the anti‐apoptotic effects of flavanones in cortical neurons
  39. Acute effects of flavonoid-rich blueberry on cognitive and vascular function in healthy older adults
  40. Adult‐onset brain tumors and neurodegeneration: Are polyphenols protective?
  41. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease
  42. Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease
  43. Advances in research on active constituents of Chinese materia medica in treatment of Alzheimer’s disease [J]
  44. Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity
  45. Age-related cognitive impairment as a sign of geriatric neurocardiovascular interactions: may polyphenols play a protective role?
  46. Aging risk factors and Parkinson’s disease: contrasting roles of common dietary constituents
  47. Alcohol Consumption in Predementia and dementia Syndromes
  48. Alcohol intake and risk of dementia
  49. Alcohol, wine and mental health: focus on dementia and stroke
  50. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Göteborg
  51. Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents
  52. Alpha-secretase ADAM10 regulation: insights into Alzheimer’s disease treatment
  53. Alpha-Synuclein and synuceinopathies as related to Parkinson’s disease
  54. Alpha-synuclein oligomers—neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
  55. Altered Micro-RNA Regulation and Neuroprotection Activity of Eremostachys labiosiformis in Alzheimer’s Disease Model
  56. Alzheimer’s and Parkinson’s Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier-Ligand Docking to Screen Natural Compounds Related to Classic …
  57. Alzheimer’s Dementia: Can It Be Prevented?
  58. Alzheimer’s disease (AD) genes: Enrichment in cancer genes and those related to comorbid conditions, risk factors (pollution and pathogens) or beneficial agents …
  59. Alzheimer’s Disease & Treatment
  60. Alzheimer’s Disease & Treatment
  61. Alzheimer’s Disease & Treatment
  62. Alzheimer’s Disease & Treatment, Vol. 1
  63. Alzheimer’s disease and antioxidant therapy: how long how far?
  64. Alzheimer’s disease and its current treatments; Is there a possibility for a cure
  65. Alzheimer’s Disease and Metal Contamination: Aspects on Genotoxicity
  66. Alzheimer’s disease and natural products: Future regimens emerging from nature
  67. Alzheimer’s disease and other Neurodegenerative disorders
  68. Alzheimer’s Disease and Oxidative Stress
  69. Alzheimer’s Disease and Parkinson’s Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and …
  70. Alzheimer’s Disease and the Main Aspects-Literature Review
  71. Alzheimer’s DISEASE AND THE MICROBIOME
  72. Alzheimer’s disease as oligomeropathy
  73. Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
  74. Alzheimer’s Disease Theranostics
  75. Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
  76. Alzheimer’s Disease, Drosophila melanogaster and Polyphenols
  77. Alzheimer’s disease, neuroinflammation and the influence of different combinations of nutrients
  78. Alzheimer’s disease: A challenge in managing with certain medicinal plants-Areview
  79. Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL …
  80. Alzheimer’s Disease: An Approach for Non-Pharmacological Therapies
  81. Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
  82. Alzheimer’s Disease: Early Diagnosis & Fundamental Therapeutics
  83. Alzheimer’s disease: from pathology to therapeutic approaches
  84. Alzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms
  85. Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the …
  86. Alzheimers Disease & Parkinsonism
  87. Ameliorating effect of ethanol leaf extract of Ficus hispida Linn. on amyloid beta Aβ (25-35) induced cognitive deficits and oxidative stress in Alzheimer’s mice
  88. Amelioration of 6-Hydroxydopamine-Lesion Induced Neurotoxicity by Different Extracts of Ocimum sanctum Leaves in Rodent Model of Parkinson’s Disease
  89. Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type
  90. Amentoflavone Ameliorates Aβ1–42-Induced Memory Deficits and oxidative stress in Cellular and Rat Model
  91. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through PI3K/Akt and ERK signaling pathways
  92. Amentoflavone suppresses amyloid β1–42 neurotoxicity in Alzheimer’s disease through the inhibition of pyroptosis
  93. AMP‐activated protein kinase: a potential player in Alzheimer’s disease
  94. Amyloid A-Beta Peptide: In-Cell Studies and Mechanism of Polyphenol-Based Inhibition to Aggregation
  95. Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer’s disease
  96. Amyloid β-Peptide (1–42)-Induced oxidative stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
  97. Amyloid β-protein assembly as a therapeutic target of Alzheimer’s disease
  98. Amyloid‐β deposition in Alzheimer transgenic mice is associated with oxidative stress
  99. An alternative approach to drug discovery for Alzheimer’s disease dementia
  100. An Evaluation of Cholesterol-lowering Effect of Soy Protein and Isoflavones on Postmenopausal Women and Hypercholesterolemic Humans.
  101. An Overview of Parkinson’s Disease and Oxidative Stress: Herbal Scenario
  102. An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
  103. An overview on global trends in nanotechnological approaches for Alzheimer therapy
  104. An overview on potential neuroprotective compounds for management of Alzheimer’s disease
  105. An overview on therapeutics attenuating amyloid β level in Alzheimer’s disease: Targeting neurotransmission, inflammation, oxidative stress and enhanced …
  106. An update on plant-originated treatment for Alzheimer’s disease
  107. An updated review on Anti-Alzheimer’s herbal drugs
  108. Analgesic and acetylcholinesterase inhibition potential of polyphenols from Scolopia crenata (Flacourtiaceae): An endemic medicinal plant of India
  109. Analysis of amino acid and phenolic content in honey by UPLC-ESI-MS/MS
  110. Analysis of technological developments in the treatment of Alzheimer’s disease through patent documents
  111. Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson’s Disease
  112. Anesthesia Implications of the Use of Essential Oils in Alzheimer’s Dementia
  113. Animal models of Parkinson’s disease: a gateway to therapeutics?
  114. Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease
  115. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer’s type
  116. Anti-acetylcholinesterase and antioxidant activities and HPLC-MS analysis of polyphenol from extracts of Nelsonia canescens (Lam.) Spreng.
  117. Anti-adipogenic Effect of a Dietary flavonoid Fisetin in 3T3-L1 Cells
  118. Anti-aging and anti-aggregation properties of polyphenolic compounds in C. elegans
  119. Anti-Alzheimer potential of Green Moong Bean
  120. Anti-Alzheimer’s studies on β-sitosterol isolated from Polygonum hydropiper L.
  121. Anti-amnesic Effect of Leea indica Extract in Scopolamine-induced Amnesia of Alzheimer’s Type in Rats
  122. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer’s β-amyloid fibrils in vitro
  123. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease
  124. Anti-amyloidogenic properties of some phenolic compounds
  125. Anti-Demential Effect of EGB 761 on dementia Induced Wistar Rats
  126. Anti-Inflammatory Agents in Parkinson’s Disease
  127. Anti-inflammatory and immune therapy for Alzheimer’s disease: current status and future directions
  128. Anti-inflammatory and immunomodulatory properties of dietary flavonoids
  129. Anti-inflammatory Effects of flavonoid Compounds on TNBS-induced Acute Colitis in Rats
  130. Anti-inflammatory effects of flavonoids in Neurodegenerative disorders
  131. Anti-inflammatory Effects of O-methylated Flavonoid
  132. Anti-inflammatory, anti-diabetic, and anti-Alzheimer’s effects of prenylated flavonoids from Okinawa propolis: an investigation by experimental and computational …
  133. Anti-inflammatory, immunomodulatory, and prebiotic properties of dietary flavonoids
  134. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease
  135. Anti-Parkinson potential of silymarin: mechanistic insight and therapeutic standing
  136. Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?
  137. Antiaging Interventions: An Insight into Polyphenols and Brain Aging
  138. Antiapoptotic role of Agaricus blazei extract in rodent model of Parkinson’s disease
  139. Antidementic activity of Brassica oleracea l. var. Italica (brassicaceae) flower on memory deficit in young male rats
  140. Antidepressant flavonoids and their relationship with oxidative stress
  141. Antihepatotoxic, nephroprotective, and antioxidant activities of phenolic compounds from Satureja macrostema leaves against carbon tetrachloride-induced hepatic …
  142. Antioxidant activity and total phenolic content of ethanolic extract of Caesalpinia bonducella seeds
  143. Antioxidant activity of selected phenols estimated by ABTS and FRAP methods.
  144. Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention
  145. Antioxidant and anti‐inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental …
  146. Antioxidant and Anticholinesterase Activities of Macrosphyra Longistyla (DC) Hiern Relevant in the Management of Alzheimer’s Disease
  147. Antioxidant and Choline Esterase Inhibitory Activity of Phenolic Rich Extracts from Bombax ceiba L. Flowers.
  148. Antioxidant and neuroprotective Effects of Synthetic Curcumin Analogues and Natural Phenolics
  149. Antioxidant and neuroprotective properties of blueberry polyphenols: a critical review
  150. Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence
  151. Antioxidant Capacity and Behavioral Relevance of a Polyphenolic Extract of Chrysanthellum americanum in a Rat Model of Irritable Bowel Syndrome
  152. Antioxidant Capacity is Decreased in Alzheimer’s Disease and Mild Cognitive Impairment Patients
  153. ANTIOXIDANT EFFECT OF flavonoids IN Neurodegenerative DISEASES.
  154. Antioxidant effect of flavonoids present in Euterpe oleracea Martius and Neurodegenerative diseases: A literature review
  155. Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach
  156. Antioxidant Nutraceuticals and Parkinson’s Disease
  157. Antioxidant phenolic constituents from Parthenocissus tricuspidata
  158. Antioxidant plant polyphenols and cognitive disorders
  159. ANTIOXIDANT PROPERTIES OF A Ginkgo biloba LEAF EXTRACT (EGb 761) IN ANIMAL MODELS OF Alzheimer’s AND Parkinson’s DISEASES.
  160. Antioxidant properties of Crocus sativus L. and its constituents and relevance to Neurodegenerative diseases; focus on Alzheimer’s and Parkinson’s disease
  161. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer’s disease
  162. Antioxidant therapy in Alzheimer’s disease: theory and practice
  163. Antioxidants and Alzheimer’s disease: from bench to bedside (and back again)
  164. Antioxidants and dementia risk: consideration through a cerebrovascular perspective
  165. Antioxidants as a potential therapy against age-related Neurodegenerative diseases: amyloid beta toxicity and Alzheimer’s disease
  166. Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
  167. Antioxidants, diet, polyphenols and dementia
  168. Apolipoprotein ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
  169. Apples and their products effect on neurodegeneration and Alzheimer’s disease
  170. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer’s disease
  171. Applying Epigenetics to Alzheimer’s Disease via the Latent Early–life Associated Regulation (LEARn) Model
  172. Applying transcriptomic and proteomic knowledge to Parkinson’s disease drug discovery
  173. Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
  174. Are polyphenols strong dietary agents against neurotoxicity and neurodegeneration?
  175. Arecanut (Areca catechu L) decreases Alzheimer’s disease symptoms: Compilation of research works
  176. Artemisia amygdalina Upregulates Nrf2 and Protects Neurons Against oxidative stress in Alzheimer Disease
  177. Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer’s disease
  178. Assessment of anticholinesterase activities and antioxidant potentials of Anisomeles indica relevant to the treatment of Alzheimer’s disease
  179. Assessment of the effect of selected African plants on an in vitro model of Parkinson’s disease
  180. association of tea consumption with risk of Alzheimer’s disease and anti-beta-amyloid effects of tea
  181. ATR-IR study of the mechanism of aluminum chloride induced Alzheimer’s disease; curative and protective effect of Lipidium sativum water extract on …
  182. Attention-deficit/hyperactivity disorder–unifying mechanism involving antioxidant therapy: Phenolics, reactive oxygen species, and oxidative stress
  183. Attenuation of iNOS and COX2 by blueberry polyphenols is mediated through the suppression of NF-κB activation
  184. Auraptene Mitigates Parkinson’s Disease-Like Behavior by Protecting Inhibition of Mitochondrial Respiration and Scavenging Reactive Oxygen Species
  185. Autophagy in Alzheimer’s disease and promising modulatory effects of herbal medicine
  186. Autophagy, polyphenols and healthy ageing
  187. Aβ propagation and strains: implications for the phenotypic diversity in Alzheimer’s disease
  188. BACE inhibitors as potential therapeutics for Alzheimer’s disease
  189. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease
  190. Baicalein reduces β‐amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
  191. Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease
  192. Behavioral and neurochemical alterations induced by vanillin in a mouse model of Alzheimer’s disease
  193. Beneficial effect of flavone derivatives on Aβ-induced memory deficit is mediated by peroxisome proliferator-activated receptor γ coactivator 1α: a comparative study
  194. Beneficial effect of the flavonoid luteolin on neuroinflammation
  195. Beneficial effects of flavonoids against Parkinson’s disease
  196. Beneficial Effects of flavonoids on Neurological Disorders
  197. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson’s disease: the role of glia and NRf2 regulation
  198. Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration
  199. Beneficial effects of phenolic compounds from fruit and vegetables in Neurodegenerative diseases
  200. Beneficial effects of polyphenols on chronic diseases and ageing
  201. Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation
  202. Benefits from dietary polyphenols for brain aging and Alzheimer’s disease
  203. Berry phenolics and their antioxidant activity
  204. Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer’s disease
  205. Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain
  206. Biflavonoids as potential small molecule therapeutics for Alzheimer’s disease
  207. Bioactive composition and promising health benefits of natural food flavors and colorants: potential beyond their basic functions
  208. Bioactive flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers-Implications for Parkinson’s Disease
  209. Bioactivity of olive oil phenols in neuroprotection
  210. Bioanalytical Approach to the Interaction of Novel sym-Triazine Derivatives with Alzheimer’s Disease Biomarkers
  211. Bioanalytical Approaches to Investigate Antioxidant Molecules and Nucleic Acid-Protein Interactions in Alzheimer’s Disease
  212. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts
  213. Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming Alzheimer’s disease
  214. Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases
  215. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update
  216. Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer’s disease
  217. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis
  218. Biological reactivity of polyphenolic− glutathione conjugates
  219. Biopharmaceutical Monotargeting versus ‘Universal Targeting’of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds
  220. Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease
  221. Biophenols: Enzymes (β-secretase, Cholinesterases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.)
  222. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from …
  223. Bioprocessing Strategies to Enhance L-DOPA and Phenolic Bioactives in the Fava Bean (Vicia Faba)
  224. Biosynthesized metal nanoparticles as potential Alzheimer’s disease therapeutics
  225. Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils
  226. Blanching alters the phenolic constituents and in vitro antioxidant and anticholinesterases properties of fireweed (Crassocephalum crepidioides)
  227. Blueberry polyhphenols and neuroprotection
  228. Blueberry polyphenols and neuroprotection
  229. Botanical phenolics and brain health
  230. Botanics: a potential source of new therapies for Alzheimer’s disease
  231. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer’s disease
  232. Brain food for Alzheimer-free ageing: focus on herbal medicines
  233. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease
  234. Brain iron accumulation in Parkinson’s disease: An investigation of genes related to iron metabolism and homeostasis and dietary behavior data in a case …
  235. Brain iron metabolism dysfunction in Parkinson’s disease
  236. Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson’s disease
  237. C0550 Neuroinflammation in Alzheimer’s Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals
  238. Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats
  239. Can co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer’s disease?
  240. Can consuming flavonoids restore old microglia to their youthful state?
  241. Can we prevent Parkinson’s disease
  242. Cannabis Flavonoids—Antioxidant & Anti-Inflammatory Benefits
  243. Carbohydrates and Glycomimetics in Alzheimer’s Disease Therapeutics and Diagnosis
  244. Carbon nanomaterials and amyloid beta interactions: Possible potentials in the detection and treatment of Alzheimer’s disease
  245. Catechin polyphenols: neurodegeneration and neuroprotection in Neurodegenerative diseases
  246. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)
  247. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for Neurodegenerative diseases
  248. Cellular and molecular aspects of Parkinson treatment: future therapeutic perspectives
  249. Cellular and molecular mechanisms of antioxidants in Parkinson’s disease
  250. Cellular phenotypes as inflammatory mediators in Parkinson’s disease: interventional targets and role of natural products
  251. Cerebral area differential redox response of neonatal rats to selenite-induced oxidative stress and to concurrent administration of highbush blueberry leaf polyphenols
  252. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s …
  253. Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms
  254. Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury
  255. Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of Alzheimer disease: an important role of in silico …
  256. Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
  257. Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
  258. Characterization of neurotoxic effects of NMDA and the novel neuroprotection by phytopolyphenols in mice.
  259. Characterization of phenolic compounds using UPLC–HRMS and HPLC–DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves
  260. CHARACTERIZATION OF THE neuroprotective ACTIVITY OF THE polyphenol (-)-EPIGALLOCATECHIN-3-GALLATE IN THE BRAIN
  261. Charnoly body as a novel biomarker of nutritional stress in Alzheimer’s Disease
  262. Chemical fingerprint of Bacopa monnieri L. and Rosmarinus officinalis L. and their neuroprotective activity against Alzheimer’s disease in rat model’s putative …
  263. Chemical structures, bioactivities and molecular mechanisms of citrus polymethoxyflavones
  264. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease
  265. Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior
  266. Chocolate/Cocoa Polyphenols and Oxidative Stress
  267. Cholinesterase inhibitors as Alzheimer’s therapeutics
  268. Chroman-like cyclic prenylflavonoids promote neuronal differentiation and neurite outgrowth and are neuroprotective
  269. Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer’s disease transgenic mouse model
  270. Chronic Hypoxia Alters mRNA Expression of the Genes Related to Alzheimer’s Disease in Primary Neuronal Cells
  271. Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
  272. Chronic treatment with resveratrol, a natural polyphenol found in grapes, alleviates oxidative stress and apoptotic cell death in ovariectomized female rats subjected to …
  273. Cinnamon, a promising prospect towards Alzheimer’s disease
  274. Citrus Fruit Polyphenols and Flavonoids: Applications to Psychiatric Disorders
  275. Clinical benefit and preservation of flavonols in dark chocolate manufacturing
  276. Clinical Development of a Novel Parkinsonian Drug in USA
  277. Cocoa and dark chocolate polyphenols: from biology to clinical applications
  278. Cocoa flavanols, exercise and the brain
  279. Cocoa Powder Triggers neuroprotective and Preventive Effects in a Human Alzheimer 0 s Disease Model by Modulating BDNF Signaling Pathway
  280. Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer’s disease model by modulating BDNF signaling pathway
  281. Coffee phenolic phytochemicals and kaempferol protect against oxidative damage of neuronal cells and memory impairments
  282. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review
  283. Cognitive Function and Consumption of Fruit and Vegetable Polyphenols in a Young Population: Is There a Relationship?
  284. Cognitive stimulation with leisure activities for prevention of cognitive decline and dementia: The aktiva study
  285. Cognitive-enhancing effect of quercetin in a rat model of Parkinson’s disease induced by 6-hydroxydopamine
  286. Combating oxidative stress disorders with citrus flavonoid: Naringenin
  287. Combination of EPA with carotenoids and polyphenol synergistically attenuated the transformation of microglia to M1 phenotype via inhibition of NF-κB
  288. Commentary: The flavonoid Baicalein Rescues Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer’s Disease
  289. Comparative analysis of total phenolic and total flavonoid contents, rutin, tannins and antioxidant capacity in Apiaceae and Lamiaceae families
  290. Comparative antioxidant activity of twenty traditional Indian medicinal plants and its correlation with total flavonoid and phenolic content
  291. Comparative evaluation of Helichrysi flos herbal extracts as dietary sources of plant polyphenols, and macro-and microelements
  292. Comparative evaluation of the antioxidant and anti-Alzheimer’s disease potential of coumestrol and puerarol isolated from pueraria lobata using molecular modeling …
  293. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative …
  294. Comparison of protective effects of four polyphenols on neuropathology and behavior of APP/PS1-21 transgenic mice, a model of Alzheimer’s disease
  295. Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
  296. Complementary Therapies for Parkinson’s Disease: What’s Promoted, Rationale, Potential Risks and Benefits
  297. Compositional Changes in Anthocyanins, Flavonols, and Ellagitannins in Processed Blackberries
  298. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
  299. Computational approaches to the investigation of proteins involved in Parkinson’s Disease
  300. Computational modeling of multi-target-directed inhibitors against Alzheimer’s disease
  301. Computer-aided structure-based design of multitarget leads for Alzheimer’s disease
  302. Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease: possible mechanisms of formation involving reactive oxygen species
  303. Conservative iron chelation for Neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
  304. Considerations for the use of polyphenols as therapies in Neurodegenerative diseases
  305. Consumption of anthocyanin-rich cherry juice for 12 weeks improves memory and cognition in older adults with mild-to-moderate dementia
  306. Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer’s disease
  307. Consumption of polyphenol plants may slow aging and associated diseases
  308. Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
  309. Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
  310. Copper-Catalyzed Oxidative Esterification of 2-Carbonyl Substituted Phenols with Alcohols
  311. Correlation between the polyphenol content and antioxidant effect of Cynara scolymus L. mother tincture
  312. Critical Evaluation of Current Alzheimer′ s Drug Discovery (2018-19) & Futuristic Alzheimer drug model approach
  313. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson’s disease
  314. Curcumin and Apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
  315. Curcumin and Its Nanoformulations as Therapeutic for Alzheimer’s Disease
  316. Curcumin exposure induces expression of the Parkinson’s disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells
  317. Curcumin has potent anti‐amyloidogenic effects for Alzheimer’s β‐amyloid fibrils in vitro
  318. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models
  319. Curcumin prevents and ameliorates biochemical and behavioral toxicities of MPTP in C57Bl/6J mice: its potential use in preventing and treating parkinsonism
  320. Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson’s disease
  321. Current Alzheimer’s management with berries fruits therapy
  322. CURRENT Alzheimer’s MANAGEMENT WITH DIETARY SEEDS THERAPY
  323. Current and emerging pharmacological targets for the treatment of Alzheimer’s disease
  324. Current and emerging therapeutic targets of Alzheimer’s disease for the design of multi-target directed ligands
  325. Current and investigational drugs for treatment of Alzheimer’s disease
  326. Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer’s disease
  327. Current evidence on the effect of dietary polyphenols intake on chronic diseases
  328. Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson’s disease
  329. Current perspectives and mechanisms of relationship between intestinal microbiota dysfunction and dementia: a review
  330. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
  331. Current status of metals as therapeutic targets in Alzheimer’s disease
  332. Cytological profiling of natural product scaffolds libraries for Parkinson’s disease
  333. Cytoprotection by Achyrocline satureioides (Lam) DC and some of its main flavonoids against oxidative stress
  334. Cytoprotective effects of phenolic antioxidants and essential fatty acids in human blood monocyte and neuroblastoma cell lines: Surrogates for neurological damage in …
  335. De B. Acetylcholinesterase inhibitory properties of black tea and its polyphenolic components
  336. Defective insulin signalling, mediated by inflammation, connects obesity to Alzheimer disease; relevant pharmacological therapies and preventive dietary …
  337. dementia IN SURINAME
  338. Dementia, preclinical studies in neurodegeneration and its potential for translational medicine in South America
  339. Design and characterization of enzymatic deglycosylation systems to produce drugs against Alzheimer’s disease
  340. Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer’s disease
  341. Design and Molecular dynamic investigations of 7, 8-Dihydroxyflavone Derivatives as potential neuroprotective Agents Against Alpha-synuclein
  342. Design and Molecular dynamic Investigations of 7, 8-Dihydroxyflavone Derivatives as Potential neuroprotective Agents Against Alpha-synuclein
  343. Design and systhesis of nanoparticles for therapy and imaging of Alzheimer’s disease
  344. Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease
  345. Design, Synthesis and Biological Assessment of Ferulic Acid Derivatives as Inhibitors of β-Amyloid Oligomerization in Alzheimer’s Disease
  346. Design, synthesis and biological evaluation of 3-piperazinecarboxylate sarsasapogenin derivatives as potential multifunctional anti-Alzheimer agents
  347. Design, synthesis and biological evaluation of scutellarein derivatives as potential anti-Alzheimer’s disease candidates based on metabolic mechanism
  348. Design, synthesis and evaluation of 4′-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer’s disease treatment
  349. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer’s disease
  350. Designing multi-targeted therapeutics for the treatment of Alzheimer’s disease
  351. Destabilization of Alzheimer’s Aβ42 protofibrils with a novel drug candidate wgx-50 by molecular dynamics simulations
  352. Determination of Flavonoids
  353. Determination of total flavonoid content of different parts of Garcinia cowa
  354. Development and application of nano-flavor-drug carriers in Neurodegenerative diseases
  355. Development and validation of analytical methods for the identification and quantification of phenolic compounds from Euterpe oleracea fruits
  356. Development of a grape seed polyphenolic extract with anti‐oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies
  357. Development of Electrochemical Sensors for the Analysis of Therapeutic Compounds and Proteases related to Alzheimer’s disease
  358. Development of multifunctional molecules as potential therapeutic candidates for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis in the …
  359. Development of tau aggregation inhibitors for Alzheimer’s disease
  360. Development of technologies for the production of polyphenolic nutraceuticals from muscadine grapes and rabbiteye blueberries
  361. Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches
  362. Diabetes and Alzheimer’s disease: can tea phytochemicals play a role in prevention?
  363. Diet and brain health: which role for polyphenols?
  364. Diet And Lifestyle Guidelines And Desirable Levels Of Risk Factors And Protective Factors For Prevention Of Dementia-A Scientific Statement From Joint …
  365. Diet and medical foods in Parkinson’s disease
  366. Diet and Nutrition in Alzheimer’s Disease and Healthy Aging
  367. Diet and Nutrition in Alzheimer’s Disease and Healthy Aging
  368. Diet and nutrition in dementia and cognitive decline
  369. Diet and the Risk of Parkinson’s Disease—Research Suggests Dietary Interventions May Prevent It and Lessen Symptom Severity By Densie Webb, PhD, RD
  370. Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer’s disease pathology?
  371. Dietary coconut and amyloid beta metabolism in the pathogenesis of Alzheimer’s disease
  372. Dietary Directions Against dementia Disorders
  373. Dietary factors in the etiology of Parkinson’s disease
  374. Dietary fatty acids and predementia syndromes
  375. Dietary fatty acids intake: possible role in cognitive decline and dementia
  376. Dietary fatty acids, cognitive decline, and dementia
  377. Dietary flavonoid intake in older adults: how many days of dietary assessment are required and what is the impact of seasonality?
  378. Dietary flavonoid intake to reduce the risk of chronic diseases
  379. Dietary flavonoids as potential neuroprotectants
  380. Dietary flavonoids Interaction with CREB-BDNF Pathway: An Unconventional Approach for Comprehensive Management of Epilepsy
  381. Dietary intake of natural antioxidants: vitamins and polyphenols
  382. Dietary lipids and their oxidized products in Alzheimer’s disease
  383. Dietary modifications in Parkinson’s disease: A neuroprotective intervention?
  384. Dietary modulation of oxidative stress in Alzheimer’s disease
  385. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity
  386. Dietary phenolics in apples and cider and their bioavailability in healthy humans and subjects with an ileaostomy
  387. Dietary Plant Lectins May be an ‘Unknown Etiology’in Parkinson’s Disease and Dietary Bioactive Compounds Affect Lifespan and Fat Storage Aspects of …
  388. Dietary polyphenols and mitochondrial function: role in health and disease
  389. Dietary polyphenols and neurogenesis: Molecular interactions and implication for brain ageing and cognition
  390. Dietary polyphenols and the prevention of diseases
  391. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects
  392. Dietary Polyphenols as Modulators of Brain Functions: Biological Actions and Molecular Mechanisms…
  393. Dietary polyphenols as potential remedy for dementia
  394. Dietary Polyphenols—Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases. A Systematic Review
  395. Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
  396. Dietary polyphenols: A novel strategy to modulate microbiota-gut-brain axis
  397. Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s Disease
  398. Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson’s …
  399. Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress
  400. Dietary Supplements as Cognitive Enhancers: The Role of Flavonoid-Rich Foods and their Relevance in Age-Related Neurodegeneration
  401. Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down-regulates Alzheimer’s markers in SAMP8 mice
  402. Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols
  403. Differential Protection among Fractionated Blueberry Polyphenolic Families against DA-, Aβ42- and LPS-Induced Decrements in Ca2+ Buffering in Primary …
  404. Direct Evaluation of Alzheimer’s Disease-Specific oxidative stress with Multiphoton Microscopy
  405. Discovery development of drugs for alzheimers disease neuroinflammation and elucidating their molecular mechanism of action
  406. Discovery of Gut Bacteria Specific to Alzheimer’s Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on …
  407. Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult: A Drug Discovery Effort against Alzheimer’s Disease
  408. Disease contraindication drug use behavior in patients with Parkinson’s disease
  409. Disruption of Calcium Homeostasis in Alzheimer’s Disease: Role of Channel Formation by β Amyloid Protein
  410. Dissecting molecular mechanisms in the living brain of dementia patients
  411. Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1–42)
  412. Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations
  413. Docking of GSK-3β with novel inhibitors, a target protein involved in Alzheimer’s disease
  414. Docking study and structure-activity relationships of human glutaminyl cyclase inhibitors for the drug discovery of Alzheimer’s disease
  415. Does Parkinson’s disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?
  416. Dopamine-Mediated oxidative stress Associated with Neurodegeneration in Parkinson Disease
  417. Dopaminergic Neuroprotection with Atremorine in Parkinson´ s Disease
  418. Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells
  419. Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells
  420. Dracocephalum moldavica L. and Melissa officinalis L.: Chemistry and bioactivities relevant in Alzheimer’s disease therapy
  421. Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades
  422. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease
  423. Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease
  424. Dual/multitargeted xanthone derivatives for Alzheimer’s disease: where do we stand?
  425. DYRK1A inhibition as potential treatment for Alzheimer’s disease
  426. Dysregulation of stress systems and nitric oxide signaling underlies neuronal dysfunction in Alzheimer’s disease
  427. Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer’s disease
  428. Eat to Beat Alzheimer’s
  429. EFEITO PROTETOR DO RESVERATROL NA DOENÇA DE ALZHEIMER
  430. Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection
  431. Effect of Black Raisins (Vitis vinifera) on Aluminum Chloride Induced Alzheimer’s Disease in Male Albino Rat.
  432. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer’s disease in rats
  433. Effect of Chinese herbal medicine on Alzheimer’s disease
  434. Effect of dietary supplementation of dates in Alzheimer’s disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status
  435. Effect of extraction procedures, genotypes and screening methods to measure the antioxidant potential and phenolic content of orange-fleshed sweetpotatoes …
  436. Effect of Imperatorin in Neuropathology of Parkinson’s Disease: An In Silico Study
  437. Effect of oil palm phenolics on beta amyloid deposition in cholesterol induced rat model of Alzheimer’s disease: Histological evidence
  438. Effect of phenolic-rich plant materials on protein and lipid oxidation reactions
  439. Effect of plant extracts on Alzheimer’s disease: An insight into therapeutic avenues
  440. Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia
  441. Effect of polyphenols on protein misfolding
  442. Effects and mechanisms of actions of phytochemicals on Alzheimer’s disease neuropathology
  443. Effects and Possible Mechanisms of Some Phytochemicals on Drosophila Models of Alzheimer’s Disease
  444. Effects of berry polyphenols on cognitive function in humans
  445. Effects of Berry, Pomegranate, Grape and their Biophenols on Cognitive Function: A General Re-view
  446. Effects of biflavonoids from Garcinia madruno on a triple transgenic mouse model of Alzheimer’s disease
  447. Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia
  448. Effects of Dietary Components on Microglia Inactivation in Alzheimer’s Disease
  449. Effects of dietary docosahexaenoic acid supplementation on pathology and cognition in a mouse model of Alzheimer’s disease
  450. Effects of essential oils and aromatherapy on cognitive function in dementia: laboratory studies and application in aged care facility residents
  451. Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia
  452. Effects of flavonoids on MMP-13 Expression of IL-1β-treated Articular Chondrocytes and Their Cellular Mechanisms: Inhibition of c-Fos/AP-1 and JAK/STAT …
  453. Effects of green tea polyphenol on cognitive and acetylcholinesterase activities
  454. Effects of Horticultural Activities and Flower Tea Drinking Based on Reminiscent Storytelling on Demented Elders’ Cognitive and Emotional Functions
  455. Effects of huanglian-jie-du-tang and its modified formula on the modulation of amyloid-β precursor protein processing in Alzheimer’s disease models
  456. Effects of Isoflavone Extract from Fermented Soybean, Chungkukjang, on Cell Cycle Arrest and Apoptosis of MCF-7 Cells
  457. Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats
  458. Effects of medicinal plants on Alzheimer’s disease and memory deficits
  459. Effects of peptides on the structure of lipid bilayers: Implication for its therapeutic effect in Alzheimer’s disease
  460. Effects of polyphenols on brain ageing and Alzheimer’s disease: focus on mitochondria
  461. Effects of resveratrol and other polyphenols on Sirt1: relevance to brain function during aging
  462. Effects of resveratrol and other polyphenols on the most common brain age-related diseases
  463. Effects of stilbenoid polyphenols (pterostilbene and gnetol) on cardiomyocyte hypertrophy in vitro and in vivo in spontaneously hypertensive heart failure rats
  464. Effects of tea catechins on Alzheimer’s disease: Recent updates and perspectives
  465. Effects of the flavonoids, silibinin and catechin, on the motility of extended cooled caprine sperm
  466. Effects of various flavonoids on the-synuclein fibrillation process
  467. Effects on Cognition of Berry, Pomegranate, Grape and Biophenols: A General Review
  468. EFFICACY STUDY OF BRAHMYADI YOGA IN THE MANAGEMENT OF Alzheimer’s DISEASE (SMRITI BHRAMSHA)
  469. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer’s disease
  470. Electroanalysis of α-Synuclein Aggregation Related to Parkinson’s Disease
  471. Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson’s disease–A review
  472. Emerging role of polyphenolic compounds in the treatment of Neurodegenerative diseases: a review of their intracellular targets
  473. Emerging Signal Regulating Potential of Genistein against Alzheimer Disease: A Promising Molecule of Interest
  474. Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer’s disease
  475. Enhancing human cognition with cocoa flavonoids
  476. Enrichment of phenolic antioxidants from cranberry (Vaccinium macrocarpon) to improve biological functionality
  477. Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: a potential agent for Parkinson’s disease
  478. Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent …
  479. Epigallocatechin-3-gallate, a promising molecule for Parkinson’s disease?
  480. Epigenetic drug discovery for Alzheimer’s disease
  481. Epigenetic effects of natural polyphenols: A focus on SIRT1‐mediated mechanisms
  482. ESPEN guidelines on nutrition in dementia
  483. Establishing a Connection between Alzheimer’s Disease and Cellular Energy Transduction
  484. Establishment of CD method for studies of amyloid-oligomerization process during Alzheimer disease
  485. Estimation of antioxidative properties of the natural polyphenols in the oxidation process of model liposome membranes
  486. Estimation of dietary flavonoid intake and major food sources of Korean adults
  487. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: key role of neuron-glia crosstalk
  488. Ethanol extract of Epipremnum aureum leaves attenuate intranigral-rotenone induced Parkinson’s disease in rats
  489. Ethnobotanical treatment strategies against Alzheimer’s disease
  490. Ethnomedicinal Survey of Plants Used as Remedy for Alzheimer’s Disease in Ebonyi State, Nigeria
  491. Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs
  492. Eupatilin: a natural pharmacologically active flavone compound with its wide range applications
  493. Evaluating the neuroprotective effects of fermented rooibos herbal tea in Wistar rats exposed to bisphenol-A during gestation and lactation
  494. Evaluation of anti-oxidant activities and total phenolic content of Chromolaena odorata
  495. Evaluation of antioxidant activities and total phenolic content of methanolic extract of Rhodiola heterodanta roots
  496. evaluation of antiparkinson activity of hesperetin pyridoxine against olanzepine and manganese induced parkinsonism
  497. Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease
  498. Evaluation of Memory Enhancing Activity of Methanolic Extract of Oxalis corniculata Linn on dementia in Experimental Animals
  499. Evaluation of plant phenolic metabolites as a source of Alzheimer’s drug leads
  500. Evaluation of the neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays
  501. Evaluation to the antioxidant activity of total flavonoids extract from persimmon (Diospyros kaki L.) leaves
  502. Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism
  503. Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows
  504. Evolutionary medicine’perspectives on Alzheimer’s Disease: Review and new directions
  505. Exploration of Mitochondrial Dysfunction, Depolarization and Polyphenols by Creative Synthesis for Product Development
  506. Exploring the benefits of cellular models to uncover bioactive polyphenols for neurodegeneration
  507. Exploring the bioavailability of (poly) phenols from berries and their potential activities in humans
  508. Exploring the efficacy of natural products in alleviating Alzheimer’s disease
  509. Exploring the mechanism of flavonoids through systematic bioinformatics analysis
  510. Exploring the potential of marine microbes in clinical management of Alzheimer’s disease: A road map for bioprospecting and identifying promising isolates
  511. Extra-virgin olive oil for potential prevention of Alzheimer disease
  512. Extra-virgin olive oil for potential prevention of Alzheimer disease
  513. Factors affecting the levels of tea polyphenols and caffeine in tea leaves
  514. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination?
  515. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer’s disease
  516. Ferulic Acid and Alzheimer’s Disease: Promises and Pitfalls
  517. Fight Alzheimer’s with Vitamins and Antioxidants
  518. Fight Parkinson’s and Huntington’s with Vitamins and Antioxidants
  519. First synthesis of the antiangiogenic homoisoflavanone, cremastranone
  520. Flavan-3-ol compounds from wine wastes with in vitro and in vivo antioxidant activity
  521. Flavanols, mild cognitive impairment, and Alzheimer’s dementia
  522. Flavanonol glucosides from the aerial parts of Agrimonia pilosa Ledeb. and their acetylcholinesterase inhibitory effects
  523. Flavins and flavoproteins: applications in medicine
  524. Flavone: An Important Scaffold for Medicinal Chemistry
  525. Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration?
  526. Flavones from the root of Scutellaria baicalensis Georgi—drug of the future in neurodegeneration and neuroprotection
  527. Flavones: An important scaffold for medicinal chemistry
  528. flavonoid baicalein attenuates activation-induced cell death of brain microglia
  529. flavonoid bioactivity: transport across blood-brain-barrier and neuroprotective effects. In vivo studies
  530. flavonoid enhances the glyoxalase pathway in cerebellar neurons to retain cellular functions
  531. flavonoid hesperidin induces synapse formation and improves memory performance through the astrocytic TGF-β1
  532. flavonoid in enhancing memory function
  533. flavonoid inhibitors of alpha-synuclein fibrillation: A therapeutic strategy for Parkinson’s disease, and, The effect of membranes on SMA fibrillation
  534. flavonoid Intake and Dementia
  535. flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries
  536. flavonoid modulation of GABAA receptors
  537. flavonoid transport across blood-brain barrier: Implication for their direct neuroprotective actions
  538. flavonoid transport across RBE4 cells: a blood-brain barrier model
  539. flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia
  540. Flavonoid-based therapies in the early management of Neurodegenerative diseases
  541. Flavonoid-rich foods (FRF): A promising nutraceutical approach against lifespan-shortening diseases
  542. Flavonoidal Compound Derived from Chrysanthemum indicum L. Suppresses MUC5AC Mucin Gene Expression, Production and Secretion from Cultured …
  543. Flavonoids
  544. flavonoids and Aging
  545. flavonoids and anthranquinones as xanthine oxidase and monoamine oxidase inhibitors: a new approach towards inflammation and oxidative stress
  546. flavonoids and brain health: multiple effects underpinned by common mechanisms
  547. flavonoids and cognition: potential therapeutic role in Alzheimer’s disease
  548. flavonoids and cognition: the molecular mechanisms underlying their behavioural effects
  549. flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies
  550. flavonoids and dementia: an update
  551. flavonoids and Diarylheptanoids: neuroprotective Activities of Phytochemicals
  552. flavonoids and neuroprotection: biochemical and population-based analyses of potential neuroprotective factors related to dementia.
  553. flavonoids and Phenolic Acids as Potential Natural Antioxidants
  554. flavonoids and the aging brain
  555. flavonoids and the brain: Evidences and putative mechanisms for a protective capacity
  556. flavonoids and their relation to human health
  557. flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
  558. flavonoids as detoxifying and pro-survival agents: What’s new?
  559. flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects
  560. flavonoids as neuroprotective and therapeutic agents against aging related neurological disorders
  561. flavonoids as novel neuroprotective nutraceuticals
  562. flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders
  563. flavonoids as regulators of amyloid precursor protein processing
  564. flavonoids as therapeutic agents in Alzheimer’s and Parkinson’s diseases: a systematic review of preclinical evidences
  565. flavonoids in Foods and Their Role in Healthy Nutrition
  566. flavonoids in human health: from structure to biological activity
  567. flavonoids in neurodegeneration: Limitations and strategies to cross CNS barriers
  568. flavonoids in the treatment of Alzheimer’s and other Neurodegenerative diseases
  569. flavonoids in Transgenic Alzheimer’s Disease Mouse Models
  570. flavonoids in Transgenic Alzheimer’s Disease Mouse Models
  571. flavonoids inhibit heparin-induced aggregation of the third repeat (r3) of microtubule-binding domain of Alzheimer’s tau protein
  572. flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in …
  573. flavonoids with Novel Nicotinic Activity as Potential Pharmacotherapies to Treat Ethanol-Induced Neurotoxicity
  574. Flavonoids-food sources and health benefits
  575. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease
  576. Flavonoids: an overview
  577. Flavonoids: Broad Spectrum Agents on Chronic Inflammation
  578. Flavonoids: important biocompounds in food
  579. Flavonoids: its working mechanism and various protective roles
  580. Flavonoids: modulators of brain function?
  581. Flavonol Glycosides and Phenolic Compounds from Euphorbia maculata
  582. Flavonol-rich dark cocoa significantly decreases plasma endothelin-1 and improves cognition in urban children
  583. Food antioxidants and Alzheimer’s disease
  584. Food, polyphenols and neuroprotection
  585. Forestalling the Epidemics of Parkinson’s Disease Through Plant-Based Remedies
  586. Formation of the 42-mer Amyloid 𝜷 Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer’s Disease
  587. Formulation development and optimization of novel drug delivery systems for the treatment of alzheimers disease
  588. Free radical scavenging activity and qualitative analysis of polyphenols by RP-HPLC in the flowers of Couroupita guianensis Abul.
  589. Free radical–mediated damage to brain in Alzheimer’s disease: role of acrolein and preclinical promise of antioxidant polyphenols
  590. Free radicals and polyphenols: The redox chemistry of Neurodegenerative diseases
  591. From the baker to the bedside: yeast models of Parkinson’s disease
  592. Fruit and vegetable intake and its association with dementia in the English Longitudinal Study of Ageing
  593. Fruit polyphenols and their effects on neuronal signaling and behavior in senescence
  594. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer’s disease
  595. Functions of flavonoids in the central nervous system: astrocytes as targets for natural compounds
  596. Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the oxidative stress Hypothesis
  597. Gallotannins and Tannic Acid: First Chemical Syntheses and In Vitro Inhibitory Activity on Alzheimer’s Amyloid β‐Peptide Aggregation
  598. Gene-environment interaction research and transgenic mouse models of Alzheimer’s disease
  599. GENERAL PRACTITIONER’S APPROACH TO DIAGNOSIS, DISCLOSURE AND MANAGEMENT OF dementia IN THE
  600. Genetics of iron regulation and the possible role of iron in Parkinson’s disease
  601. Genistein ameliorates learning and memory deficits in amyloid β (1–40) rat model of Alzheimer’s disease
  602. Ginger components as anti-Alzheimer drugs: focus on drug design
  603. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo‐controlled double‐blind study
  604. Ginkgo biloba as an alternative medicine in the treatment of anxiety in dementia and other psychiatric disorders
  605. Ginkgo biloba extract in Alzheimer’s disease: from action mechanisms to medical practice
  606. Gold Nanoparticles and Peptoids as Novel Inhibitors of Amyloid Beta Aggregation in Alzheimer’s Disease
  607. Gold nanoparticles and peptoids as novel inhibitors of Aβ aggregation in Alzheimer’s disease
  608. Gold Nanoparticles in Diagnosis and Treatment of Alzheimer’s Disease
  609. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer’s disease
  610. Green Tea confers Protection on the Retina in MPTP Mice Model of Parkinson’s Disease
  611. Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: A systematic review
  612. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth
  613. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration
  614. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate promotes the rapid protein kinase C‐and proteasome‐mediated degradation of Bad: implications for …
  615. Green tea polyphenols enhance sodium nitroprusside‐induced neurotoxicity in human neuroblastoma SH‐SY5Y cells
  616. Green tea polyphenols prevent Parkinson’s disease: in vitro and in vivo studies
  617. GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson’s Disease: A Mini Review
  618. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer’s disease.
  619. Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review
  620. Health benefits of nongallated and gallated flavan-3-ols: a prospectus
  621. Health effects of foods rich in polyphenols
  622. Healthy Eating to Reduce the Risk of Dementia
  623. Hepatoprotective effects of apple polyphenol extract on aluminum-induced liver oxidative stress in the rat
  624. Herbal treatment of Parkinsonism: a review
  625. Herbs and dementia: a focus on Chinese and other traditional herbs
  626. Herbs and Nutrients for Neurologic Disorders: Treatment Strategies for Alzheimer’s, Parkinson’s, Stroke, Multiple Sclerosis, Migraine, and Seizures
  627. Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling
  628. Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and …
  629. Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity
  630. High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults
  631. Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents
  632. Hippocampal neurogenesis in Alzheimer’s disease: is there a role for dietary modulation?
  633. Histological Evidence Of The Effect Of Oil Palm Phenolics In Atherogenic Diet Induced Rat Model Of Alzheimer’s Disease
  634. HPLC-DAD fingerprinting analysis, antioxidant activities of Tithonia diversifolia (Hemsl.) A. Gray leaves and its inhibition of key enzymes linked to Alzheimer’s …
  635. HPLC-PDA isolation and LC-MS/MS detection of an acetylcholinesterase inhibitory flavonoid from Tephrosia purpurea (L.) Pers. in zebrafish brain
  636. Human Tau Isoform Aggregation and Selective Detection of Misfolded Tau from Post-Mortem Alzheimer’s Disease Brains
  637. Hypericum perforatum improve memory and learning in Alzheimer’s model:(experimental study in mice)
  638. Hypericum perforatum phenolic compounds: protective role in the toxicity induced by heterologous expression of α-synuclein and huntingtin in yeast cells
  639. Hyperphosphorylation of Tau Protein in Down’s dementia and Alzheimer’s disease: methylation and implications in prevention and therapy
  640. Identification of 5-methoxyflavone as a novel DNA polymerase-beta inhibitor and neuroprotective agent against beta-amyloid toxicity
  641. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer’s disease
  642. Identification of polyphenolic compounds and black tea extract as potent inhibitors of lipid membrane destabilization by Aβ 42 aggregates
  643. IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients
  644. Il trattamento con RSV e l’espressione transgenica di PGC-1α proteggono i neuroni dopaminergici nel modello MPTP murino del morbo di Parkinson.
  645. Immuno-modulatory effects of microbial metabolites of flavan-3-ols and dimeric procyanidins
  646. Impact of Diet on the Pathogenesis of Alzheimer’s Disease
  647. Impact of flavonoids on cellular and molecular mechanisms underlying age-related cognitive decline and neurodegeneration
  648. Impact of heat treatment on selected vegetables: bioaccessibility of (poly) phenolic compounds after in vitro gastrointestinal digestion and colonic microbiota …
  649. Impact of plant-derived flavonoids on Neurodegenerative diseases
  650. Implication of green tea as a possible therapeutic approach for Parkinson disease
  651. Implications for Degenerative Disorders: Antioxidative Activity, Total Phenols, Flavonoids, Ascorbic Acid, β-Carotene and β-Tocopherol in Aloe vera
  652. Implications of polyphenols on endogenous antioxidant defense systems in human diseases
  653. Improved mitochondrial function in brain aging and Alzheimer disease-the new mechanism of action of the old metabolic enhancer piracetam
  654. In search of therapeutic solutions for Alzheimer’s disease
  655. In silico investigation of the pharmacological mechanisms of beneficial effects of Ginkgo biloba L. on Alzheimer’s Disease
  656. In silico studies applied to natural products with potential activity against Alzheimer’s disease
  657. In vitro anti-nitrosative, antioxidant, and cytotoxicity activities of plant flavonoids: a comparative study
  658. In vitro antioxidant activity and total phenolic content of ethanolic leaf extract of Stevia rebaudiana Bert.
  659. In vitro antioxidant, anti-diabetes, anti-dementia, and inflammation inhibitory effect of Trametes pubescens fruiting body extracts
  660. In vitro enzyme inhibition potentials and antioxidant activity of synthetic flavone derivatives
  661. In vitro evaluation of extracts from Mentha species for potential treatment of Alzheimer’s disease
  662. In vitro peroxynitrite scavenging activity of 6-hydroxykynurenic acid and other flavonoids fromGingko biloba yellow leaves
  663. In vivo antioxidant activity of total flavonoids from indocalamus leaves in aging mice caused by D-galactose
  664. In Vivo Characterization of CLR01, an Aggregation and Toxicity Inhibitor, with anAlzheimer’s Disease Focus
  665. In Vivo Imaging Agents Based on flavonoids for Amyloid’s Plaques in the Brains of Patients with Alzheimer’s Disease
  666. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial
  667. In-depth investigation of the binding of flavonoid taxifolin with bovine hemoglobin at physiological pH: Spectroscopic and molecular docking studies
  668. In-Vitro Assessment Of Phenolic, Flavonoid, Flavonolic Contents And Antioxidant Activities Of Plant Pleurotus Ostreatus For Neurodegenerative Disorders
  669. In-vitro cholinesterase inhibitory activity of dry fruit extract of Phyllanthus emblica relevant to the treatment of Alzheimer’s disease
  670. In-vitro evaluation of acetylcholinesterase inhibition and antioxidant activity of selected Palestinian medicinal plants: Implications for Alzheimer’s disease …
  671. In-Vitro Evaluation of Cholinesterase Inhibitory and Antioxidant Activities of Tamarindus indica for the Treatment of Alzheimer’s Disease
  672. In-vitro screening of acetylcholinesterase inhibitory activity of extracts from Palestinian indigenous flora in relation to the treatment of Alzheimer’s disease
  673. In‐vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer’s disease
  674. Indian Herbal Medicines used for Treatment of Dementia: An Overview
  675. Indian herbs and their therapeutic potential against Alzheimer’s Disease and other neurological disorders
  676. Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer’s disease hippocampus
  677. Induction of neuronal differentiation of murine N2a cells by two polyphenols present in the mediterranean diet mimicking neurotrophins activities: resveratrol and …
  678. Inflammaging as a prodrome to Alzheimer’s disease
  679. Inflammation in Alzheimer’s Disease, and Prevention with Antioxidants and Phenolic Compounds–What Are the Most Promising Candidates?
  680. Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications
  681. Inflammation: role in Parkinson’s disease and target for therapy
  682. Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons: possible relevance to the etiology of Parkinson’s disease
  683. INFLUENCE OF EXTRACT AND PHENOL GLYCOSIDES FROM ROSE PETALS ON THE FIBRILS OF AMYLOID PEPTIDE Aβ (1-42). STUDY BY …
  684. Influence of hesperidin combined with Sinemet on genetical and biochemical abnormalities in rats suffering from Parkinson’s disease
  685. Influence of nitrogen fertilizer micro‐dosing on phenolic content, antioxidant, and anticholinesterase properties of aqueous extracts of three tropical leafy vegetables
  686. Influences of Diet, Exercise, and Stress on Hippocampal Health in Depression and Alzheimer’s Disease
  687. inhibition and antioxidant activity of selected Palestinian medicinal plants: Implications for Alzheimer’s disease therapy
  688. Inhibition and disaggregation of α‐synuclein oligomers by natural polyphenolic compounds
  689. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism
  690. Inhibition of early upstream events in prodromal Alzheimer’s disease by use of targeted antioxidants
  691. Inhibition of Hepatic Insulin Resistance by Licorice flavonoids as Mediated by PTP1B Repression
  692. Inhibition of Rat Prostate Testosterone 5α-Reductase Activity by Isoflavonoids
  693. Inhibition of α-Synuclein contributes to the ameliorative effects of dietary flavonoids luteolin on arsenite-induced apoptotic cell death in the dopaminergic PC12 cells
  694. Inhibitory Effect of a flavonoid Dihydromyricetin against Aβ40 Amyloidogenesis and Its Associated Cytotoxicity
  695. Inhibitory Effects of Bombusae concretio Salicea on Neuronal Secretion of Alzheimer’s β-Amyloid Peptides, a Neurodegenerative Peptide
  696. Inhibitory Effects of Isoflavonoids on Rat Prostate Testosterone 5α-Reductase
  697. Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids
  698. Inhibitory potential of plant secondary metabolites against Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural …
  699. Inhibitory properties of phenolic compounds against enzymes linked with human diseases
  700. Insights on Metal Ions and Misfolded Proteins in Alzheimer’s Disease Using flavonoid Derivatives and X-ray Fluorescence Microscopy.
  701. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance
  702. Intake of flavonoids and risk of dementia
  703. Intake of flavonoids and risk of dementia
  704. Interaction between 24‐hydroxycholesterol, oxidative stress, and amyloid‐β in amplifying neuronal damage in Alzheimer’s disease: three partners in crime
  705. Interaction between flavonoids and the blood–brain barrier: in vitro studies
  706. Interaction of polyphenols with other food components as a means for their neurological health benefits
  707. Interaction of α-synuclein with Rhus typhina tannin–Implication for Parkinson’s disease
  708. Interplay between Alpha-Synuclein and oxidative stress in Parkinson´ s Disease Cell Models
  709. Intranasal therapeutic strategies for management of Alzheimer’s disease
  710. Investigating blood plasma levels of cytokines and amyloid-β as potential diagnostic biomarkers for preclinical Alzheimer’s disease
  711. Investigating the neuroprotective effect of plant (poly) phenols in models of Parkinson´ s disease
  712. Investigation of an Interaction of flavonoids on the Antioxidant Activity of Alpha Tocopherol
  713. Investigation of anti-inflammatory compounds from food and plant libraries for use in Alzheimer’s disease
  714. Investigation of in-vitro antioxidant potential in crotalaria verrucosa along with identification and quantification of its polyphenolic compounds
  715. Investigational α-synuclein aggregation inhibitors: hope for Parkinson’s disease
  716. Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon …
  717. Involvement of astrocytes in Alzheimer’s disease from a neuroinflammatory and oxidative stress perspective
  718. Iridoid Glycosides and Phenolic Glycosides from Buddleja asiatica with Anti-inflammatory and Cytoprotective Activities
  719. Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects
  720. Iron as a therapeutic target for Parkinson’s disease
  721. Iron dysregulation in Alzheimer’s disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein …
  722. Is pharmacological prevention of Alzheimer’s a realistic goal?
  723. Isoflavones and Alzheimer’s disease: the effects of soy in diet
  724. Isolation of eupatorin (3′,5-dihydroxy-4′,6,7-trimethoxyflavone) from Albizia odoratissima and its application for l-tryptophan sensing
  725. Isolation of flavonoides from Artemisia macrocephala anticholinesterase activity: Isolation, characterization and its in vitro anticholinesterse activity supported by …
  726. Isolation, synthesis, and metabolism of polyphenols: Stilbenoids, gallotannins and ellagitannins
  727. Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia
  728. Lamiaceae family plants as a potential anticholinesterase source in the treatment of Alzheimer’s disease
  729. Lamiaceae phenols as multifaceted compounds: bioactivity, industrial prospects and role of “positive-stress”
  730. Lavandula stoechas (L) a Very Potent Antioxidant Attenuates dementia in Scopolamine Induced Memory Deficit Mice
  731. Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer’s disease treatment
  732. Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer’s disease
  733. Lifestyle patterns as a modifiable risk factor for late-life cognitive decline: A narrative review regarding dementia prevention
  734. Lifestyle-related factors in predementia and dementia syndromes
  735. Links between insulin resistance, lipoprotein metabolism and amyloidosis in Alzheimer’s Disease
  736. Lipid Peroxidation and Mitochondrial Dysfunction in Alzheimer’s and Parkinson’s Diseases: Role of Natural Products as Cytoprotective Agents
  737. Liposomal flavonoid in Combating Age-Related Cerebral Oxidative Damage
  738. Literature Evidence and ARRIVE Assessment on neuroprotective Effects of Flavonols in Neurodegenerative Diseases’ Models
  739. Literature Evidence and Arrive Assessment on neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models
  740. Literature-related discovery: common factors for Parkinson’s disease and Crohn’s disease
  741. Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease
  742. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer’s disease
  743. Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer’s disease
  744. Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE−/− Mice Experimental Model
  745. Low-Molecular Weight Metabolites from Polyphenols as Effectors for Attenuating Neuroinflammation
  746. Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease
  747. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia
  748. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent
  749. Management of cognitive determinants in senile dementia of Alzheimer’s type: therapeutic potential of a novel polyherbal drug product
  750. Management of oxidative stress and other pathologies in Alzheimer’s disease
  751. Mangiferin: a multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models
  752. Mannosylated liposomal flavonoid in combating age-related ischemia–reperfusion induced oxidative damage in rat brain
  753. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide
  754. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
  755. Mechanisms of aging and potential role of selected polyphenols in extending healthspan
  756. Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation
  757. Mechanisms of neuroprotection by polyphenols
  758. Mechanistic description of natural herbs in the treatment of dementia: A systematic review
  759. Medical management of Parkinson’s disease: focus on neuroprotection
  760. Medicinal chemistry approaches for the treatment and prevention of Alzheimer’s disease
  761. Medicinal plants and Alzheimer’s disease: Integrating ethnobotanical and contemporary scientific evidence
  762. Medicinal plants and dementia therapy: herbal hopes for brain aging?
  763. Medicinal plants as protective strategies against Parkinson’s disease
  764. Medicinal plants from northeastern Brazil against Alzheimer’s disease
  765. Medicinal Plants from Northeastern Brazil against Alzheimer’s Disease
  766. Medicinal plants of Brazil and Alzheimer’s disease: Evolution in traditional use and pre-clinical studies
  767. Medicinal Plants with Acetylcholinesterase Inhibitory Activity: Therapeutic Potential of Brazilian Plants for the Treatment of Alzheimer’s Disease
  768. Medicinal Plants, Phytochemicals and Alzheimer’s
  769. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and …
  770. Mediterranean and MIND diets containing olive biophenols reduces the prevalence of Alzheimer’s disease
  771. Mediterranean diet and risk for Alzheimer’s disease
  772. Mediterranean Diet as a Potential Strategy to Reduce Cognitive Decline and dementia in Elderly
  773. Mediterranean diet in predementia and dementia syndromes
  774. Mediterranean diet, cognitive function, and dementia: a systematic review
  775. Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins …
  776. Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease
  777. Metabolic and immune risk factors for dementia and their modification by flavonoids: New targets for the prevention of cognitive impairment?
  778. Metabolic links between diabetes and Alzheimer’s disease
  779. Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
  780. Metabolomics analysis of Xanthoceras sorbifolia husks protection of rats against Alzheimer’s disease using liquid chromatography mass spectrometry
  781. Metal Binding of flavonoids and Their Distinct Inhibition Mechanisms Toward the Oxidation Activity of Cu2+–β-Amyloid: Not Just Serving as Suicide Antioxidants!
  782. Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or …
  783. Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer’s disease
  784. Metal dyshomeostasis and inflammation in Alzheimer’s and Parkinson’s diseases: possible impact of environmental exposures
  785. Metal dysregulation in the pathogenesis of Alzheimers disease An experimental study in rat brain and cultured neuroblastoma cells
  786. Metal ions and metal complexes in Alzheimer’s disease
  787. Metals and amyloid‐β in Alzheimer’s disease
  788. Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease
  789. Methylglyoxal, glyoxal, and their detoxification in Alzheimer’s disease
  790. MICE MODEL OF Parkinson’s DISEASE
  791. Microwave assisted extraction of flavonoids from cultivated Epimedium sagittatum: Extraction yield and mechanism, antioxidant activity and chemical composition
  792. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study
  793. MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer’s disease prevention pilot trial
  794. Mitigating Alzheimer’s disease with natural polyphenols: a review
  795. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer’s disease
  796. Mitochondria as potential targets in Alzheimer disease therapy: An update
  797. Mitochondria as targets for neuronal protection against excitotoxicity: a role for phenolic compounds?
  798. Mitochondria in neuroprotection by phytochemicals: bioactive polyphenols modulate mitochondrial apoptosis system, function and structure
  799. Mitochondria-targeted protective compounds in Parkinson’s and Alzheimer’s diseases
  800. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease
  801. Mitochondrial cascade hypothesis of Alzheimer’s disease: myth or reality?
  802. Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
  803. Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and neuroprotection
  804. Mitochondrial dysfunction—a pharmacological target in Alzheimer’s disease
  805. Mitochondrial dysfunction: cause and consequence of Alzheimer’s
  806. Mitochondrial dysfunction: cause and consequence of Alzheimer’s disease
  807. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer’s disease—therapeutic aspects
  808. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer’s disease?
  809. Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
  810. Mitochondrial Therapeutic Approaches in Parkinson’s Disease
  811. Moderate consumption of Cabernet Sauvignon attenuates Aβ neuropathology in a mouse model of Alzheimer’s disease
  812. Modulating Effect of Diet on Alzheimer’s Disease
  813. Modulation of Alzheimer-like Pathology in Type 2 Diabetic Rats via Grape Seed or Ginseng Extracts
  814. Modulation of endogenous antioxidant system by wine polyphenols in human disease
  815. Modulation of mitochondrial calcium as a pharmacological target for Alzheimer’s disease
  816. Modulation of multiple neuroinflammatory signalling pathways by the dietary glycosidic flavonoid tiliroside
  817. MODULATION OF NEUROINFLAMMATION BY MEDICINAL HERBS AND FLAVONOIDS
  818. Modulation of Nrf2 by olive oil and wine polyphenols and neuroprotection
  819. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and Neurodegenerative disorders
  820. Modulation of Pro-inflammatory Mediators by Eugenol in AlCl3 Induced dementia in Rats
  821. Molecular characterization of multi-targets by bis (7)-tacrineat amyloid β cascade associated with Alzheimer’s disease
  822. Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1–42 Dimer
  823. Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols
  824. Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer’s disease
  825. Molecular mechanisms underlying the flavonoid-induced inhibition of α-synuclein fibrillation
  826. Molecular pathology and pharmacogenomics in Alzheimer’s disease: polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression
  827. Molecular pharmacology of rosmarinic and salvianolic acids: Potential seeds for Alzheimer’s and vascular dementia drugs
  828. Molecular study of cell culture models of Parkinson’s disease and Huntington’s disease.
  829. Molecular targets in Alzheimer’s disease: from pathogenesis to therapeutics
  830. Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy
  831. Monoamine Oxidase B and Free Radical Scavenging Activities of Natural flavonoids in Melastoma candidum D. Don
  832. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
  833. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
  834. Mucuna pruriens seeds in treatment of Parkinson’s disease: pharmacological review
  835. Mulberry fruit extract protects against memory impairment and hippocampal damage in animal model of vascular dementia
  836. Multi-target directed drugs as a modern approach for drug design towards Alzheimer’s disease: an update
  837. Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer’s disease
  838. Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer’s disease
  839. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer’s disease
  840. Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer’s disease drugs
  841. Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease
  842. Multiple pharmacological activities of Caesalpinia crista against aluminium-induced neurodegeneration in rats: Relevance for Alzheimer’s disease
  843. Multipotent natural agents to combat Alzheimer’s disease. Functional spectrum and structural features1
  844. Na+‐K+‐ATPase, a potent neuroprotective modulator against Alzheimer disease
  845. Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for Neurodegenerative diseases and brain tumors
  846. Nano-encapsulation of a natural polyphenol, green tea catechins: way to preserve its antioxidative potential
  847. Nanoformulations of polyphenols for prevention and treatment of cardiovascular and metabolic disorders
  848. Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease
  849. Nanoparticle formulations in the diagnosis and therapy of Alzheimer’s disease
  850. Nanoparticles as nanocarriers of resveratrol for Alzheimer’s disease
  851. Nanotechnology and Alzheimer’s Disease: What has been Done and What to Do’
  852. Nanotechnology based Theranostic approaches in Alzheimer’s disease management: current status and future perspective
  853. Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
  854. Nanotherapeutic strategies for the treatment of Alzheimer’s disease
  855. Nardostacys Jatamansi DC Protects from the loss of memory and cognition deficits in sleep deprived Alzheimer’s disease (Ad) mice model
  856. Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin …
  857. Naringin ameliorates memory deficits in experimental paradigm of Alzheimer’s disease by attenuating mitochondrial dysfunction
  858. Natural Antioxidants in Dementia: An Overview
  859. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer’s disease–a translational perspective
  860. Natural compounds and their derivatives as multifunctional agents for the treatment of alzheimer disease
  861. Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
  862. Natural compounds for Alzheimer’s disease therapy: a systematic review of preclinical and clinical studies
  863. Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder
  864. Natural Neuroprotectives for the Management of Parkinson’s Disease
  865. Natural phenolic compounds as therapeutic and preventive agents for cerebral amyloidosis
  866. Natural phytochemicals in the treatment and prevention of dementia: An overview
  867. Natural Phytoestrogens: A Class of Promising neuroprotective Agents for Parkinson Disease
  868. Natural plant-derived acetylcholinesterase inhibitors: Relevance for Alzheimer’s disease
  869. Natural polyphenols against Neurodegenerative disorders: potentials and pitfalls
  870. Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases
  871. Natural polyphenols effects on protein aggregates in Alzheimer’s and Parkinson’s prion-like diseases
  872. Natural polyphenols in the treatment of Alzheimer’s disease
  873. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
  874. Natural Product Chemical Probe Discovery against Parkinson’s Disease
  875. Natural product formulations for the prevention and treatment of Alzheimer’s disease: a patent review
  876. Natural product polyphenols of relevance to human health
  877. Natural products against Alzheimer’s disease: Pharmaco-therapeutics and biotechnological interventions
  878. Natural products and derivatives affecting neurotransmission relevant to Alzheimer’s and Parkinson’s disease
  879. Natural products and their derivatives as multifunctional ligands against Alzheimer’s disease
  880. Natural products as a source of Alzheimer’s drug leads
  881. Natural products as promising drug candidates for the treatment of Alzheimer’s disease: molecular mechanism aspect
  882. Natural products combating neurodegeneration: Parkinson’s disease
  883. Natural Products for the Treatment of Alzheimer’s Disease: Present and Future Expectations
  884. Natural Products for Treatment of Alzheimer’s Disease
  885. Natural products in Alzheimer’s disease therapy: would old therapeutic approaches fix the broken promise of modern medicines?
  886. Natural Products-Based Drugs: Potential Therapeutics against Alzheimer’s Disease and other Neurological Disorders
  887. Natural stilbenes effects in animal models of Alzheimer’s disease
  888. Natural Therapeutics for Alzheimer’s Disease
  889. Naturally Inspired Privileged Structures in Drug Discovery: Multifunctional Compounds for Alzheimer’s Disease Treatment
  890. Nature as a source of metabolites with cholinesterase‐inhibitory activity: an approach to Alzheimer’s disease treatment
  891. neuro Protective Role of Selected medicinal Plant In Alzheimers Disease Design of Novel Drugs
  892. Neuro-nutrients as anti-Alzheimer’s disease agents: A critical review
  893. Neurobiological aspects of Alzheimer’s disease
  894. Neurobiological effects of Hyperforin and its potential in Alzheimer’s disease therapy
  895. Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits
  896. Neurocognitive improvement through plant food bioactives: A particular approach to Alzheimer’s disease
  897. Neurodegenerative diseases: might citrus flavonoids play a protective role?
  898. Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin
  899. Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer’s disease
  900. Neurogenic traditional Chinese medicine as a promising strategy for the treatment of Alzheimer’s disease
  901. Neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals
  902. Neuroinflammatory mechanisms in Parkinson’s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention
  903. Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects?
  904. Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases
  905. Neuronal death in Alzheimer’s disease and therapeutic opportunities
  906. Neuronutrition and Alzheimer’s disease
  907. Neuropharmacological Activity of Apium graveolens L. and its neuroprotective Effect on MPTP-Induced Parkinson-Like Symptoms
  908. Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—a mini-review
  909. Neuroprotection by natural polyphenols: molecular mechanisms
  910. Neuroprotection in Alzheimer Disease
  911. Neuroprotection of brain-targeted bioactive dietary artoindonesianin O (AIO) from mulberry on rat neurons as a novel intervention for Alzheimer’s disease
  912. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway
  913. neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features
  914. neuroprotective actions of flavonoids
  915. neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice
  916. neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson’s disease therapeutics
  917. neuroprotective effect and antioxidant activity of Passiflora edulis fruit flavonoid fraction, aqueous extract, and juice in aluminum chloride-induced Alzheimer’s …
  918. neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion
  919. neuroprotective effect of brassica oleracea sprouts crude juice in a cellular model of Alzheimer’s disease
  920. neuroprotective effect of cocoa flavonids on in vitro oxidative stress
  921. neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson’s disease
  922. neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: possible behavioural and …
  923. neuroprotective effect of flavonoids via up-regulation of Nrf2-ARE pathway, in MPP+-induced PC12 cells
  924. neuroprotective Effect of Flavonoids: A Systematic Review
  925. neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson’s disease
  926. neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer’s …
  927. neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats
  928. neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis
  929. neuroprotective effect of natural products against Alzheimer’s disease
  930. neuroprotective effect of olive oil polyphenols in Alzheimer’s disease
  931. neuroprotective effect of phytic acid in Parkinson’s disease
  932. neuroprotective effects associated with wine and its phenolic constituents
  933. neuroprotective effects of amantadine–flavonoid conjugates
  934. neuroprotective effects of citrus Fruit-Derived flavonoids, nobiletin and Tangeretin in Alzheimer’s and Parkinson’s Disease
  935. neuroprotective effects of digested polyphenols from wild blackberry species
  936. neuroprotective effects of epigallocatechin gallate in cell culture and animal models of Parkinson’s disease
  937. neuroprotective effects of fisetin in Alzheimer’s and Parkinson’s Diseases: From chemistry to medicine
  938. neuroprotective effects of naturally occurring polyphenols on quinolinic acid‐induced excitotoxicity in human neurons
  939. neuroprotective effects of phenolic and carboxylic acids on oxidative stress-induced toxicity in human neuroblastoma SH-SY5Y cells
  940. neuroprotective Effects of Polyphenols
  941. neuroprotective Effects of Polyphenols in Aging and Age‐Related Neurological Disorders
  942. neuroprotective Effects of Quercetin in Alzheimer’s Disease
  943. neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma
  944. neuroprotective effects of resveratrol in Alzheimer disease pathology
  945. neuroprotective effects of rutin and quercetin flavonoids in glaucium corniculatum methanol and water extracts
  946. neuroprotective effects of selected microbial-derived phenolic metabolites and aroma compounds from wine in human sh-sy5y neuroblastoma cells and their …
  947. neuroprotective mechanisms of resveratrol in Alzheimer’s disease: role of SIRT1
  948. neuroprotective natural products for the treatment of Parkinson’s disease by targeting the autophagy–lysosome pathway: A systematic review
  949. neuroprotective potential of withania somnifera in rotenone induced parkinsonism in mice
  950. neuroprotective properties of a standardized extract from Myracrodruon urundeuva Fr. All.(Aroeira-Do-Sertao), as evaluated by a Parkinson’s disease model in rats
  951. neuroprotective properties of dietary polyphenols in Parkinson’s disease
  952. neuroprotective Properties of Partridgeberry (Vaccinium vitis-idaea L. var. minus Lodd) Polyphenols
  953. neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease
  954. neuroprotective role of antioxidant and pyranocarboxylic acid derivative against AlCl3 induced Alzheimer’s disease in rats
  955. neuroprotective Role of Green Tea Polyphenols on the Superior Colliculus in MPTP Mice Model of Parkinson’s Disease
  956. neuroprotective role of natural polyphenols
  957. neuroprotective strategies in Parkinson’s disease
  958. neuroprotective Strategies in Parkinson’s Disease Using the Models of 6‐Hydroxydopamine and MPTPa
  959. neuroprotective Strategies in Parkinson’s Disease Using the Models of 6‐Hydroxydopamine and MPTPa
  960. neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism
  961. neuroprotective therapies for Alzheimer’s disease
  962. Neurosupportive role of vanillin, a natural phenolic compound, on rotenone induced neurotoxicity in SH-SY5Y neuroblastoma cells
  963. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
  964. New acetylcholinesterase inhibitors for Alzheimer’s disease
  965. New methodology for the biomimetic synthesis of Flavan-3, 4-diols and derivatives
  966. NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols
  967. Nitric oxide mediates neurovascular coupling in the brain effect of polyphenols in animal models of Alzheimer’s disease
  968. Nonpeptide neurotrophic agents useful in the treatment of Neurodegenerative diseases such as Alzheimer’s disease
  969. Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions
  970. Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease
  971. Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology
  972. Nootropic Medicinal Plants: Therapeutic Alternatives for Alzheimer’s disease
  973. Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer’s disease treatment
  974. Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer’s therapy
  975. Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease
  976. Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson’s Disease
  977. Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties
  978. Novel neuroprotective Therapies for Alzheimer’s and Parkinsons’s Disease
  979. Novel photoaffinity probes of homoisoflavonoids for target identification of retinal neovascularization
  980. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease
  981. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity
  982. Novel tacrine-scutellarin hybrids as multipotent anti-Alzheimer’s agents: Design, synthesis and biological evaluation
  983. Novel tactics for neuroprotection in Parkinson’s disease: role of antibiotics, polyphenols and neuropeptides
  984. Novel targets for parkinsonism-depression comorbidity
  985. Novel therapeutic strategies for dementia
  986. Novel Therapeutics in Alzheimer’s Disease
  987. Nutraceutical potential of phenolics from′ brava′ and′ mansa′ extra-virgin olive oils on the inhibition of enzymes associated to Neurodegenerative disorders in …
  988. Nutraceutical Potential of Phenolics fromBrava´ andMansa´ Extra-Virgin Olive Oils on the Inhibition of Enzymes Associated to Neurodegenerative Disorders in …
  989. Nutraceuticals and amyloid Neurodegenerative diseases: a focus on natural phenols
  990. Nutraceuticals and their preventive or potential therapeutic value in Parkinson’s disease
  991. Nutraceuticals in cognitive impairment and Alzheimer’s
  992. Nutraceuticals in cognitive impairment and Alzheimer’s disease
  993. Nutraceuticals in the Prevention or Treatment of Parkinson’s Disease
  994. Nutraceuticals Neuroprotect Naturally: Alzheimer’s disease, Parkinson’s disease, Stroke and Major Depressive Disorder
  995. Nutraceuticals: a novel concept in prevention and treatment of Alzheimer’s disease and related disorders
  996. Nutraceuticals: an emerging therapeutic approach against the pathogenesis of Alzheimer’s disease
  997. Nutraceuticals: dietary flavonoids
  998. Nutrients in the Prevention of Alzheimer’s Disease
  999. Nutrition and AGE-ing: Focusing on Alzheimer’s Disease
  1000. Nutrition and the risk for Parkinson’s disease: review of the literature
  1001. Nutrition and the risk of Alzheimer’s disease
  1002. Nutrition increases Survival and Reverses NAFLD and Alzheimer’s disease
  1003. Nutrition Society Silver Medal Lecture Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain
  1004. Nutrition: Review on the possible treatment for Alzheimer’s disease
  1005. Nutritional and pharmacological strategies to regulate microglial polarization in cognitive aging and Alzheimer’s disease
  1006. Nutritional approaches to combat oxidative stress in Alzheimer’s disease
  1007. Nutritional approaches to modulate oxidative stress in Alzheimer’s disease
  1008. Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients
  1009. Nutritional habits, risk, and progression of Parkinson disease
  1010. Nutritional prevention of cognitive decline and dementia
  1011. O-Methylated flavonoid Isorhamnetin Protects against oxidative stress via Activation of Nrf2 and Target Gene Expression
  1012. Oil palm phenolics inhibit the in vitro aggregation of β-amyloid peptide into oligomeric complexes
  1013. Old age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa
  1014. Olive biophenols reduces Alzheimer’s pathology in SH-SY5Y cells and APPswe mice
  1015. Olive polyphenols: New promising agents to combat aging-associated neurodegeneration
  1016. Omics and Epigenetics of Polyphenol-Mediated Neuroprotection: The Curcumin Perspective
  1017. On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer’s disease
  1018. ON THE THERAPEUTIC PROPERTIES OF NATURALLY OCCURRING FLAVONOID-QUERCETIN: A MAGICAL THERAPEUTIC AGENT
  1019. One‐compound‐multiple‐targets strategy to combat Alzheimer’s disease
  1020. Original Research Phenolics, antioxidant and anti-inflammatory activities of Melia azedarachextracts
  1021. Orobol: An Isoflavone Exhibiting Regulatory Multifunctionality against Four Pathological Features of Alzheimer’s Disease
  1022. Orthosiphon stamineus improves memory in scopolamine-induced amnesia model of cholinergic hypothesis of Alzheimer’s disease
  1023. Outsmarting Alzheimer’s: What You Can Do to Reduce Your Risk
  1024. Overview of Alzheimer’s disease and some therapeutic approaches targeting Aβ by using several synthetic and herbal compounds
  1025. Overviews of biological importance of quercetin: A bioactive flavonoid
  1026. Oxidant/antioxidant imbalance and the risk of Alzheimer’s disease
  1027. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8‐hydroxyguanine levels in substantia nigra
  1028. Oxidative modification of vesicular transporters in an animal model of Alzheimer’s disease
  1029. oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents
  1030. oxidative stress and amyloid beta toxicity in Alzheimer’s disease: intervention in a complex relationship by antioxidants
  1031. oxidative stress and inflammation: what polyphenols can do for us?
  1032. oxidative stress and neuroinflammation in Alzheimer’s disease and amyotrophic lateral sclerosis: From biology to therapeutic strategies
  1033. oxidative stress events and neuronal dysfunction in Alzheimer’s disease: focus on APE1/Ref-1-mediated survival strategies
  1034. oxidative stress in Alzheimer patients in different stages of the disease
  1035. oxidative stress in Alzheimer’s Disease: A Review on Emergent Natural Polyphenolic Therapeutics
  1036. oxidative stress in Alzheimer’s disease: implications for prevention and therapy
  1037. oxidative stress in Parkinson’s disease
  1038. oxidative stress in Parkinson’s disease
  1039. oxidative stress in Parkinson’s disease; parallels between current animal models, human studies and cells
  1040. Oxidative stress: a bridge between Down’s syndrome and Alzheimer’s disease
  1041. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease
  1042. Parkinson’s disease and tea: a quantitative review
  1043. Parkinson’s Disease Model in vitro and in C. elegans
  1044. Parkinson’s Disease-associated LRRK2 Mutation Causes Abnormal Protein Accumulation-related Cytotoxicity
  1045. Parkinson’s disease: from pathogenesis to pharmacogenomics
  1046. Parkinson’s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation
  1047. Partridgeberry polyphenols protect primary cortical and hippocampal neurons against β-amyloid toxicity
  1048. Past and Present Drug Development for Alzheimer’s Disease
  1049. Pelargonidin improves memory deficit in amyloid β25-35 rat model of Alzheimer’s disease by inhibition of glial activation, cholinesterase, and oxidative stress
  1050. Pelargonidin improves passive avoidance task performance in a rat amyloid beta25-35 model of Alzheimer’s disease via estrogen receptor independent pathways
  1051. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer’s disease
  1052. Pharmacoepigenomic interventions as novel potential treatments for Alzheimer’s and Parkinson’s diseases
  1053. Pharmacogenomics in Alzheimer’s disease
  1054. Pharmacogenomics of Alzheimer’s disease: Novel therapeutic strategies for drug development
  1055. Pharmacokinetics and Tissue Distribution of 14C-Labeled Grape Polyphenols in the Periphery and the Central Nervous System Following Oral Administration
  1056. PHARMACOLOGICAL ACTIVITY OF NATURAL PRODUCTS IN VITRO AND IN ANIMAL MODELS OF Parkinson’s DISEASE AND DEPRESSION
  1057. Pharmacological effects of active components of Chinese herbal medicine in the treatment of Alzheimer’s disease: a review
  1058. PHARMACOLOGICAL EVALUATION OF TRIPHALA CHURNA INSTREPTOZOTOCIN (ICV) INDUCED dementia IN RATS
  1059. Pharmacological Investigation and Unraveling Mechanism of Action ofJasminum sambac Flowers for Predicated Treatment of Alzheimer’s Disease
  1060. Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson’s disease
  1061. Pharmacological properties and therapeutic potential of naringenin: a citrus flavonoid of pharmaceutical promise
  1062. PHARMACOLOGY OF OLIVE BIOPHENOLS IN Alzheimer’s DISEASE PREVENTION AND TREATMENT
  1063. Pharmacophore-based drug design of novel potential tau ligands for Alzheimer’s disease treatment
  1064. Pharmacotherapies for Alzheimer’s disease: beyond cholinesterase inhibitors
  1065. Pharmacotherapies for Alzheimer’s Disease: From Natural Compounds to Target Synthetic Drugs
  1066. Phenolic Acid Intake, Delivered Via Moderate Champagne Wine Consumption, Improves Spatial Working Memory Via the Modulation of Hippocampal and Cortical …
  1067. Phenolic acids exert anticholinesterase and cognition-improving effects
  1068. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity
  1069. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
  1070. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
  1071. Phenolic composition, antioxidant and enzyme inhibitory activities of acetone, methanol and water extracts of Clinopodium vulgare L. subsp. vulgare L.
  1072. Phenolic compounds and their health benefits: A review
  1073. Phenolic compounds characteristic of the mediterranean diet in mitigating microglia-mediated neuroinflammation
  1074. Phenolic compounds from edible algae: Bioactivity and health benefits
  1075. Phenolic Compounds from the Leaves and Stems of Desmodium Caudatum
  1076. Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic diseases
  1077. Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic diseases
  1078. Phenolic compounds of green tea: Health benefits and technological application in food
  1079. Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-β aggregation pathway
  1080. Phenolic compounds prevent the oligomerization of α‐synuclein and reduce synaptic toxicity
  1081. Phenolic Compounds with IL-6 Inhibitory Activity from Akebia quinata
  1082. Phenolic content of grapevine leaves (Vitis labrusca var. Bordo) and its neuroprotective effect against peroxide damage
  1083. Phenolic content, enzyme inhibitory and antioxidative activity potentials of Phlomis nissolii and P. pungens var. pungens
  1084. Phenolic contents and bioactive potential of peach fruit extracts
  1085. Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L
  1086. Phenolic Extracts from Clerodendrum volubile Leaves Inhibit Cholinergic and Monoaminergic Enzymes Relevant to the Management of Some Neurodegenerative …
  1087. Phenolic profile and antioxidative properties of pulp and seeds of Randia monantha Benth
  1088. Phenolic profile of three wild edible mushroom extracts from Ordu, Turkey and their antioxidant properties, enzyme inhibitory activities
  1089. Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of Iris germanica var; florentina
  1090. Phenylpropanoids and Alzheimer’s disease: A potential therapeutic platform
  1091. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson’s disease in mice
  1092. Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease
  1093. Phosphorylation and sequence dependency of neurofilament protein oxidative modification in Alzheimer disease
  1094. Phyto‐Tacrine Hybrids as Promising Drugs to Treat Alzheimer’s Disease
  1095. Phytochemical and pharmacological properties of flavonols
  1096. Phytochemical Evaluation of Lagerstroemia indica (L.) Pers. Leaves as Anti-Alzheimer’s
  1097. Phytochemicals and cognitive health: Are flavonoids doing the trick?
  1098. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
  1099. Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
  1100. Phytochemicals, Antioxidants, and Cholinesterase Inhibitory Profiles of Elatostema Papillosum Leaves: An Alternative Approach for Management of Alzheimer’s …
  1101. Pinus halepensis essential oil attenuates the toxic Alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus
  1102. PLANT BASED INDIAN TRADITIONAL MEDICINE FOR Neurodegenerative DISEASES-A NOVEL APPROACH TO TREAT ALZHEIMER
  1103. Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson’s Disease Models
  1104. Plant phenolics affect oxidation of tryptophan
  1105. Plant phenolics as functional food ingredients
  1106. Plant polyphenols as dietary antioxidants in human health and disease
  1107. Plant polyphenols as dietary modulators of brain functions
  1108. Plant polyphenols as natural drugs for the management of Down syndrome and related disorders
  1109. Plants as potential sources for drug development against Alzheimer’s disease
  1110. Plants traditionally used in age-related brain disorders (dementia): an ethanopharmacological survey
  1111. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders
  1112. Plasma antioxidant status in patients with Alzheimer’s disease and cognitively intact elderly: a meta-analysis of case-control studies
  1113. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson’s disease
  1114. Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease
  1115. Polymethoxyflavones: Novel β-secretase (BACE1) inhibitors from citrus peels
  1116. polyphenol amentoflavone affords neuroprotection against neonatal hypoxic‐ischemic brain damage via multiple mechanisms
  1117. polyphenol antioxidants from natural sources and contribution to health promotion
  1118. polyphenol composition, antioxidant and bioplaguicide activities of the solid residue from hydrodistillation of Rosmarinus officinalis L.
  1119. polyphenol compounds and PKC signaling
  1120. polyphenol health effects on cardiovascular and Neurodegenerative disorders: A review and meta-analysis
  1121. polyphenol modulation of blood flow and oxygenation
  1122. polyphenol Pharmacokinetics and Cardiovascular, Cognitive and Exercise Pharmacodynamics following Montmorency Tart Cherry Intake in Humans
  1123. polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases
  1124. Polyphenol-enriched cocoa protects the diabetic retina from glial reaction through the sirtuin pathway
  1125. Polyphenol-rich Boswellia serrata gum prevents cognitive impairment and insulin resistance of diabetic rats through inhibition of GSK3β activity, oxidative …
  1126. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk
  1127. Polyphenolic antioxidants and neuronal regeneration
  1128. Polyphenolic Compound from Vitis vinifera L. have Potential for the Alzheimer Disease Treatment
  1129. Polyphenolic compounds for treating Neurodegenerative disorders involving protein misfolding
  1130. Polyphenols and brain health
  1131. Polyphenols and cognitive function
  1132. Polyphenols and health: new and recent advances
  1133. Polyphenols and human health: a review
  1134. Polyphenols and human health: prevention of disease and mechanisms of action
  1135. Polyphenols and inflammation
  1136. Polyphenols and Metabolites Enhance Survival in Rodents and Nematodes—Impact of Mitochondria
  1137. Polyphenols and Neurodegenerative diseases
  1138. Polyphenols and Neurodegenerative Diseases
  1139. Polyphenols and neuroprotection against ischemia and neurodegeneration
  1140. Polyphenols and public health
  1141. Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits
  1142. Polyphenols as acetylcholinesterase inhibitors: structural specificity and impact on human disease
  1143. Polyphenols As Natural, Dual-Action Therapeutics For Alzheimer’s Disease
  1144. Polyphenols beyond barriers: a glimpse into the brain
  1145. Polyphenols derived from lychee seed suppress Aβ (1-42)-induced neuroinflammation
  1146. Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective
  1147. Polyphenols from Food and Natural Products: Neuroprotection and Safety
  1148. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative
  1149. Polyphenols in dementia: From molecular basis to clinical trials
  1150. Polyphenols in disease: from diet to supplements
  1151. Polyphenols in health and disease: practice and mechanisms of benefits
  1152. Polyphenols in neurodegeneration and neuroendocrine alterations: a metabolomic approach
  1153. Polyphenols in Parkinson’s disease: A systematic review of in vivo studies
  1154. Polyphenols in the Prevention of Alzheimer’s Disease: some food for thought?
  1155. Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
  1156. Polyphenols neuroprotective effect in a Parkinson’s disease yeast model: phosphoproteome alterations
  1157. Polyphenols suppress and modulate inflammation: possible roles in health and disease
  1158. Polyphenols Targeting Brain Cells Longevity, Brain’s Redox Status, and Neurodegenerative Diseases
  1159. Polyphenols-What’s Behind their Antiaging Brain Reputation
  1160. Polyphenols: a diverse class of multi-target anti-HIV-1 agents
  1161. Polyphenols: Food sources and health benefits
  1162. Polyphenols: multipotent therapeutic agents in Neurodegenerative diseases
  1163. Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!
  1164. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease
  1165. Pomegranate’s neuroprotective effects against Alzheimer’s disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites
  1166. Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols
  1167. Possible role of common spices as a preventive and therapeutic agent for Alzheimer’s disease
  1168. Possible therapeutic role of grape (Vitis vinifera) leaves polyphenolic extract in the regression of aluminium-induced Alzheimer’s disease in rats
  1169. Possible Therapeutic Uses of Salvia triloba and Piper nigrum in Alzheimer’s Disease–Induced Rats
  1170. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer’s disease
  1171. Potent Inhibitory Effect of flavonoids in Scutellaria baicalensis on Amyloid β Protein-Induced Neurotoxicity
  1172. Potential application of dietary polyphenols from red wine to attaining healthy ageing
  1173. Potential beneficial effects of a diet with walnuts in aging and Alzheimer’s disease
  1174. Potential complementarity of high-flavanol cocoa powder and spirulina for health protection
  1175. Potential for brain accessibility and analysis of stability of selected flavonoids in relation to neuroprotection in vitro
  1176. Potential health benefits of tea polyphenols—a review
  1177. Potential of medicinal plant compounds to targeting Tau protein in the therapy of Alzheimer’s disease–A review
  1178. Potential of South African medicinal plants targeting the reduction of Aβ42 protein as a treatment of Alzheimer’s disease
  1179. Potential protection of green tea polyphenols against 1800 MHz electromagnetic radiation-induced injury on rat cortical neurons
  1180. Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease
  1181. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
  1182. Potential role of olive oil phenolic compounds in the prevention of Neurodegenerative diseases
  1183. Potential Role of Vitamin C in the Prevention of Alzheimer’s Disease
  1184. Potential therapeutic strategies for Alzheimer’s disease targeting or beyond β-amyloid: insights from clinical trials
  1185. Potential therapeutic strategies to prevent the progression of alzheimer to disease states
  1186. Precautionary Ellagic Acid Treatment Ameliorates Chronically Administered Scopolamine Induced Alzheimer’s Type Memory and Cognitive Dysfunctions in …
  1187. Preclinical and potential applications of common western herbal supplements as complementary treatment in Parkinson’s disease
  1188. Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer’s disease
  1189. Prediction of Anti‐Alzheimer’s Activity of flavonoids Targeting Acetylcholinesterase in silico
  1190. Prenylated flavonoids from the Roots of Sophora flavescens Promote Vascular Relaxation via Endothelium-Dependent Mechansims
  1191. Pretreatment with natural flavones and neuronal cell survival after oxidative stress: a structure− activity relationship study
  1192. Prevention and reversal of Alzheimer’s disease: treatment protocol
  1193. Prevention and treatment of Alzheimer disease and aging: antioxidants
  1194. Prevention of Dementia
  1195. Prevention of oxidative injury by flavonoids from stems and leaves of Scutellaria Baicalensis georgi in PC12 cells
  1196. Preventive and Therapeutic Effects of Traditional Medicines on Diabetic Complications: Sophora flavescens, Pueraria lobata, Coptis chinensis, Cirsium …
  1197. Preventive effect of small-leaved kuding tea (Ligustrum robustum (Roxb.) Bl.) polyphenols on D-galactose-induced oxidative stress and aging in mice
  1198. PREVENTIVE EFFECTS OF GREEN TEA CATECHINS ON DEMENTIA
  1199. Primary Prevention of Alzheimer’s Disease (AD)
  1200. Processing of the β‐amyloid precursor protein and its regulation in Alzheimer’s disease
  1201. Profiling of in vitro neurobiological effects and phenolic acids of selected endemic Salvia species
  1202. Progress in drug development for Alzheimer’s disease: an overview in relation to mitochondrial energy metabolism
  1203. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset.
  1204. Proposed Mechanism of Alzheimer’s Disease: the Role of oxidative stress A Review of Scientific Literature
  1205. Prospective associations between single foods, Alzheimer’s dementia and memory decline in the elderly
  1206. Protection of Okadaic Acid-induced Tau Hyperphosphorylation by Bioflavonoids in Neuroblastoma Cells
  1207. Protective effect of a (poly) phenol-rich extract derived from sweet cherries culls against oxidative cell damage
  1208. Protective effect of a phenolic‐rich fraction from Schisandra chinensis against H2O2‐induced apoptosis in SH‐SY5Y cells
  1209. Protective effect of black tea extract against aluminium chloride-induced Alzheimer’s disease in rats: A behavioural, biochemical and molecular approach
  1210. Protective effect of daidzein against streptozotocin‐induced Alzheimer’s disease via improving cognitive dysfunction and oxidative stress in rat model
  1211. Protective effect of ginger (Zingiber officinale) on Alzheimer’s disease induced in rats
  1212. Protective Effect of Green Tea Extract on Neuronal Cell Death in Alzheimer Model using -amyloid Peptide
  1213. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils
  1214. Protective effect of iris germanica l. In β-amyloid-induced animal model of Alzheimer’s disease
  1215. Protective effect of isoflavones from Trifolium pratense on dopaminergic neurons
  1216. Protective effect of kaempferol on the transgenic Drosophila model of Alzheimer’s disease
  1217. Protective effect of mulberry crude extract against nonylphenol-induced thyroid disruption by inhibiting the activity of deiodinase in rats
  1218. Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats
  1219. Protective effect of Picrorhiza kurroa on Alzheimer’s disease induced by aluminium chloride in rats
  1220. Protective effect of raisin (currant) against spatial memory impairment and oxidative stress in Alzheimer disease model
  1221. Protective effect of rutin, a polyphenolic flavonoid against haloperidol‐induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical …
  1222. Protective effect of standardized extract of Passiflora incarnata flower in Parkinson’s and Alzheimer’s disease
  1223. Protective Effect of the Leaves of Solanum torvums wartz on Drosophila melanogaster against β-Amyloid Induced Alzheimer Disease
  1224. Protective effects of berry polyphenols against age-related cognitive impairment
  1225. Protective effects of dietary polyphenols in human diseases and mechanisms of action
  1226. Protective effects of fisetin and other berry flavonoids in Parkinson’s disease
  1227. Protective effects of flavonoid baicalein against menadione-induced damage in SK-N-MC cells
  1228. Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions
  1229. Protective effects of foods containing flavonoids on age-related cognitive decline
  1230. Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer’s disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta-secretases …
  1231. Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s disease
  1232. Protective effects of Portulaca oleracea against rotenone mediated depletion of glutathione in the striatum of rats as an animal model of Parkinson’s disease
  1233. Protective effects of water extract of propolis on dopaminergic neurons, brain derived neurotrophic factor and stress oxidative factors in the rat model of Parkinson’s …
  1234. Protective role of caffeic acid in an Aβ25-35-induced Alzheimer’s disease model
  1235. Protein drug targets of lavandula angustifolia on treatment of rat Alzheimer’s disease
  1236. Protein folding and aggregation into amyloid: the interference by natural phenolic compounds
  1237. Proteomics in traditional Chinese medicine with an emphasis on Alzheimer’s disease
  1238. Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease
  1239. Quercetin enrich diet during the early-middle not middle-late stage of Alzheimer’s disease ameliorates cognitive dysfunction
  1240. Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer’s disease
  1241. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution
  1242. Rational approach to discover multipotent anti-Alzheimer drugs
  1243. Rational Design, Preparation, and Analysis of Chemical Reagents for Investigating Multiple Pathological Factors in Alzheimer’s Disease
  1244. Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson’s disease
  1245. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
  1246. Recent advances from metabolomics and lipidomics application in Alzheimer’s disease inspiring drug discovery
  1247. Recent advances in health promoting effect of dietary polyphenols
  1248. Recent advances in herbal medicines treating Parkinson’s disease
  1249. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)
  1250. Recent Advances in Nanoencapsulation Systems Using PLGA of Bioactive Phenolics for Protection against Chronic Diseases
  1251. Recent advances in the antioxidant therapies for Alzheimer’s disease: Emphasis on natural antioxidants
  1252. Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy
  1253. Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer’s?
  1254. Recent advances in the genetics of Parkinson’s disease
  1255. Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer’s disease
  1256. Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer’s Disease
  1257. Recent findings in Alzheimer disease and nutrition focusing on epigenetics
  1258. Recent Plant Based Remedies for Alzheimer’s Disease, Parkinson’s Disease and Cerebral Ischemic Stroke
  1259. Recent progress in multifunctional metal chelators as potential drugs for Alzheimer’s disease
  1260. Recent Studies on Mechanisms of New Drug Candidates for Alzheimer’s Disease Interacting with Amyloid-β Protofibrils Using Molecular Dynamics Simulations
  1261. Recent trends in drug discovery against Alzheimer’s disease: use of natural products and nutraceuticals from botanicals
  1262. Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson’s disease
  1263. Recent updates on the association between Alzheimer’s disease and vascular dementia
  1264. Recent Updates on the Association Between Alzheimer’s Disease and Vascular Dementia
  1265. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers
  1266. Recovery of new diarylheptanoid sources in Betulaceae: Characterisation of the phenolic profile of Corylus species by HPLC-ESI-MS methods
  1267. Recycling acetate for improving flavanones production from Escherichia coli
  1268. Red grape juice and Alzheimer’s disease
  1269. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of …
  1270. Red wine retards Abeta deposition and neuroinflammation in Alzheimer’s disease
  1271. Red wine, resveratrol, and Alzheimer’s disease
  1272. Redox chemistry of green tea polyphenols: therapeutic benefits in Neurodegenerative diseases
  1273. Reduction is the New Youth: The Effect of Polyphenols on Brain Aging and Diseases
  1274. Regulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration
  1275. Relationship between Wine Consumption and Alzheimer’s Disease
  1276. Relationship of Wine Consumption with Alzheimer’s Disease
  1277. Relationships of dietary patterns, foods, and micro-and macronutrients with Alzheimer’s disease and late-life cognitive disorders: a systematic review
  1278. Research Article Improvement of Learning and Memory by Morin, A flavonoid in Young and Aged Mice
  1279. Research of polyphenols with neuroprotective potential in a yeast model of degeneration
  1280. Restoration of stressor-induced calcium dysregulation and autophagy inhibition by polyphenol-rich açaí (Euterpe spp.) fruit pulp extracts in rodent brain cells in vitro
  1281. Resveratrol and Grape’s Extract-Loaded Solid Lipid Nanoparticles for the Treatment of Parkinson’s and Alzheimer’s Diseases
  1282. Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer’s disease
  1283. Resveratrol—a boon for treating Alzheimer’s disease?
  1284. Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia
  1285. Reverse Alzheimer’s Disease Naturally: Alternative Treatments for dementia including Alzheimer’s Disease
  1286. Review of natural products on Parkinson’s disease pathology
  1287. Review of Traditional and Natural Methods of Treating Alzheimer’s Disease
  1288. REVIEW ON CURRENT TREATMENT STRATEGY IN Alzheimer’s DISEASE AND ROLE OF HERBS IN TREATING NEUROLOGICAL DISORDERS
  1289. Review on potential phytocompounds in drug development for Parkinson disease: a pharmacoinformatic approach
  1290. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
  1291. Rhodiola rosea L. and Alzheimer’s Disease: From Farm to Pharmacy
  1292. Rhodiola rosea L.-An evaluation of safety and efficacy in the context of a neurological disorder, Alzheimer Disease
  1293. Role of Acetylcholinesterase Inhibitors and Alzheimer Disease
  1294. Role of alpha-synuclein primary structure and oxidative stressin Parkinson’s disease pathology
  1295. Role of amyloid-β–metal interactions in Alzheimer’s disease
  1296. Role of flavonoids in Neurodegenerative Disorders with Special Emphasis on Tangeritin
  1297. Role of flavonoids in oxidative stress
  1298. ROLE OF HESPERETIN & PYRIDOXINE PROTECT IN THE NIGROSTRIATAL DOPAMINERGIC PROJECTION IN A NEUROTOXIN MODEL OF PARKINSON’S
  1299. Role of intestinal microbiota in the generation of polyphenol‐derived phenolic acid mediated attenuation of Alzheimer’s disease β‐amyloid oligomerization
  1300. Role of medicinal plants against Alzheimer’s disease
  1301. Role of medicinal plants in Neurodegenerative diseases with special emphasis to alzheimer’s
  1302. Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer’s disease
  1303. Role of Nutraceuticals in Alzheimer’s disease
  1304. Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy
  1305. Role of plant polyphenols in Alzheimer’s disease
  1306. Role of plant-derived flavonoids and their mechanism in attenuation of Alzheimer’s and Parkinson’s diseases: An update of recent data
  1307. Role of polyphenols in cell death control
  1308. Role of Polyphenols in the prevention of neurodegeneration
  1309. Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer’s and Parkinson’s diseases
  1310. Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a …
  1311. Role of the APP non-amyloidogenic signaling pathway and targeting α-secretase as an alternative drug target for treatment of Alzheimer’s disease
  1312. Role of the Microbiome in polyphenol Metabolite-Mediated Attenuation of β-amyloid and tau Protein Misfolding in Alzheimer’s Disease
  1313. Roles of AMP-activated protein kinase in Alzheimer’s disease
  1314. Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion
  1315. Roundoc Rx: Neurodegenerative Disease: Part 2—Top Herbs and Supplements for Addressing Alzheimer’s and Parkinson’s Disease
  1316. Rutin as a natural therapy for Alzheimer’s disease: Insights into its mechanisms of action
  1317. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson’s disease
  1318. Screening and evaluation of natural compounds for therapeutic application in Alzheimer’s disease
  1319. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer’s disease and in other Neurodegenerative diseases
  1320. Secretase inhibitors for the treatment of Alzheimer’s disease: Long road ahead
  1321. Secretory phospholipase A2-IIA in Alzheimer’s disease and inflammatory responses in astrocytes
  1322. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
  1323. Separations with Raman Spectroscopy for Identification of Oxidatively Modified Components in Parkinson’s Disease
  1324. Serum concentrations of vitamin E and carotenoids are altered in Alzheimer’s disease: A case-control study
  1325. Several targets involved in Alzheimer’s disease amyloidogenesis are affected by morin and isoquercitrin
  1326. Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
  1327. Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function
  1328. Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function
  1329. Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664
  1330. Signaling pathway cross talk in Alzheimer’s disease
  1331. Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
  1332. Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer’s disease mouse model
  1333. Silymarin’s inhibition and treatment effects for Alzheimer’s disease
  1334. Simple In Vivo Models of Alzheimer’s Disease
  1335. Simultaneous determination of phenolic compounds in Catharanthus roseus leaves by HPLC method
  1336. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases
  1337. Sir-2.1 mediated attenuation of α-synuclein expression by Alaskan bog blueberry polyphenols in a transgenic model of Caenorhabditis elegans
  1338. Sirtuins as novel targets for Alzheimer’s disease and other Neurodegenerative disorders: experimental and genetic evidence
  1339. Sirtuins in Alzheimer’s disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics
  1340. Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues
  1341. Small molecule natural products and Alzheimer’s disease
  1342. Sophora Tomentosa Extract Prevents MPTP-Induced Parkinsonism in C57BL/6 Mice Via the Inhibition of GSK-3β Phosphorylation and Oxidative Stress
  1343. Spices And Herbs: An Essential Guide To Spice Up Your Health And Flavor Your Diet
  1344. ß-Amyloid and oxidative stress in the Pathogenesis of Alzheimer’s Disease
  1345. Stahl’s Illustrated Alzheimer’s Disease and Other Dementias
  1346. Statistical and Data Mining Methodologies for Behavioral Analysis in Transgenic Mouse Models of Alzheimer’s Disease: Parallels with Human AD Evaluation
  1347. Stem Cell Biology for Therapeutic Development in Parkinson’s Disease
  1348. STEM CELL-BASED THERAPY FOR Alzheimer’s DISEASE
  1349. Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
  1350. Strategies for Multi-target Directed Ligands: Application in Alzheimer’s Disease (AD) Therapeutics
  1351. Structural Analysis of Flavonoid/Drug Target Complexes: Natural Products as Lead Compounds for Drug Development
  1352. Structural Elucidation of Novel Phenolic Glycosides in Cimicifugae Rhizoma by Structure-based Chemical Screening using LC-NMR and LC-UV-MS
  1353. Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
  1354. Structure-activity relationships of flavonoids
  1355. Structure–activity relationships of acetylated flavone glycosides from Galeopsis ladanum L.(Lamiaceae)
  1356. Studies on Amyloid Beta Peptide Aggregation and Its Modulation by Garlic Components: Relevance to Alzheimer’s Disease
  1357. Studies on the Leaves of Punica Granatum Linn. and its Invitro Inhibition of Ache for Potential Use in Alzheimer’s Treatment
  1358. Study of oxidative stress and Alzheimer’s disease in transgenic mice and pharmacological agents to counteract nutritional deficiency
  1359. Study of Possible neuroprotective Effects of Certain Drugs on Experimentally Induced Parkinson’s Disease in Rats
  1360. Study on neuroprotective capacity of key flavonoids of ampelopsis grossedentata
  1361. Sub-critical solvent extraction of flavonoid-rich grape by-products
  1362. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review
  1363. Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na+, K+-ATPase and cholinesterases
  1364. Suppression of presymptomatic oxidative stress and inflammation in neurodegeneration by grape-derived polyphenols
  1365. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity
  1366. Sweet Cherry Phenolic Compounds: Identification, Characterization, and Health Benefits
  1367. Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease
  1368. Synergistic action of melatonin in combination with Anti-Parkinsonian drugs in experimental model of parkinson s disease
  1369. Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson’s disease model
  1370. Synergistic Effect of Selected Hydroxy Cinnamic Acid Derivative (HCA) With Rivastigmine in Dementia
  1371. Synergistic neuroprotective effects of Withania somnifera with specific dietary derived polyphenols
  1372. Synergistic properties of bioavailable phenolic compounds from olive oil: electron transfer and neuroprotective properties
  1373. Synthesis and antioxidant activity of phenolic amides
  1374. Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization
  1375. Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants
  1376. Synthesis and evaluation of neuroprotective selenoflavanones
  1377. Synthesis of Isooctyl Phenol Analogs from Insect-Flower
  1378. Synthesis of phenolic amides and evaluation of their antioxidant and anti-inflammatory activity in vitro and in vivo
  1379. Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson’s disease
  1380. T lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer’s disease: potential pools of new biomarkers
  1381. Target-based selection of flavonoids for Neurodegenerative disorders
  1382. Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
  1383. Targeting dysregulation of brain iron homeostasis in Parkinson’s disease by iron chelators
  1384. Targeting ERK signaling pathway by polyphenols as novel therapeutic strategy for neurodegeneration
  1385. Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines
  1386. Targeting miRNAs by polyphenols: novel therapeutic strategy for aging
  1387. Targeting multiple Alzheimer’s disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
  1388. Targeting NADPH Oxidase and Phospholipases A2 in Alzheimer’s Disease
  1389. Targeting Parkinson’s-tyrosine hydroxylase and oxidative stress as points of interventions
  1390. Targeting the Nrf2/amyloid-beta liaison in Alzheimer’s disease: A rational approach
  1391. Targeting the progression of Parkinson’s disease
  1392. Targeting α-synuclein aggregation for Parkinson’s disease treatment
  1393. Targeting α-Synuclein as a Parkinson’s Disease Therapeutic
  1394. Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches
  1395. Tea and Parkinson’s disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits
  1396. Tea flavonoids and their effect on chronic inflammation induced in Trypanosoma brucei brucei infected mice
  1397. Tea-Derived Polyphenols and Stilbenes on Amyloid Neurotoxicity
  1398. The ability of three African herbal remedies to offer protection against an in vitro model of Parkinson’s disease
  1399. The action of polyphenols in diabetes mellitus and Alzheimer’s disease: A common agent for overlapping pathologies
  1400. The Alzheimer’s Prevention Cookbook: 100 Recipes to Boost Brain Health
  1401. The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization
  1402. The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
  1403. The anti-amyloidogenic effect is exerted against Alzheimer’s β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure
  1404. The Antimicrobial Activity Mechanism of Sophoraflavanone B against Methicillin-Resistant Staphylococcus aureus
  1405. The antioxidant properties of 4–quinolones compared to structurally related flavonoids
  1406. The Association Between Dietary flavonoid Intake and Chronic Obstructive Pulmonary Disease, Systemic Inflammation, and Comorbidity Burden
  1407. The beneficial and deleterious role of dietary polyphenols on chronic degenerative diseases by regulating gene expression
  1408. The beneficial effects of dietary flavonoids: Sources, bioavailability and biological functions
  1409. The beneficial effects of fruit polyphenols on brain aging
  1410. The beneficial role of Naringin-a citrus bioflavonoid, against oxidative stress-induced neurobehavioral disorders and cognitive dysfunction in rodents: A systematic …
  1411. THE BENEFITS OF RESVERATROL WITH POLYPHENOLS IN Parkinson’s DISEASE WITH Alzheimer’s CHANGES
  1412. The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson’s disease
  1413. The cascade of oxidative stress and tau protein autophagic dysfunction in Alzheimer’s disease
  1414. The Change of Neurotransmitters in Plasma of dementia Patients after Aromatherapy.
  1415. The Crocus sativus compounds trans-crocin 4 and trans-crocetin modulate the amyloidogenic pathway and tau misprocessing in Alzheimer disease neuronal cell …
  1416. The development of preventives and therapeutics for Alzheimer’s disease that inhibit the formation of β-amyloid fibrils (fAβ), as well as destabilize preformed fAβ
  1417. The Effect of Essential Oil on Plasma Level of 5-HT in dementia Patients
  1418. The effect of Ginkgo biloba extract on parkinsonisminduced biochemical changes in brain of irradiated rats
  1419. The effect of green tea consumption on oxidative stress markers and cognitive function in patients with Alzheimer’s disease: A prospective intervention study
  1420. The effect of polyphenols on protein degradation pathways: implications for neuroprotection
  1421. The effect of Scutellaria baicalensis stem-leaf flavonoids on spatial learning and memory in chronic cerebral ischemia-induced vascular dementia of rats
  1422. The effects of flavonoid and other polyphenol consumption on cognitive performance: a systematic research review of human experimental and epidemiological …
  1423. The effects of the flavonoid baicalein and osmolytes on the Mg 2+ accelerated aggregation/fibrillation of carboxymethylated bovine 1SS-α-lactalbumin
  1424. The Effects of the Green Tea polyphenol Epigallocatechin Gallate on the Central Nervous, Endocrine, and Innate Immune Systems
  1425. The epidemiology of Parkinson’s disease: risk factors and prevention
  1426. The flavanol (−)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against …
  1427. The flavone luteolin improves central nervous system disorders by different mechanisms: a review
  1428. The flavonoid baicalein promotes NMDA receptor‐dependent long‐term potentiation and enhances memory
  1429. The flavonoid Derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-chromen-4-one Protects Against Aβ42-Induced Neurodegeneration in Transgenic Drosophila: Insights …
  1430. The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model …
  1431. The flavonoids ameliorates: protective mechanisms in Neurodegenerative diseases
  1432. The GC-MS analyses of the n-hexane extract of Nitraria schoberi L., its total phenolics and in vitro antioxidant activity
  1433. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide‐induced toxicity: involvement of its flavonoid constituents and protein …
  1434. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide‐induced toxicity: involvement of its flavonoid constituents and protein …
  1435. The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex
  1436. The gut microbiota links dietary polyphenols with management of psychiatric mood disorders
  1437. The Healthy Mind Cookbook: Big-flavor Recipes to Enhance Brain Function, Mood, Memory, and Mental Clarity
  1438. The immunomodulatory and anti-inflammatory role of polyphenols
  1439. The impact of flavonoids on memory: physiological and molecular considerations
  1440. The impact of fruit flavonoids on memory and cognition
  1441. The impact of gastrointestinal modifications, blood-brain barrier transport, and intracellular metabolism on polyphenol bioavailability: an overview
  1442. The influence of beverage composition on delivery of phenolic compounds from coffee and tea
  1443. The influence of common free radicals and antioxidants on development of Alzheimer’s Disease
  1444. The influence of oxidative stress in Alzheimer’s disease-possible beneficial relevance of the antioxidants from wheatgrass juice. Review Article
  1445. The influence of plant extracts on Ȼ Amyloid induced pathologies in an APP/PS1 mouse model of Alzheimer’s disease
  1446. The interactions of flavonoids within neuronal signalling pathways
  1447. The mechanisms of action of flavonoids in the brain: direct versus indirect effects
  1448. The medicinal chemistry of natural and semisynthetic compounds against Parkinson’s and Huntington’s diseases
  1449. The Mind Diet: A Scientific Approach to Enhancing Brain Function and Helping Prevent Alzheimer’s and Dementia
  1450. The molecular basis of the prevention of Alzheimer’s disease through healthy nutrition
  1451. The molecular basis of working mechanism of natural polyphenolic antioxidants
  1452. The n-Butanol Fraction and Rutin from Tartary Buckwheat Improve Cognition and Memory in an In Vivo Model of Amyloid-β-Induced Alzheimer’s Disease
  1453. The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction
  1454. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
  1455. The neuroprotective potential of flavonoids: a multiplicity of effects
  1456. The neuroprotective potential of phenolic-enriched fractions from four Juniperus species found in Portugal
  1457. The Nrf2/HO-1 Axis as Targets for Flavanones: Neuroprotection by Pinocembrin, Naringenin, and Eriodictyol
  1458. The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease
  1459. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer’s disease
  1460. The oxidative stress hypothesis in Alzheimer’s disease
  1461. The potential of flavonoids for the treatment of Neurodegenerative diseases
  1462. The potential role of dietary polyphenols in Parkinson’s disease
  1463. The prenylflavonoid xanthohumol reduces Alzheimer-like changes and modulates multiple pathogenic molecular pathways in the neuro2a/APPswe cell …
  1464. The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review
  1465. The protective role of plant biophenols in mechanisms of Alzheimer’s disease
  1466. The relevance body mass index on the oxidative stress status of Alzheimer’s disease pathology
  1467. The role of dietary coconut for the prevention and treatment of Alzheimer’s disease: potential mechanisms of action
  1468. The Role of HIV-1 Proteins in Alzheimer’s Disease Pathology
  1469. The role of iron-induced fibrin in the pathogenesis of Alzheimer’s disease and the protective role of magnesium
  1470. The role of lifestyle factors in cognitive aging and dementia
  1471. The role of lipids and membranes in the pathogenesis of Alzheimer’s disease: a comprehensive view
  1472. The role of natural products in Alzheimer’s and Parkinson’s disease
  1473. The role of natural products in the discovery of new drug candidates for the treatment of Neurodegenerative disorders II: Alzheimer’s disease
  1474. The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer’s disease
  1475. The role of nutrition in the prevention and treatment of dementia
  1476. The Role of oxidative stress and Cholesterol in Animal Models of Alzheimer’s Disease
  1477. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation …
  1478. The role of phytochemicals in the treatment and prevention of dementia
  1479. The role of polyphenolic antioxidants in health, disease, and aging
  1480. The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer’s disease
  1481. The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review
  1482. The role of rutin and diosmin, two citrus polyhydroxyflavones in disease prevention and treatment
  1483. The role of the ubiquitin proteasome system in Alzheimer’s disease
  1484. The Safe and Effective Applications of Essential Oils in Alzheimer’s Dementia
  1485. The science of cocoa flavanols: bioavailability, emerging evidence, and proposed mechanisms
  1486. The Simplicity of dementia A Guide for Family and Carers
  1487. The Structural Hybrids of Acetylcholines-terase Inhibitors in the Treatment of Alzheimer’s Disease: A Review
  1488. The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer’s disease
  1489. The Therapeutic Role of Turmeric in Treatment and Prevention of Alzheimer’s Disease
  1490. The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies
  1491. The Treatment of Brain Inflammation in Alzheimer’s Disease. Can Traditional Medicines Help?
  1492. The use of cell-free systems to characterize Parkinson’s disease-related gene products
  1493. The use of flavonoids in central nervous system disorders
  1494. The use of herbal medicine in Alzheimer’s disease—a systematic review
  1495. The Use of herbal supplements on minimizing the clinical manifestations of Alzheimer’s disease
  1496. The Use of Polyphenols for the Treatment of Alzheimer’s Disease
  1497. Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?
  1498. Therapeutic agents in Alzheimer’s disease through a multi-targetdirected ligands strategy: recent progress based on tacrine core
  1499. Therapeutic approaches to Alzheimer’s disease through stimulating of non-amyloidogenic processing of amyloid precursor protein
  1500. Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson’s disease
  1501. Therapeutic effect of modulating TREM-1 via anti-inflammation and autophagy in Parkinson’s disease
  1502. Therapeutic effects of Cyperus rotundus rhizome extract on memory impairment, neurogenesis and mitochondria in beta-amyloid rat model of Alzheimer’s disease
  1503. Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer’s disease
  1504. Therapeutic implications of anti-inflammatory natural products in Alzheimer’s disease
  1505. Therapeutic interventions for the suppression of Alzheimer’s disease: quest for a remedy
  1506. Therapeutic potential of baicalein in Alzheimer’s disease and Parkinson’s disease
  1507. Therapeutic Potential Of Catechins And Derivatives For The Prevention Of Alzheimer’s
  1508. Therapeutic Potential Of Catechins And Derivatives For The Prevention Of Alzheimer’s Disease
  1509. Therapeutic potential of luteolin in transgenic Drosophila model of Alzheimer’s disease
  1510. Therapeutic potential of natural products in Parkinson’s disease
  1511. Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed)
  1512. Therapeutic Potential of Polyphenols in Parkinson’s Disease
  1513. Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview
  1514. Therapeutic potentials of microalgae in the treatment of Alzheimer’s disease
  1515. Therapeutic potentials of plant iridoids in Alzheimer’s and Parkinson’s diseases: A review
  1516. Therapeutic role of sirtuins in Neurodegenerative disease and their modulation by polyphenols
  1517. Therapeutic strategies targeting amyloid-β in Alzheimer’s disease
  1518. Therapeutics of Alzheimer’s disease: Past, present and future
  1519. Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions
  1520. Therapies for prevention and treatment of Alzheimer’s disease
  1521. Thymus pulegioides L. as a rich source of antioxidant, anti-proliferative and neuroprotective phenolic compounds
  1522. Tissue injury by reactive oxygen species and the protective effects of flavonoids
  1523. To Study The Ameliorative Effect Of Hydroalcholic Extract Of Caryota urens (Arecaceae) On Streptozotocin Induced Alzheimer’s Model In Mice
  1524. Tomato (Lycopersicon esculentum) seeds: new flavonols and cytotoxic effect
  1525. Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer’s disease
  1526. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later
  1527. Total Phenolic and flavonoid Content and Biological Activities of Extracts and Isolated Compounds of Cytisus villosus Pourr.
  1528. Total Phenolic, Flavonoid, Fatty Acid Contents and Cytotoxic, Antioxidant, and Antimicrobial Activities of Hedysarum aucheri
  1529. Total Synthesis of an C-CH2-C Linked Ochnaflavone
  1530. Total Synthesis of Ochnaflavone Analogs Having CNH-C and CSC Linkages
  1531. Total Synthesis of Ochnaflavone, A Potent Plant-originated Biflavonoid with Anti-inflammatory Activity
  1532. Towards a bioinformatics analysis of anti-Alzheimer’s herbal medicines from a target network perspective
  1533. Toxic exposure and life style factors on ageing brain Neurodegenerative disease, Alzheimer’s and Parkinson’s: Role of natural antioxidants to ameliorate the condition
  1534. Traditional and modern medicine harmonizing the two approaches in the treatment of neurodegeneration (Alzheimer’s disease-AD)
  1535. Traditional Chinese medicines and Alzheimer’s disease
  1536. Traditional Medicine in the Treatment of dementia and Alzheimer’s Disease
  1537. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
  1538. Transthyretin chemical chaperoning by flavonoids: Structure–activity insights towards the design of potent amyloidosis inhibitors
  1539. Treatment of Alzheimer Disease with Phytochemicals Other Than Curcumin
  1540. Treatment of inflammatory bowel disease via green tea polyphenols: Possible application and protective approaches
  1541. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson’s disease: Possible involvement of PI3K/ERβ signaling
  1542. Type 2 diabetes mellitus and Alzheimer’s disease: bridging the pathophysiology and management
  1543. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer’s Disease Model Mice
  1544. Ulmosides A: flavonoid 6-C-glycosides from Ulmus wallichiana attenuates lipopolysacchride induced oxidative stress, apoptosis and neuronal death
  1545. Understanding Alzheimer’s Disease and Other Dementias
  1546. UNDERSTANDING PHYTOTHERAPY OF Alzheimer’s DISEASE: LAST DECADE AND COMING FUTURE
  1547. Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and Neurodegenerative diseases
  1548. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity
  1549. Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
  1550. Validation of neuroprotective action of a commercially available formulation of olive polyphenols in a zebra-fish model vis-a-vis pure hydroxytyrosol
  1551. Vanillin attenuated behavioural impairments, neurochemical deficts, oxidative stress and apoptosis against rotenone induced rat model of Parkinson’s disease
  1552. Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: a new approach to therapy
  1553. VISCUM ALBUM ENHANCES BLOOD SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVEL IN EXPERIMENTAL MODEL OF Alzheimer’s …
  1554. Walnut supplementation in the diet reduces oxidative damage and improves antioxidant status in transgenic mouse model of Alzheimer’s disease
  1555. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
  1556. Whole-food diet worsened cognitive dysfunction in an Alzheimer’s disease mouse model
  1557. Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s disorders?
  1558. Wine consumption, cognitive function and dementias–A relationship?
  1559. Wine flavonoids in health and disease prevention
  1560. Wine phenolics
  1561. Wine Polyphenols and Neurodegenerative Diseases: An Update on the Molecular Mechanisms Underpinning Their Protective Effects
  1562. Wine polyphenols: potential agents in neuroprotection
  1563. Wine-Derived Phenolic Metabolites in the Digestive and Brain Function
  1564. Withanolides: biologically active constituents in the treatment of Alzheimer’s disease
  1565. Xanthone and flavone derivatives as dual agents with acetylcholinesterase inhibition and antioxidant activity as potential anti-alzheimer agents
  1566. Xenobiotic metabolism and berry flavonoid transport across the blood− brain barrier
  1567. Zingiber officinale and Alzheimer’s disease: evidences and mechanisms
  1568. α-Synuclein Aggregation and Parkinson’s Disease
  1569. α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson’s disease
  1570. α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
  1571. α-Synuclein misfolding and Parkinson’s disease
  1572. α‐Synuclein oligomers and clinical implications for Parkinson disease
  1573. β-Synuclein Assembly as a Therapeutic Target of Parkinson’s Disease and Related Disorders
  1574. … -DAD Fingerprinting Analysis, Antioxidant Activity of Phenolic Extracts from Blighia sapida Bark and Its Inhibition of Cholinergic Enzymes Linked to Alzheimer’s …
  1575. … -rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease
  1576. … , Biological Evaluation And Molecular Modeling Studies Of Novel Multifunctional neuroprotective Drugs For The Treatment Of Parkinson’s Disease: An Effort …
  1577. … , α-Glucosidase, Pancreatic Lipase, Acetyl-and Butyrylcholinesterase Inhibition Activity of Chaenomeles Fruits Determined by Polyphenols and other Chemical …
  1578. … acid and E. resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson’s disease: a pharmacoinformatics study
  1579. … and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia
  1580. … and antioxidant potentials of a medicinal plant Abroma augusta: Implications for the alternative treatment therapy of cognitive deficits in Alzheimer’s disease
  1581. … and their acetyl cholinesterase inhibitory and antioxidant activities from leaves of Acanthopanax henryi: potential complementary source against Alzheimer’s disease
  1582. … bovine 1SS-alpha-lactalbumin as a model for disease-related amyloidogenic polypeptides: The effects of osmolytes, the flavonoid baicalein, and the GroEL …
  1583. … chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: A Preliminary anti- Alzheimer’s study
  1584. … chrysin loaded solid lipid nanoparticles against Amyloid β25–35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer’s …
  1585. … composition, antioxidant potential and in vitro inhibitory activity of leaves and acorns of Quercus suber on key enzymes relevant for hyperglycemia and Alzheimer’s …
  1586. … effects of inhaled Hypericum scabrum L.(Hypericaceae) essential oil against scopolamine-induced Alzheimer’s type dementia/Scopolamine ile oluşturulan …
  1587. … effects of water extract of propolis on dopaminergic neurons, brain derived neurotrophic factor, and stress oxidative Factors in the rat model of Parkinson’s …
  1588. … efficiency of co-administration of Ginkgo biloba and Trifolium pretense against sodium arsenite-induced neurotoxicity and dementia in different regions of brain and …
  1589. … fingerprint analysis, antioxidant properties, and inhibition of cholinergic enzymes (acetylcholinesterase and butyrylcholinesterase) of phenolic extracts from Irvingia …
  1590. … flavonoid attenuates cognitive dysfunction and neuronal loss associated with amyloid β (25-35)-induced oxidative stress: an experimental model of Alzheimer’s …
  1591. … for the Therapy of Proteinopathies Underlying the Neurodegenerative Conditions: Protein Misfolding and Fibrillization in Alzheimer’s Disease and Parkinson’s …
  1592. … from sesame cake reduce oxidative stress and amyloid-β-induced toxicity by upregulation of SKN-1 in a transgenic Caenorhabditis elegans model of Alzheimer’s …
  1593. … Impairment Attenuating Effect of Phenolic Compound Rich Fraction of Trianthema portulacastrum in Scopolamine Induced Alzheimer’s Disease Like Condition
  1594. … IN THE PREVENTION AND MANAGEMENT OF AGE RELATED Neurodegenerative DISORDERS WITH SPECIAL REFERENCE TO SENILE DEMENTIA
  1595. … in tumor necrosis factor like weak inhibitor of apoptosis induced dopaminergic neuronal cell death and microglial activation in invitro and in vivo models of Parkinson …
  1596. … INDUCES PKD1 ACTIVATION AND PROTECTS DOPAMINERGIC NEURONS IN CELL CULTURE AND MITOPARK ANIMAL MODELS OF Parkinson’s …
  1597. … inhibitory potential and estimation of alkaloids (lycorine and galanthamine) from Crinum species: an important source of anticancer and anti-Alzheimer drug
  1598. … KATEKIN GAMBIR TERHADAP KADAR BACE-1 DAN BETA AMYLOID 42 CAIRAN SEREBROSPINAL PADA TIKUS Sprague dawley MODEL ALZHEIMER
  1599. … modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer’s …
  1600. … mombim L.(Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer’s …
  1601. … neurorescue against Aβ toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate
  1602. … of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer’s and other neurological …
  1603. … of diagnostic agents, self-assembly inhibitors, and hippocampal transcriptional changes specific to amyloid β-proteinassemblies linked to Alzheimer’s disease
  1604. … of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer’s disease mice model
  1605. … of flavonoids, baicalein, and daidzein in estrogenic and neuroprotective effects: a development of potential health products and therapeutic drugs against Alzheimer’s …
  1606. … of hydroalcoholic extract of Ziziphora clinopodioides L. on spatial memory and neuronal density of hippocampal CA1 region in rats with sporadic Alzheimer’s …
  1607. … of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer’s …
  1608. … of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology …
  1609. … OF THE POSSIBLE ANTIOXIDANT EFFECTS OF PEGANUM HARMALA AND GINKGO BILOBA IN AMELIORATING Alzheimer’s DISEASE IN RAT MODEL
  1610. … OF ΑLPHA-YNUCLEIN SEEDED NUCLEATION-DEPENDENT AGGREGATION AND TOXICITY AS A POTENTIAL THERAPEUTIC STRATEGY FOR Parkinson’s …
  1611. … performance in relation to urinary anthocyanins and their flavonoid-based products following blueberry supplementation in older adults at risk for dementia
  1612. … pluricaulis (Shankhapushpi) ameliorates human microtubule-associated protein tau (hMAPτ) induced neurotoxicity in Alzheimer’s disease Drosophila model
  1613. … pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer’s …
  1614. … STRESS, NEUROINFLAMMATION AND NEURODEGENERATION AGAINST LIPOPOLYSACCHARIDE-INDUCED Alzheimer’s DISEASE VIA JNK-3 AND …
  1615. … the brain functions by bitter (Vernonia amygdalina) and water bitter (Struchium sparganophora) leaves extracts: comparison of phenolic constituents versus nootropic …
  1616. … the functional diversity of flavonoids derived from Chinese Materia Medica: Drug developments for the prevention of Alzheimer’s disease and osteoporosis
  1617. … with HPLC-FTMS of exogenous and endogenous chemicals susceptible to the administration of chotosan in an animal model of type 2 diabetes-induced dementia
  1618. “A GREAT PERTURBATION IN NATURE”-Parkinson’s DISEASE AND SLEEP DISORDERS–
  1619. “Polyphenolic-food” Effects on Brain Health (Human Data review)
  1620. 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine is a potent neurotoxin: Gamma-tocopherol recuperate behavior, dopamine, and oxidative stress on Parkinsonic …
  1621. 10. neuroprotective effects of oxyresveratrol from fruit against neurodegeneration in Alzheimer’s disease
  1622. 15 Alzheimer’s Disease and Other Forms of Dementia
  1623. 15 Apple Phenolics and Alzheimer’s Disease
  1624. 15 Botanical Phenolics and Neurodegeneration
  1625. 15 Dietary flavonoids as neuroprotective Agents
  1626. 15 Green Tea Flavan-3-ols
  1627. 16 Actions of Bioactive Phytochemicals in Cell Function and Alzheimer’s Disease Pathology
  1628. 17 Effects of flavonoids on Cognitive Performance
  1629. 19 Natural Phenolics and Metal Metabolism in Neurodegenerative Diseases
  1630. 19 The neuroprotective Capacity of Achyrocline satureioides (Lam) DC and Its Flavonoids
  1631. 2 Direct Evaluation of Alzheimer’s Disease-Specific oxidative stress with Multiphoton Microscopy
  1632. 3, 5, 4′-trihydroxy-6, 7, 3′-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell …
  1633. 4 Coffee and Alzheimer’s Disease: Animal and Cellular Evidence
  1634. 6 neuroprotective Mechanisms: oxidative stress as a Target for neuroprotective Therapies in Alzheimer’s and Parkinson’s
  1635. 6-Shogaol has neuroprotective Effects in Parkinson’s Disease Model
  1636. 7, 8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders
  1637. 7, 8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders
  1638. 8 Neuroprotection by Dietary and Citrus Flavonoids
  1639. A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats
  1640. A botanical containing freeze dried açai pulp promotes healthy aging and reduces oxidative damage in sod1 knockdown flies
  1641. A brief review on the neuroprotective mechanisms of vitexin
  1642. A Close Look at Echium amoenum Processing, Neuroactive Components, and Effects on Neuropsychiatric Disorders
  1643. A cocoa peptide protects Caenorhabditis elegans from oxidative stress and β-amyloid peptide toxicity
  1644. A Combination of Green Tea Extract and l-Theanine Improves Memory and Attention in Subjects with Mild Cognitive Impairment: A Double-Blind Placebo-Controlled …
  1645. A comparative study of the in vitro enzyme inhibitory and antioxidant activities of Butea monosperma (Lam.) Taub. and Sesbania grandiflora (L.) Poiret from Pakistan …
  1646. A comparative study on the antioxidant and immunomodulatory properties of curcumin conjugated gold nanospheres and free curcumin
  1647. A comparative thin layer chromatography study of different brands of five herbal remedies
  1648. A Comparison of Inhibitory Effects on Catecholamine Secretion between CGP42112 and CGP42112 plus PD123319
  1649. A comparison of the efficacy and tolerability of interferon-beta (INFb) products used as initial or follow-up therapy for the treatment of relapsing multiple sclerosis …
  1650. A Comprehensive Insight on the Health Benefits and Phytoconstituents of Camellia sinensis and Recent Approaches for Its Quality Control
  1651. A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases
  1652. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies
  1653. A crosssectional study of ethnopharmacology in the Noakhali district of Bangladesh and exploring potential ocular immunostimulatory activity of the medicinal …
  1654. A current perspective on the inhibition of cholinesterase by natural and synthetic inhibitors
  1655. A current update on phytochemistry, pharmacology and herb–drug interactions of Hypericum perforatum
  1656. A diet for dopaminergic neurons?
  1657. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of …
  1658. A life-course contribution of nutrition to future cognitive decline
  1659. A Mini Review on the Protective Effect of Lignans for the Treatment of Neurodegenerative Disorders
  1660. A mixture of fucoxanthin and punicic acid prevents obesity in high-fat diet-induced obese mice
  1661. A New Therapeutic Concept of LMT356 for Stroke Therapy: Extension of the Thrombolytic Time Window of tPA
  1662. A Novel Approach towards Nutraceuticals and Biomedical Applications
  1663. A Novel neuroprotective and Antioxidative Efficacy of a Unique Combination of Standardized Huperzia serrata, Convolvulus pluricaulis and Celastrus …
  1664. A pharmacognostic and pharmacological review on Vigna aconitifolia (Moth bean)
  1665. A Pharmacological Review of Bioactive Constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch
  1666. A Pilot Study to Evaluate Chemopreventive Effects of Blueberry (Vaccinium spp.)
  1667. A Polysaccharide Produced by a New Streptomyces Strain Modulates Immunological Activity in RAW264. 7 Cells
  1668. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects
  1669. A possible role for π-stacking in the self-assembly of amyloid fibrils
  1670. A potential alternative against Neurodegenerative diseases: Phytodrugs
  1671. A Potential Natural Product Combination Targeting Memory Disorders
  1672. A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical …
  1673. A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: in vitro and in vivo efficacy and molecular …
  1674. A refined concept: α-synuclein dysregulation disease
  1675. A review of dietary Ziziphus jujuba fruit (Jujube): developing health food supplements for brain protection
  1676. A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone
  1677. A review of neuroprotective agents
  1678. A Review of neuroprotective Agents
  1679. A review of some medicinal plants used for nervous disorders
  1680. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to Neurodegenerative processes
  1681. A review of the medicinal properties and applications of Pycnanthus angolensis (Welw) Warb
  1682. A review of the pharmacology and toxicology of aucubin
  1683. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy
  1684. A review of therapeutic effects of curcumin
  1685. A review of three commonly used herbs which enhance memory and new evidences which show their combination could improve memory in young animals
  1686. A review on ethnomedicinal, phytochemical, and pharmacological significance of Terminalia sericea Burch. Ex DC.
  1687. A review on medicinal importance, pharmacological activity and toxicology of ”Nutraceuticals”
  1688. A review on medicinal properties of saffron toward major diseases
  1689. A Review on Natural Antioxidants
  1690. A review on natural memory enhancers (Nootropics)
  1691. A Review on Neuronutrition
  1692. A review on nutraceuticals: classification and its role in various diseases
  1693. A Review on Pharmaceutically Important Medicinal plant: Bacopa monnieri
  1694. A Review on Phytochemistry and Pharmacology of Otostegia persica (Burm. f.) Boiss.
  1695. A review on possible therapeutic effect of Nigella sativa and thymoquinone in Neurodegenerative diseases
  1696. A review on spikenard (Nardostachys jatamansi DC.)-an ‘endangered’essential herb of India
  1697. A review on the phytopharmacological studies of the genus Polygala
  1698. A review on the possible neuroprotective effects of Moringa oleifera leaf extract
  1699. A Review on Therapeutic Potentials of Crocetin-A Carotenoid Derived from Saffron
  1700. A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its …
  1701. A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
  1702. A review study on medicinal plants affecting amnesia through cholinergic system
  1703. A Role for Activated Microglia and Peroxynitrite in Lewy Body Diseases–Implications for Prevention and Control
  1704. A Role for Orexin Neuron Activity in Cytotoxic Chemotherapy-Induced Fatigue
  1705. A Role of Gallic Acid in Oxidative Damage Diseases: A Comprehensive Review
  1706. A simple and efficient HPLC method for quantitative analysis of Gingkolides extracted from Ginkgonis Semen
  1707. A Splicing Variant of AIMP2 as a Therapeutic Controller for Neurodegenerative Diseases
  1708. A status review on the medicinal properties of essential oils
  1709. A STUDY ON ANTI-INFLANNATORY AND neuroprotective EFFECTS OS COSTUNOLIDE ON LIPOPOLYSACCHARIDE ACTIVATED MURINE BRAIN …
  1710. A STUDY ON CNS EFFECTS OF MILK EXTRACT OF NUTS OF SEMECARPUS ANACARDIUM. LINN,(ANACARDIACEAE).
  1711. A study on nephroprotectiveness and pharmacokinetic properties of selected nutraceuticals and evaluation of chronic renal failure inducing model for their …
  1712. A Synthetic Snake-Venom-Based Tripeptide Protects PC12 Cells from the Neurotoxicity of Acrolein by Improving Axonal Plasticity and Bioenergetics
  1713. A systematic and comprehensive review on Withania somnifera (L.) dunal-an indian ginseng
  1714. A systematic Approach to Evaluate Herb-drug Interaction Mechanisms: Investigation of a Purified Ginseng Extracts
  1715. A systematic overview of the scientific literature on the association between Mediterranean Diet and the Stroke prevention
  1716. A systematic review on Piper longum L.: Bridging traditional knowledge and pharmacological evidence for future translational research
  1717. A systematic review on the vocational pharmacy education and pharmacists’ role in the Singapore’s healthcare system
  1718. A therapeutic connection between dietary phytochemicals and ATP synthase
  1719. A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and neuroprotective compounds
  1720. AARP Prescription for Drug Alternatives: All Natural Options for Better Health without the Side Effects
  1721. AARP The Immortality Edge: Realize the Secrets of Your Telomeres for a Longer, Healthier Life
  1722. ABC transporters and drug efflux at the blood-brain barrier
  1723. Açaí: An Extraordinary Antioxidant-Rich Palm Fruit
  1724. Acanthus ebracteatus leaf extract provides neuronal cell protection against oxidative stress injury induced by glutamate
  1725. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats
  1726. Acer okamotoanum protects SH-SY5Y neuronal cells against hydrogen peroxide-induced oxidative stress
  1727. Acetyl cholinesterase inhibition potential and antioxidant activities of ferulic acid isolated from Impatiens bicolor Linn
  1728. Acetylcholinesterase from human erythrocytes membrane: a screen for evaluating the activity of some traditional plant extracts
  1729. Acetylcholinesterase inhibition and antioxidant activities of polysaccharide-peptide complexes from edible mushrooms
  1730. Acetylcholinesterase inhibition and antioxidant activity of Syzygium cumini, S. aromaticum and S. polyanthum from Indonesia
  1731. Acetylcholinesterase inhibition and in vitro and in vivo antioxidant activities of Ganoderma lucidum grown on germinated brown rice
  1732. Acetylcholinesterase inhibition by medicinal plants: A Review
  1733. Acetylcholinesterase Inhibition, Antioxidant, Antiinflammatory, Antimicrobial and Phytochemical Properties of Huernia hystrix
  1734. Acetylcholinesterase inhibitors of natural origin
  1735. Acetylcholinesterase Inhibitory Activity and Antioxidant Activity of Selected Medicinal Plant Extracts Used Against Cognitive Dysfunction and Memory Loss in Sri …
  1736. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products
  1737. Acetylcholinesterase inhibitory and antioxidant properties of root extract from Pueraria mirifica
  1738. Acetylcholinesterase inhibitory effect of capsicum oleoresins–an in vitro study
  1739. Acetylcholinesterase Inhibitory Potential and Insecticidal Activity of an Endophytic Alternaria sp. from Ricinus communis
  1740. Acetylcholinesterase inhibitory potentiality of some minor fruits of West Bengal, India
  1741. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family
  1742. Acetylcholineterase inhibitory and antioxidant properties of Rhododendron yedoense var. Poukhanense bark
  1743. Achillea fragrantissima: Pharmacology Review
  1744. Acid Intake, Delivered Via Moderate Champagne Wine Consumption, Improves Spatial Working Memory Via the Modulation of Hippocampal and Cortical …
  1745. Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases
  1746. Activation of anti-oxidant of curcumin pyrazole derivatives through preservation of mitochondria function and Nrf2 signaling pathway
  1747. Activation of Autophagy by Globular Adiponectin Protects against Ethanolinduced Apoptosis in HepG2 Cells
  1748. Activation of Protease-activated Receptor 2 through Gastric Refluxants Stimulates Proliferation and Interleukin (IL)-6, IL-8 and Matrix Metallopeptidase (MMP) …
  1749. Activation of the NRF2 Pathway in Non-adherent Mammosphere Culture System
  1750. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague‐Dawley rats
  1751. Acute and Chronic Exercise Effects on NrF2 and Antioxidants in the Muscle and Brain Tissue of Sprague Dawley Rats
  1752. Acute Autophagy-Dependent Non-inflammatory Epithelial Death Plays as an Intrinsic Defense to Bacteria
  1753. Acute neurocognitive effects of epigallocatechin gallate (EGCG)
  1754. Add Life to Your Years & Years To Your Life: Experience New Energy, Strength & Vitality to Age Gracefully, Joyfully & Healthily
  1755. Adenosine monophosphate (AMP)-activated protein kinase: a new target for nutraceutical compounds
  1756. Adherence to Mediterranean diet and subjective cognitive function in men
  1757. Adiponectin Modulates Anti-Inflammatory MicroRNA Expression in RAW 264.7 Macrophages
  1758. Administration of chinpi, a component of the herbal medicine ninjin-youei-to, reverses age-induced demyelination
  1759. Advanced chemometric modeling approaches for the design of multitarget drugs against Neurodegenerative diseases
  1760. Advanced Glycation Endproducts (AGEs) in Food: Health Implications and Mitigation Strategies
  1761. Advanced glycation endproducts: what is their relevance to diabetic complications?
  1762. Advances in Date Palm (Phoenix dactylifera L.) Breeding
  1763. Advances in drug discovery to assess cholinergic neurotransmission: a systematic review
  1764. Advances in Nutraceuticals
  1765. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
  1766. Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein
  1767. Advances in therapeutics for Neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species
  1768. Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors
  1769. Advancing medicine with food and nutrients
  1770. Advancing neuroprotective-based treatments for schizophrenia
  1771. Advocacy in Geriatric Neurology
  1772. Aerobic exercise, diet, and neurocognition among individuals with high blood pressure
  1773. African medicinal plants acting on the reproductive, cardiovascular, and central nervous systems
  1774. Age before beauty
  1775. Age-related deficits in electron transport chain complexes in rat neurons and 3xTg-AD mouse neurons
  1776. Age-related differences in stress response: Increase markers for oxidative stress and liver damage after heat stress in aged rats?
  1777. Age-related epigenetic drift and phenotypic plasticity loss: implications in prevention of age-related human diseases
  1778. Age-Related Neurodegenerative
  1779. Age-related oxidative protein damages in central nervous system of rats: modulatory role of grape seed extract
  1780. Ageing and eating
  1781. Ageing and Neurodegenerative diseases
  1782. Ageing, cellular senescence and Neurodegenerative disease
  1783. Ageing: biology and nutrition
  1784. Ageless Brain: Think Faster, Remember More, and Stay Sharper by Lowering Your Brain Age
  1785. Aging and Microglial Activation in Neurodegenerative Diseases
  1786. Aging and the cerebral microvasculature: clinical implications and potential therapeutic interventions
  1787. Aging is not a disease: implications for intervention
  1788. Aging microglia: relevance to cognition and neural plasticity
  1789. Aging without growing old
  1790. Aging, Nutrition and Taste: Nutrition, Food Science and Culinary Perspectives for Aging Tastefully
  1791. Aging: an important factor for the pathogenesis of Neurodegenerative diseases
  1792. Aging: minimizing free radical damage
  1793. AIMP1 as a Modulator of Immune Functions and Pharmacological Implications
  1794. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies
  1795. Alcohol, ageing and cognitive function: a nutritional perspective
  1796. Alkaloids from Peumus boldus and their Acetylcholinesterase, Butyrylcholinesterase and Prolyl Oligopeptidase Inhibition Activity
  1797. Allergen-specific memory CD4 T cells require IL-7 signaling for its homeostasis in mediastinal lymph node
  1798. Allergic Asthma Pathogenesis and Antioxidant Therapy
  1799. Almonds and brain functionality
  1800. Alpha-lipoic acid and mesuagenin c-induced co-regulation of nf-κβ-cytokines and chemokines via pi3k-akt/gsk-3β and erk1/2 in in vitro neuronal models/Muhamad …
  1801. Alpha-synuclein suppresses retinoic acid-induced neuronal differentiation by targeting the glycogen synthase kinase-3β/β-catenin signaling pathway
  1802. Alpha-Synuclein-Induced Dysregulation of Neuronal Differentiatio
  1803. Alpha-synuclein, oxidative stress and autophagy failure: dangerous liaisons in dopaminergic neurodegeneration
  1804. Alteration of cholesterol homeostasis in the Huntington’s disease brain
  1805. Altered brain metabolism of iron as a cause of Neurodegenerative diseases?
  1806. Aluminium (III) as a promoter of cellular oxidation
  1807. Aluminum Induced Reproductive Dysfunction in Male Rats: The Ameliorative Effect of Saffron Extract
  1808. Always Eat After 7 PM: The Revolutionary Rule-Breaking Diet That Lets You Enjoy Huge Dinners, Desserts, and Indulgent Snacks—While Burning Fat …
  1809. Amazing Bible Healing Plants, Remedies and Recipes
  1810. Amazing Health Benefits of Green Tea
  1811. Amelioration of oxidative stress in differentiated neuronal cells by rutin regulated by a concentration switch
  1812. Amelioration of scopolamine-induced learning and memory impairment by 𝛼-Pinene in C57BL/6 mice
  1813. Amelioration of the Impact of Physical Fatigue on Cognitive Performance by Phytochemicals: The Effect of a Blackcurrant Supplement: A thesis presented in partial …
  1814. Ameliorative Effects of ferulic acid against lead acetate-induced oxidative stress, mitochondrial dysfunctions and toxicity in prepubertal rat brain
  1815. Ameliorative effects of ferulic Acid against lead acetate-induced oxidative stress, mitochondrial dysfunctions and toxicity in prepubertal rat brain.
  1816. Ameliorative effects of lotus seedpod proanthocyanidins on cognitive deficits and oxidative damage in senescence-accelerated mice
  1817. Ameliorative Effects of Nutraceuticals in Neurological Disorders
  1818. Ameliorative Potential of Euphorbia hirta (Linn.) Extract against Lipopolysaccharide Induced-neuroinflammation and Oxidative Damage in Rats
  1819. Amino acids in human nutrition and health
  1820. Ampelopsin attenuates 6-OHDA-induced neurotoxicity by regulating GSK-3β/NRF2/ARE signalling
  1821. Amphiphilic nanocarrier systems for curcumin delivery in Neurodegenerative disorders
  1822. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
  1823. AMPK-dependent Hypoglycemic Effect of Ajoene, a Stable Garlic Component
  1824. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB
  1825. Amyloid ß-derived switch-peptides as tool to study conformational changes relevant in degenerative diseases
  1826. Amyloid State of Proteins in Human Disease
  1827. Amyloidogenic Peptide Structure, Aggregation, And Membrane Interaction
  1828. Amyloidogenic protein–membrane interactions: mechanistic insight from model systems
  1829. An egg yolk’s phospholipid-pennyroyal nootropic nanoformulation modulates monoamino oxidase-A (MAO-A) activity in SH-SY5Y neuronal model
  1830. An Energy Restricted Mediterranean Diet Does Not Compromise Dietary Antioxidant Intake: Preliminary Evidence in the Balearic Islands Subgroup of the …
  1831. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect®
  1832. An ex vivo erythrocyte study: the protective effects of antioxidants against the toxicity of heavy metals in cigarette smoke.
  1833. An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an …
  1834. An Herbalist’s Guide to Formulary: The Art & Science of Creating Effective Herbal Remedies
  1835. An In Vitro and In Vivo Cholinesterase Inhibitory Activity of Pistacia khinjuk and Allium sativum Essential Oils
  1836. An investigation into pro-apoptotic targets in experimental glaucoma and the neuroprotective effects of Ginkgo biloba in retinal ganglion cells
  1837. An Investigation Into the neuroprotective Properties of Curcumin
  1838. An investigation of potential sources of nutraceuticals from the Niger Delta areas, Nigeria for attenuating oxidative stress
  1839. An Investigation To Explore The neuroprotective Efficacy Of Zingiber Officinale By Evaluation Of Alterations In Certain Neurochemical Parameters Under …
  1840. An Isolation, Characterization and In-vitro Evaluation Study of Cholinesterase Inhibitory and Antioxidant Activities of Mimosa pudica for the Treatment …
  1841. An Open clinical study of Siddha drugs Thirutharakchatha Chooranam (Internal) and Aruganver Thylam (External) in the treatment of Viyagulaunmatham (Depression)
  1842. An optoelectronic tongue based on an array of gold and silver nanoparticles for analysis of natural, synthetic and biological antioxidants
  1843. An overview of benzo [b] thiophene-based medicinal chemistry
  1844. An Overview of Natural Beverages
  1845. An Overview of Target Specific Neuro-Protective and Neuro-Restorative Strategies
  1846. An overview of the molecular mechanisms and novel roles of Nrf2 in Neurodegenerative disorders
  1847. An overview of the pharmacology of olive oil and its active ingredients
  1848. An overview on inventions related to ginger processing and products for food and pharmaceutical applications
  1849. An Overview on Neurodegenerative Diseases and Possible Leads from Natural Products
  1850. An Overview on Nutraceuticals as Pharmacological Agents.
  1851. An Unashamed Defense of Coffee
  1852. An untapped resource in the spotlight of medicinal biotechnology: The genus Scutellaria
  1853. An update on Shankhpushpi, a cognition-boosting Ayurvedic medicine
  1854. An update on the role of medicinal plants in amelioration of aluminium toxicity
  1855. An Updated Review of Pharmacological, Standardization Methods and Formulation Development of Rutin
  1856. An updated review on Catharanthus roseus: phytochemical and pharmacological analysis
  1857. An updated review on herbal drugs: Nootropic activity and possible mechanisms
  1858. Analgesic and antibutyrylcholinestrasic activities of the venom prepared from the Mediterranean jellyfish Pelagia noctiluca (Forsskal, 1775)
  1859. Analysis and entrapment of select antioxidants from chokecherry and Saskatoon berry fruits
  1860. Analysis of Cardiovascular Adverse Drug Reactions Reported the Korea Drug and Food Administration
  1861. Analysis of Metabolites of Major Components in Natural Medicines
  1862. Analysis of methanolic extracts and crude polysaccharides from the leaves of Chuanminshen violaceum and their antioxidant activities
  1863. Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease
  1864. Analysis of natural product regulation of opioid receptors in the treatment of human disease
  1865. Analysis of selected medicinal plants as antioxidants with therapeutic potential for treating diseases related to free radical damage
  1866. Analysis of the antioxidant activity of 4-(5-chloro-2-hydroxyphenylamino)-4-oxobut-2-enoic acid derivatives using quantum-chemistry descriptors and molecular …
  1867. Analytical methods for characterizing bioactive terpene lactones in ginkgo biloba extracts and performing pharmacokinetic studies in animal and human
  1868. and Cognitive Decline
  1869. Anethum Graveolens linn (Umbelliferae) extract attenuates stress-induced urinary biochemical changes and improves cognition in scopolamineinduced amnesic rats
  1870. Animal Model of Cognitive Decline and Neural Transplantation of Stem Cells as a Prospective Therapy
  1871. Annurca apple-rich diet restores long-term potentiation and induces behavioral modifications in aged rats
  1872. Anthocyanin tissue bioavailability in animals: Possible implications for human health. A systematic review
  1873. Anthocyanin-rich açai (Euterpe oleracea Mart.) fruit pulp fractions attenuate inflammatory stress signaling in mouse brain BV-2 microglial cells
  1874. Anthocyanins and human health: biomolecular and therapeutic aspects
  1875. Anthocyanins and Their Metabolites as Therapeutic Agents for Neurodegenerative Disease
  1876. Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide
  1877. Anthocyanins from Black Chokeberry (Aroniamelanocarpa Elliot) Delayed Aging-Related Degenerative Changes of Brain
  1878. Anthocyanins improve hippocampus-dependent memory function and prevent neurodegeneration via JNK/Akt/GSK3β signaling in LPS-treated adult mice
  1879. Anthocyanins in Food
  1880. Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex
  1881. Anthocyanins protect from complex I inhibition and APPswe mutation through modulation of the mitochondrial fission/fusion pathways
  1882. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats
  1883. Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination
  1884. Anthocyanins: From plant pigments to health benefits at mitochondrial level
  1885. Anthocyanins: Janus Nutraceuticals Displaying Chemotherapeutic and neuroprotective Properties
  1886. Anthocyanins: Multi-target agents for prevention and therapy of chronic diseases
  1887. Anthostema aubryanum Baill: Its Anti-inflammatory and Antioxidant Activities of the root bark extract
  1888. Anti-Acetylcholinesterase Activities of Mono-Herbal Extracts and Exhibited Synergistic Effects of the Phytoconstituents: A Biochemical and Computational Study
  1889. Anti-Acetylcholinesterase, Anti-Inflammatory and Anti-Oxidant Activities of Raw-Extract Centella Asiatica (RECA) on Lipopolysaccharide (LPS)-Induced …
  1890. Anti-Ageing Medicines: The Facts, What Works and What Doesn’t
  1891. Anti-aging Effect of the Ethanol Extract from G. bimaculatus
  1892. Anti-aging Properties of 4-hydroxybenzoic acid in Caenorhabditis elegans
  1893. Anti-amnesic effect of aqueous extract of Crataeva nurvala stem bark in scopolamine induced amnesia
  1894. Anti-amnesic effect of Dendropanax morbifera via JNK signaling pathway on cognitive dysfunction in high-fat diet-induced diabetic mice
  1895. Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa
  1896. Anti-amyloidogenic Effect of Anti-inflammatory Compound, Thiacremonone in Astrocytes
  1897. Anti-cholinesterase potential of diverse botanical families from Malaysia: Evaluation of crude extracts and fractions from liquid-liquid extraction and acid-base …
  1898. Anti-Fatigue and Hypnotic Effects of a Traditional Herbal Extract on Multiple Sclerosis Patients: A double blind randomized clinical trial
  1899. Anti-Fatigue and Hypnotic Effects of a Traditional Herbal Extract on Multiple Sclerosis Patients: A double blind randomized clinical trial.
  1900. Anti-fibrillogenic and fibril destabilizing effects of metal ions on cystatin fibrils
  1901. Anti-genotoxic Effects of Ethyl Acetate Fraction from Agrimonia pilosa Ledeb in LPS-stimulated RAW 264.7 Cells
  1902. Anti-glycative and anti-inflammatory effects of protocatechuic acid in brain of mice treated by D-galactose
  1903. Anti-helicobacter and anti-inflammatory effects of ethanol extract of Sohamhyoongtang in Helicobacter pylori-induced inflammation in human gastric epithelial …
  1904. Anti-inflammatory Activities of l-Methone and Camphor Isolated from Agastache rugosa (Fisch. & Mey.) Kuntze
  1905. Anti-inflammatory Activity and Protective Ability of Water Extract from Pinus densiflora Bark against DNA Damage
  1906. Anti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua in LPS-stimulated BV2 Microglial Cells
  1907. Anti-Inflammatory Activity of Sulfur-containing Compounds from Garlic
  1908. Anti-inflammatory and antioxidant activities of Memecylon umbellatum. Burm. f. leaf extract under in vitro
  1909. Anti-inflammatory and Pro-inflammatory Mediators as Potential Targets for Chemoprevention and Therapy
  1910. Anti-inflammatory Dietary Ingredients, Medicinal Plants, and Herbs Exert Beneficial Health Effects in Aging
  1911. Anti-inflammatory Effect of 4-tert-butyl Phenyl Salicylic Acid in Lipopolysaccharides-Stimulated Raw 264.7 Mouse Macrophage Cells
  1912. Anti-inflammatory Effect of Clematis mandshurica in LPS-induced RAW 264.7 cells
  1913. Anti-Inflammatory Effect of Erinacine C on NO Production Through Down-Regulation of NF-κB and Activation of Nrf2-Mediated HO-1 in BV2 Microglial Cells Treated …
  1914. Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity
  1915. Anti-inflammatory effects of rice bran components
  1916. Anti-inflammatory function of Phyllostachys edulis extract in the hippocampus of HIV-1 transgenic rats
  1917. Anti-inflammatory natural foods
  1918. Anti-ischemic effect of Ginkgo biloba extract: facts and myths
  1919. Anti-metastatic Activity of Pinosylvin, a Natural Stilbenoid, is Associated with the Suppression of MMPs
  1920. Anti-microbial Activity of AC-care, a Composition of Herbal Extract, Against Propionibacterium Acne
  1921. Anti-Neurodegenerative effects of sage (Salvia officinalis) via modulation of stress response signaling in C. elegans
  1922. Anti-neuroinflammatory effects of Ephedra sinica Stapf extract-capped gold nanoparticles in microglia
  1923. Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells
  1924. ANTI-NOCICEPTIVE AND ANTI-INFLAMMATORY EFFECTS OF AN ETHANOLIC EXTRACT OF THE AERIAL PARTS OF HILLERIA LATIFOLIA (LAM.) H. WALT …
  1925. Anti-oxidant Properties of Some Lesser Known Fruits and Vegetables Consumed by families in South East Zone of Nigeria.
  1926. Anti-oxidants and their role in disease management
  1927. Anti-Oxidants, the Aging Brain and Age-Related Brain Disorders
  1928. Anti-oxidative and anti-inflammatory effects of 2-cyclopropylimino-3-methyl-1, 3-thiazoline hydrochloride on glutamate-induced neurotoxicity in rat brain
  1929. Anti-platelet aggregation activity of melaleuca bracteata var. revolution gold derived betulinic acid and its derivatives
  1930. Anti-senescence compounds: a potential nutraceutical approach to healthy aging
  1931. Anti-wrinkle Effect of Korean Rice Wine Cake
  1932. Anti‐amyloidogenic activity of tetracyclines: studies in vitro
  1933. Antiaging effects of bioactive molecules isolated from plants and fungi
  1934. Antiamnesic Effect of Broccoli (Brassica oleracea var. italica) Leaves on Amyloid Beta (Aβ)1–42-Induced Learning and Memory Impairment
  1935. Antiapoptotic effects of EGb 761
  1936. Antibacterial activities of selected medicinal plants used to treat sexually transmitted infections in Blouberg area, Limpopo Province
  1937. Antibacterial, antioxidant, antifungal and anti-inflammatory activities of crude extract from Nitraria schoberi fruits
  1938. Antibody Based Diagnostic and Therapeutic
  1939. Anticholinesterase and antioxidant effects of traditional herbal medicines used in the management of Neurodegenerative diseases in mauritius
  1940. Anticholinesterase and antioxidative properties of aqueous extract of Cola acuminata seed in vitro
  1941. Anticholinesterase constituents from the leaves of Spondias mombin L.(Anacardiaceae)
  1942. Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats
  1943. Antidepressant Plant Species from the Portuguese-Speaking African Countries (PALOP)
  1944. Antidepressant Principles of the Roots of Polygala tenuifolia
  1945. Antidepressant-and anxiolytic-like activities of an oil extract of propolis in rats
  1946. Antidepressant‐like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus
  1947. Antidepressive‐like effects and antioxidant activity of green tea and GABA green tea in a mouse model of post‐stroke depression
  1948. Antidiabetic Effect of Codonopsis Lanceolata through the Regulation of Glucose Metabolism in C75BL/KsJ-db/db Mice
  1949. Antidiabetic effects of tea
  1950. Antidiabetic Screening and Phytochemical Investigation of Selected Medicinal Plants
  1951. Antidotal effects of curcumin against neurotoxic agents: An updated review
  1952. Antifibrotic Effects of Juglans sinensis Extract against CCl4-induced Liver Fibrosis in Rats
  1953. Antifungal and antioxidant activity of Crassocephalum bauchiense (Hutch.) Milne-Redh ethyl acetate extract and fractions (Asteraceae)
  1954. Antihyperglycemic activity of ethylacetate extract of Abelmoschus esculentus seed in alloxan induced hyperglycemic mice model
  1955. Antihyperglycemic and Antihyperlipidemic Effects of Fermented Rhynchosia nulubilish in Alloxan-induced Diabetic RatsRhynchosia nulubilish in Alloxan …
  1956. Antiinflammatory Properties of Dietary n-3 Polyunsaturated Fatty Acids Protect Against Cognitive Decline in Aging and Neurodegenerative Diseases
  1957. Antimicrobial Activity and Quantum-chemical Studies of Novel 2-Arylidenehydrazinyl-4-arylthiazole Derivatives
  1958. Antimicrobial and antioxidant properties of medicinal plants used by the Bentian tribe from Indonesia
  1959. AntiNeurodegenerative and Antidiabetic Activity of Lichens
  1960. Antioxidant actions of spices and their phytochemicals on age-related diseases
  1961. Antioxidant Activities and Anti-tyrosinase Activity of Tribulus terrestris
  1962. Antioxidant activities of the essential oils and extracts of Biebersteinia multifida DC
  1963. Antioxidant Activity and Anti-inflammatory Effect of the Ethyl Acetate Fraction from Aruncus dioicus var. kamfschaticus
  1964. Antioxidant activity and enzymes inhibitory properties of several extracts from two Moroccan Asteraceae species
  1965. Antioxidant activity and protecting health effects of common medicinal plants
  1966. Antioxidant activity of a solution of thymol in ethanol
  1967. Antioxidant activity of Aegle marmelos, Withania somnifera, Bacopa monnieri, Centella asiatica, Sida cordifolia and Mucuna pruriens and its correlation with …
  1968. ANTIOXIDANT ACTIVITY OF COLDENIA PROCUMBENS LINN. WHOLE PLANT METHANOLIC EXTRACT
  1969. Antioxidant Activity of Dichloromethane Fraction from Equisetum hyemale L.
  1970. Antioxidant activity of Dung beetle extracts on a high fat diet in Sprague-Dawley rats
  1971. Antioxidant Activity of Extracts from Equisetum hyemale L.
  1972. Antioxidant activity of oral administration of Rosmarinus officinalis leaves extract on rat’s hippocampus which exposed to 6-Hydroxydopamine
  1973. Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms
  1974. Antioxidant Activity of Water Extract from Green Tea
  1975. Antioxidant activity, acetylcholinesterase and tyrosinase inhibitory potential of Pulmonaria officinalis and Centarium umbellatum extracts
  1976. Antioxidant activity, acetylcholinesterase inhibitory potential and phytochemical analysis of Sarcocephalus latifolius Sm. bark used in traditional medicine in …
  1977. Antioxidant and a-glucosidase inhibitory activity of Adina rubella Hance in vitro
  1978. Antioxidant and acetylcholinesterase inhibition properties of Amorpha fruticosa L. and Phytolacca americana L.
  1979. Antioxidant and acetylcholinesterase inhibitory activities of leaf extract and fractions of Albizia adianthifolia (Schumach) WF Wright
  1980. Antioxidant and acetylcholinesterase inhibitory potential of thai medicinal plants
  1981. Antioxidant and anti-acetylcholinesterase activities of extracts from Rapistrum rugosum in Tunisia
  1982. ANTIOXIDANT AND ANTI-ACETYLCHOLINESTERASE POTENTIAL FROM WASTE OF SELECTED SOLANACEOUS PLANTS: ISOLATION AND …
  1983. Antioxidant and anti-inflammatory activities of the root of Mussaenda glabrata
  1984. Antioxidant and anti-inflammatory activity of Polygonatum sibiricum rhizome extracts
  1985. Antioxidant and anti-inflammatory mechanisms of neuroprotection by ursolic acid: addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and depression
  1986. Antioxidant and anti-inflammatory related activities of certain botanicals frequently used in Ayurveda and other indigenous systems of medication
  1987. Antioxidant and antiacetylcholinesterase activities of chard (Beta vulgaris L. var. cicla)
  1988. Antioxidant and antiacetylcholinesterase activities of different granulometric classes of Salix alba (L.) bark powders
  1989. Antioxidant and antiacetylcholinesterase activities of Sorbus torminalis (L.) Crantz (wild service tree) fruits
  1990. Antioxidant and anticholinesterase activities of aqueous extract of Uraria picta (Jacq.) DC
  1991. Antioxidant and anticholinesterase activities of the essential oil of Eugenia dysenterica DC
  1992. Antioxidant and anticholinesterase activity of essential oils and ethanol extracts of Thymus algeriensis and Teucrium polium from Algeria
  1993. Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species
  1994. Antioxidant and anticholinesterase investigations of Rumex hastatus D. Don: potential effectiveness in oxidative stress and neurological disorders
  1995. Antioxidant and anticholinesterase potential of six thymus species
  1996. Antioxidant and Antimicrobial Investigations of dichloromethane (DCM) Extract of Garcinia cowa Bark
  1997. Antioxidant and antiproliferative properties of water extract from Mahonia bealei (Fort.) Carr. leaves
  1998. Antioxidant and cyclooxygenase-2-inhibiting effect of purple corn cob extract-loaded nanofiber patch on motor recovery in spinal cord injury rats
  1999. Antioxidant and cytotoxicity effects of Luteolin
  2000. Antioxidant and free radical scavenging activities of Ervatamia coronaria Stapf. leaves
  2001. Antioxidant and Free Radical Scavenging Activity of Different Fractions from Synurus deltoides Nakai Leaves
  2002. ANTIOXIDANT AND HEMOLYTIC ACTIVITIES OF NOVEL ORGANIC COMPOUNDS AND SOME PLANT EXTRACTS
  2003. Antioxidant and Inhibitory Effects of Aqueous Extracts of Salvia officinalis Leaves on Pro-Oxidant-Induced Lipid Peroxidation in Brain and Liver In Vitro
  2004. Antioxidant and its Applications
  2005. Antioxidant and neuroprotective Activities of Mogami-benibana (Safflower, Carthamus tinctorius Linne)
  2006. Antioxidant and neuroprotective Effects of Kaempferol and Tannic Acid against 6-Hydroxydopamine-induced Oxidative Stress
  2007. Antioxidant and neuroprotective Effects of KM-34, A Novel Synthetic Catechol, Against Oxidative Stress-Induced Neurotoxicity
  2008. Antioxidant and neuroprotective Effects of Scrophularia striata Extract Against Oxidative Stress-Induced Neurotoxicity
  2009. Antioxidant and Non-enzymatic Glycation Inhibition Ability of Rosa davurica
  2010. Antioxidant and other properties of green and black tea
  2011. Antioxidant and oxidative stress: A mutual interplay in age-related diseases
  2012. Antioxidant and phytochemicals of hexane and ethanolic extracts of Canarium schweinfurthii burseraceae.
  2013. Antioxidant and pro-oxidant capacity of catecholamines and related compounds. Effects of hydrogen peroxide on glutathione and sphingomyelinase activity in …
  2014. Antioxidant capacity of Melissa Officinalis L. on Biological Systems
  2015. Antioxidant compounds and nutraceutical benefits of mediterranean red fruit
  2016. Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro
  2017. Antioxidant Constituents from a Vietnam Herbal Tea Gynostemma laxum
  2018. ANTIOXIDANT CONTRIBUTION OF LAVENDER (Lavandula angustifolia)
  2019. Antioxidant effect of alkynylselenoalcohol compounds on liver and brain of rats in vitro
  2020. Antioxidant intake and antitumor therapy: toward nutritional recommendations for optimal results
  2021. ANTIOXIDANT MEXIDOL. The main neuropsychotropic effects and the mechanism of action mechanism of action.
  2022. Antioxidant Nutraceuticals as Health Drinks for Prevention of Diseases
  2023. Antioxidant Nutraceuticals as Health Drinks for Prevention of Diseases
  2024. Antioxidant Nutraceuticals for the Prevention and Treatment of Acute and Chronic Lung Diseases
  2025. Antioxidant potential in fresh and processed products of selected fruits
  2026. Antioxidant potential of Morinda pubescens fruits
  2027. Antioxidant potential of the ethanol extract of the leaves of Vitex negundo L
  2028. Antioxidant potentials of tannic acid on lipid peroxidation induced by several pro-oxidants in cerebral and hepatic lipids
  2029. Antioxidant profiles of new chemical entities as multifunctional hits for the treatment of Neurodegenerative disorders
  2030. Antioxidant Properties and Chemopreventive Potential Of the Bioactive Constituents Of the Roots Of Decalepis Hamiltonii
  2031. Antioxidant properties of
  2032. Antioxidant properties of 4-hydroxyquinolines
  2033. Antioxidant properties of Calendula officinalis L. (Asteraceae) on Fe2+-initiated peroxidation of rat brain mitochondria
  2034. Antioxidant Properties of Curcumin: Impact on Neurological Disorders
  2035. Antioxidant properties of food products containing lycopene are increased by the presence of chlorophyll
  2036. Antioxidant properties of Lippia javanica (Burm. f.) Spreng.
  2037. Antioxidant properties of medicinal plants used in the Southern Ecuador
  2038. ANTIOXIDANT PROPERTIES OF RED ONIONS, WHITE ONIONS (Allium cepa) AND GARLIC (Allium sativum).
  2039. Antioxidant properties of selected African vegetables, fruits and mushrooms: A review
  2040. Antioxidant Property Is the Basic Feature of Kampo Medicine
  2041. Antioxidant strategies for Neurodegenerative diseases
  2042. Antioxidant supplementation in the treatment of aging-associated diseases
  2043. Antioxidant targeting by deferiprone in diseases related to oxidative damage
  2044. Antioxidant Therapies for Neurodegenerative Diseases: Mechanisms, Current Trends, and Perspectives
  2045. Antioxidant Therapies for Neuroprotection—A Review
  2046. Antioxidant therapy and its effectiveness in oxidative stress-mediated disorders
  2047. Antioxidant therapy effectiveness: an up to date
  2048. Antioxidant therapy: current status and future prospects
  2049. Antioxidant Therapy: Potential and Limitations
  2050. Antioxidant therapy: Still in search of the ‘magic bullet’
  2051. Antioxidant treatment induces hyperactivation of the HPA axis by upregulating ACTH receptor in the adrenal and downregulating glucocorticoid receptors in the …
  2052. Antioxidant, Anti-inflammatory and neuroprotective Activities of a Plant Extract Derived from Traditional Chinese Medicine: SuHeXiang Wan (AT000)
  2053. Antioxidant, antibacterial and antiacetylcholinesterase activities of Phalaris canariensis from Tunisia
  2054. Antioxidant, antityrosinase, anticholinesterase, and nitric oxide inhibition activities of three Malaysian Macaranga species
  2055. Antioxidants
  2056. Antioxidants and cognitive function/Discussion/Comment
  2057. Antioxidants and Healthy Life
  2058. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity
  2059. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity
  2060. Antioxidants and human diseases
  2061. Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases
  2062. Antioxidants and Prooxidants: Effects on Health and Aging
  2063. Antioxidants and the Comet assay
  2064. Antioxidants as a preventive therapeutic option for age related Neurodegenerative diseases
  2065. Antioxidants as treatment for Neurodegenerative disorders
  2066. Antioxidants for the prevention and treatment of multiple sclerosis: an overview
  2067. Antioxidants in health and disease
  2068. Antioxidants in health, disease and aging
  2069. Antioxidants in Huntington’s disease
  2070. Antioxidants in medicinal plants
  2071. Antioxidants of edible mushrooms
  2072. Antioxidants World Congress
  2073. Antioxidants, quinone reductase inducers and acetylcholinesterase inhibitors from Spondias tuberosa fruits
  2074. Antioxidants: Dietary scavengers in lifestyle diseases
  2075. Antioxidants: Its medicinal and pharmacological applications
  2076. Antioxidants: new-generation therapeutic base for treatment of polygenic disorders
  2077. Antioxidants: real medicines?
  2078. Antioxidants: real medicines?: main topic
  2079. Antioxidants: scientific literature landscape analysis
  2080. Antioxidative activity and ameliorative effects of memory impairment of sulfur‐containing compounds in Allium species
  2081. Antioxidative activity and anti-inflammatory effects of diarylheptanoids isolated from Alnus hirsuta
  2082. Antioxidative and neuroprotective effects of Loranthus parasiticus (L.) Merr (Loranthaceae) against oxidative stress in NG108-15 cells
  2083. Antioxidative and neuroprotective effects of volatile components in essential oils from Chrysanthemum indicum Linné flowers
  2084. Antioxidative Components from the Whole Plants of Veronica peregrina
  2085. Antioxidative effects of Rhodiola genus: Phytochemistry and pharmacological mechanisms against the diseases
  2086. Antioxidizing Effect and Antimicrobial Activities of Saponins from Kalopanacis Cortex (Kalopanax pictus), Soybean (Glycine max) and Ginseng (Panax …
  2087. Antiproliferative Activities of Halophyte Plant, Calystegia soldanella, Growing Near Southern and Western Seashores in Korea
  2088. Antitumoral and Anticholinesterasic Activities of the Seven Species from Rubiaceae
  2089. Anxiolytic Effects of the JA-Q: Involvement of GABAergic System
  2090. Anxiolytic-like Effects of PNE-70 Using the Elevated Plus-Maze and Hole-board Apparatus in Mice
  2091. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
  2092. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model
  2093. Apigetrin from Scutellaria baicalensis Georgi Inhibits Neuroinflammation in BV-2 Microglia and Exerts neuroprotective Effect in HT22 Hippocampal Cells
  2094. Apios americana Medik flowers extract protects PC12 cells against H2O2 induced neurotoxicity via regulating autophagy
  2095. Apium plants: Beyond simple food and phytopharmacological applications
  2096. Application of phytochemicals for the treatment of Neurodegenerative diseases.
  2097. Application of precision medicine in Neurodegenerative diseases
  2098. Application of quercetin in neurological disorders: from nutrition to nanomedicine
  2099. Application of resveratrol in diabetes: rationale, strategies and challenges
  2100. Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus
  2101. Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae …
  2102. Appraisal of scopolamine-induced antiamnesic effect of Sphaeranthus indicus in mice
  2103. Aqueous extract of the Chinese medicine, Danggui‐Shaoyao‐San, inhibits apoptosis in hydrogen peroxide‐induced PC12 cells by preventing cytochrome c release …
  2104. Aqueous–ethanol extracts of some South African seaweeds inhibit beta‐amyloid aggregation, cholinesterases, and beta‐secretase activities in vitro
  2105. Araucaria angustifolia (Bertol.) Kuntze has neuroprotective action through mitochondrial modulation in dopaminergic SH-SY5Y cells
  2106. Arcopilus aureus, a Resveratrol-Producing Endophyte from Vitis vinifera
  2107. Are antioxidant supplements effective for the prevention and treatment of diseases?
  2108. ARE ANTIOXIDANTS GOOD THERAPEUTIC CANDIDATES FOR HUNTINGTON’S DISEASE?
  2109. Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration?
  2110. Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of Neurodegenerative brain disorders?
  2111. Aronia melanocarpa treatment and antioxidant status in selected tissues in Wistar rats
  2112. Ashwagandha Root Extract Inhibits Acetylcholine Esterase, Protein Modification and Ameliorates H2O2-Induced oxidative stress in Rat Lymphocytes
  2113. Asian Medicinal Remedies for Alleviating Aging Effects
  2114. Asparagus adscendens root extract enhances cognition and protects against scopolamine induced amnesia: An in-silico and in-vivo studies
  2115. Assessing neuroprotective Agents for Aβ-Induced Neurotoxicity
  2116. Assessment of acetylcholinesterase and tyrosinase inhibitory and antioxidant activity of Alchemilla vulgaris and Filipendula ulmaria extracts
  2117. Assessment of anti-cholinesterase activity and cytotoxicity of cagaita (Eugenia dysenterica) leaves
  2118. Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L.(St. John’s wort)
  2119. Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents
  2120. Assessment of In-House Natural Product and Synthetic Compound Libraries Based on In vitro Inhibition of Cholinesterases
  2121. Assessment of natural herbal based antitussive and expectorant efficacy of respiratory symptom
  2122. Assessment of neuroprotective efficacy of phytochemicals against oxidatiive stress mediated neurodegeneratiion in Drosophilla mellanogaster
  2123. Assessment of the Effect of Green tea Consumption on Fibrinogen Among Adult Healthy Sudanese Volunteers
  2124. Association of blood antioxidants status with visual and auditory sustained attention
  2125. Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: a systematic review
  2126. Astrocyte heterogeneity: impact to brain aging and disease
  2127. Asymmetric Synthesis of D-and L-ribo-Phytosphingosine
  2128. Atherosclerosis: Pathophysiology and promising herbal remedies in traditional Persian medicine
  2129. Atherothrombosis and oxidative stress: mechanisms and management in elderly
  2130. Atividade antioxidante e hepatoprotetora de plantas brasileiras, contendo compostos fenólicos.
  2131. Atropa acuminata Royle Ex Lindl. blunts production of pro-inflammatory mediators eicosanoids., leukotrienes, cytokines in vitro and in vivo models of acute …
  2132. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-κB) activation and cell death by tea extracts in neuronal cultures
  2133. Attenuation of aluminum chloride-induced neuroinflammation and caspase activation through the AKT/GSK-3β pathway by hesperidin in wistar rats
  2134. Australian Native Plants–A Source of Novel Anti-inflammatory Compounds
  2135. Autism spectrum disorders: Potential neuro-psychopharmacotherapeutic plant-based drugs
  2136. Autism, Genetics
  2137. Autism: Synthetic-and plant-derived control and treatment
  2138. Autophagy and microglia: novel partners in neurodegeneration and aging
  2139. Autophagy in health and disease
  2140. Autophagy in Neurodegeneration: Latest developments on eating ourselves out of disease
  2141. Avocado as a major dietary source of antioxidants and its preventive role in Neurodegenerative diseases
  2142. Avocado Juice Prevents the Formation of Trypsin Amyloid-Like Fibrils in Aqueous Ethanol
  2143. AzBilliards. com> Main Category> Non Pool Related> Why Is The Food Industry Trying To Kill Us?-Top 10 Food Additives to Avoid
  2144. Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain
  2145. Bacteriocin produced by Bacillus strain, isolated from Korean traditional fermented food kimchi shows broad antibacterial activity in optimized media
  2146. Baicalein as a potent neuroprotective agent: A review
  2147. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP+-treated nigrostriatal dopaminergic system in vivo
  2148. Baicalein protects C6 glial cells against hydrogen peroxide-induced oxidative stress and apoptosis through regulation of the Nrf2 signaling pathway
  2149. Baicalein suppresses Repeat Tau fibrillization by sequestering oligomers
  2150. Baicalein suppresses Tau fibrillization by sequestering oligomers
  2151. Baicalin improves chronic corticosterone-induced learning and memory deficits via the enhancement of impaired hippocampal brain-derived neurotrophic factor and …
  2152. Balsamite major Desf.: Redox properties, antiinflammatory and cytoprotective effects
  2153. Basic Research to Breakthroughs in Antibody Therapeutics
  2154. BBA-Molecular Basis of Disease
  2155. Beer as an Integral Part of Healthy Diets: Current Knowledge and Perspective
  2156. Behavioral and Biochemical Consequences of Simulated Vehicle Exhaust Exposure in Rats
  2157. BEHAVIORAL ECONOMICS APPROACH TO PERIMENOPAUSE, A LEARNING CULPABILITY OF WOMEN IN DEVELOPING NATIONS
  2158. Benefical effects of mediterranean diet in neuroinflammation and related diseases
  2159. Beneficial Effects of Carvacrol on Insulin Resistance in High Fat Diet-induced Diabetic Mice
  2160. Beneficial effects of date palm fruits on Neurodegenerative diseases
  2161. Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases
  2162. Beneficial effects of ellagic acid against animal models of scopolamine-and diazepam-induced cognitive impairments
  2163. Beneficial Effects of Extra Virgin Olive Oil (n-9 Fatty Acids) on Neurological Disorders
  2164. Beneficial Effects of Ginkgo biloba in Neurological Disorders
  2165. Beneficial effects of green tea catechins on Neurodegenerative diseases
  2166. Beneficial effects of green tea catechins on neurological disorders
  2167. Beneficial effects of propolis on neurological disorders
  2168. Beneficial Effects of Resveratrol Administration—Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions
  2169. Beneficial upshots of naturally occurring antioxidant compounds against neurological disorders
  2170. Benefits of curcumin in brain disorders
  2171. Benefits of grape chemicals on human health
  2172. Benefits of the Mediterranean Diet in the Elderly Patient
  2173. Benefits of tree nuts consumption on aging and age-related diseases: mechanisms of actions
  2174. Benzimidazole derivatives: active class of antioxidants
  2175. Berberine and neurodegeneration: A review of literature
  2176. Berberine–A Neuropsychiatric Pharmacotherapy
  2177. Bergenia ciliata ameliorates streptozotocin-induced spatial memory deficits through dual cholinesterase inhibition and attenuation of oxidative stress in rats
  2178. Berries and Health: A review of the evidence
  2179. Berries: Properties, Consumption and Nutrition
  2180. Berry fruit enhances beneficial signaling in the brain
  2181. Berry fruit supplementation and the aging brain
  2182. Berry Supplementation and Their Beneficial Effects on Some Central Nervous System Disorders
  2183. Berryfruit Cognitive Study: Final Report Berryfruit Cognitive Study
  2184. Beverage Impacts on Health and Nutrition
  2185. Beverages of lemon juice and exotic noni and papaya with potential for anticholinergic effects
  2186. Binding modes of phthalocyanines to amyloid β peptide and their effects on amyloid fibril formation
  2187. Bio prospection of antioxidant potential of Pinus roxburghii Sarg collected from different Himalayan regions of India
  2188. Bioactive chemicals and health benefits of grapevine products
  2189. Bioactive Compounds as Therapeutic Alternatives
  2190. Bioactive Compounds Contained in Mediterranean Diet and Their Effects on Neurodegenerative Diseases
  2191. Bioactive compounds from endemic plants of Southwest Portugal: Inhibition of acetylcholinesterase and radical scavenging activities
  2192. Bioactive compounds from ethnobotanically-selected plants in Indonesia
  2193. Bioactive compounds from macroalgae in the new millennium: implications for Neurodegenerative diseases
  2194. Bioactive compounds in medicinal plants: A condensed review
  2195. Bioactive compounds of chestnuts as health promoters
  2196. Bioactive compounds of kimchi inhibit apoptosis by attenuating endoplasmic reticulum stress in the brain of amyloid β-injected mice
  2197. BIOACTIVE COMPOUNDS WITH NEUROPHARMACOLOGICAL PROPERTIES FROM MEDICINAL PLANTS–A BRIEF REVIEW
  2198. Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions
  2199. Bioactive metabolites from macrofungi: ethnopharmacology, biological activities and chemistry
  2200. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease
  2201. Bioactive nutraceuticals and dietary supplements in neurological and brain disease: prevention and therapy
  2202. Bioactive Oxidised Products of Omega-6 and Omega-3, Excess Oxidative Stress, Oxidised Dietary Intake and Antioxidant Nutrient Deficiencies, in the Context of a …
  2203. Bioactive properties of Chamaerops humilis L.: antioxidant and enzyme inhibiting activities of extracts from leaves, seeds, pulp and peel
  2204. Bioactive Substances of Plant Origin 30
  2205. Bioactives from culinary spices and herbs: a review
  2206. Bioactivity of essential oils and their volatile aroma components
  2207. Bioactivity of Morus alba l. Extracts-An overview
  2208. Bioactivity Screening of One Hundred Kind Pure Compounds by ABTS and DPPH Method
  2209. Bioavailability and toxicity of aluminium to the freshwater pond snail, Lymnaea stagnalis at neutral pH
  2210. Biochemical and thermodynamic characterization of a novel, low-molecular-weight xylanase from Bacillus sp. CSB40 isolated from traditional Korean food
  2211. Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements
  2212. Biochemical insights related to the propensity of phytochemicals in forestalling/reversing neuronal dysfunctions
  2213. Biochemical pharmacology of functional foods and prevention of chronic diseases of aging
  2214. Biochemical profile and in vitro neuroprotective properties of Carpobrotus edulis L., a medicinal and edible halophyte native to the coast of South Africa
  2215. Biochemical properties and neuroprotective effects of compounds in various species of berries
  2216. Biochemical Studies on Phytocystain Purified from Brassica Alba Yellow Indian Mustard Seeds
  2217. Bioconversion of SB enhances otoprotective effect against noise induced hearing loss in mouse
  2218. Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products
  2219. Biodiversity and Therapeutic Potential of Medicinal Plants
  2220. Biodiversity, biology and conservation of medicinal plants of the Thar Desert
  2221. Bioinformatics Approaches to Find Potential Therapeutic Candidates Using Microarray and Protein-Protein Interaction Resources for Psoriasis
  2222. BIOKINETICS OF GINGER TO MITIGATE HEALTH RELATED DISORDERS
  2223. Biological activities of (−)-epicatechin and (−)-epicatechin-containing foods: Focus on cardiovascular and neuropsychological health
  2224. Biological activities of mimosine isolated from Leucaena leucocephala and identification of bioactive compounds from subtropical plant Bidens pilosa
  2225. Biological activities of the natural antioxidant oleuropein: Exceeding the expectation–A mini-review
  2226. Biological activity and phytochemistry of firethorn (Pyracantha coccinea MJ Roemer)
  2227. Biological activity of HPLC-characterized ethanol extract from the aerial parts of Haplophyllum tuberculatum
  2228. BIOLOGICAL ACTIVITY OF SOME NATURAL AND SYNTHETIC N6-SUBSTITUTED ADENOSINE DERIVATIVES (CYTOKININ RIBOSIDES)
  2229. Biological activity of Spondias pinnata: a review
  2230. Biological and chemical insights of Morina persica L.: A source of bioactive compounds with multifunctional properties
  2231. Biological applications of designed hairpin peptides: as antimicrobials and as inhibitors of amyloidogenesis
  2232. Biological Evaluation of Natural Product as a Potent Hsp90 Inhibitor.
  2233. Biological fingerprinting of herbal samples by means of liquid chromatography
  2234. Biologically active metabolites of plants. 7. Alkaloids from Corydalis yanhusuo and their biological activity.
  2235. Biologically relevant secondary metabolites of Vaccinium uliginosum: bioassay-directed natural products identification of anti-neuroninflammatory agents in the Alaska …
  2236. Biology-oriented development of novel lipophilic antioxidants with neuroprotective activity
  2237. Biomarkers in long‐term vegetarian diets
  2238. Biomarkers of Foods and Nutraceuticals: Applications in Efficacy, Safety, and Toxicity
  2239. Biopesticides from plants: Calceolaria integrifolia sl
  2240. Bioprospecting plants for natural antioxidants: An overview
  2241. Bioscience frontiers in neuromedical intervention following brain injury
  2242. Biotechnology, In Vitro Production of Natural Bioactive Compounds, Herbal Preparation, and Disease Management (Treatment and Prevention)
  2243. Black berry juice attenuates neurological disorders and oxidative stress associated with concurrent exposure of aluminum and fluoride in male rats
  2244. Black chokeberry (Aronia melanocarpa) and its products as potential health-promoting factors-An overview
  2245. Black tea: The plants, processing/manufacturing and production
  2246. Blood brain barrier inflammation and potential therapeutic role of phytochemicals
  2247. BLUEBERRIES
  2248. Blueberries and neuronal aging
  2249. Blueberry Opposes β-Amyloid Peptide-Induced Microglial Activation Via Inhibition of p44/42 Mitogen-Activation Protein Kinase
  2250. Blueberry supplementation improves memory in older adults
  2251. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats
  2252. Boost Your Brain Power in 60 Seconds: The 4-week Plan for a Sharper Mind, Better Memory, and Healthier Brain
  2253. Botanicals and phytochemicals active on cognitive decline: The clinical evidence
  2254. Boysenberry and blackcurrant drinks increased the plasma antioxidant capacity in an elderly population but had little effect on other markers of oxidative stress
  2255. BPA and Nutraceuticals, Simultaneous Effects on Endocrine Functions
  2256. Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline
  2257. Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function
  2258. Brain Fitness for Women: Keeping Your Head Clear & Your Mind Sharp at Any Age
  2259. Brain Food
  2260. Brain food: How nutrition alters our mood and behaviour
  2261. Brain iron metabolism and its perturbation in neurological diseases
  2262. Brain Protective and Erythrocytes Hemolysis Inhibition Potentials from Galls of Guiera senega lensis JF Gmel (Combretaceae)” PAED Sombie,” A. Hilou,” AY …
  2263. Brain-Building Nutrition: The Healing Power of Fats and Oils
  2264. Brief Challenges on Medicinal Plants: An Eye‐Opening Look at Ageing‐Related Disorders
  2265. Brine shrimp lethality test and acetylcholine esterase inhibition studies on selected South African medicinal plants
  2266. Broad bean (Vicia faba L.) pods: a rich source of bioactive ingredients with antimicrobial, antioxidant, enzyme inhibitory, anti-diabetic and health-promoting properties
  2267. Cacao and Human Health: from Head to Foot–A Review
  2268. Caenorhabditis elegans: a model organism for nutraceutical safety and toxicity evaluation
  2269. CAFFEIC ACID AVERTED INTRACEREBROVENTRICULAR COLCHICINE-INDUCED MEMORY DEFICITS IN RATS
  2270. Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity
  2271. CAFFEINATED BEVERAGE CONSUMPTION IN UNDERGRADUATE STUDENTS AT A PUBLIC MID-WESTERN UNIVERSITY
  2272. Caffeinated Beverages, Behavior, and Brain Structure
  2273. Caffeoylquinic acid induces ATP production and energy metabolism in human neurotypic SH-SY5Y cells
  2274. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of Neurodegenerative diseases provide multiple targets for neuroprotection
  2275. Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction
  2276. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential
  2277. Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity
  2278. Calorie restriction mimetics and aging
  2279. Can crosstalk between DOR and PARP reduce oxidative stress mediated neurodegeneration?
  2280. Can nonalcoholic beer, silicon and hops reduce the brain damage and behavioral changes induced by aluminum nitrate in young male Wistar rats?
  2281. Can tea consumption be a safe and effective therapy against diabetes mellitus-induced neurodegeneration?
  2282. Cannabinoids: A Group of Promising neuroprotective Agents
  2283. Canyon Ranch 30 Days to a Better Brain: A Groundbreaking Program for Improving Your Memory, Concentration, Mood, and Overall Well-Being
  2284. Capillarisin attenuates muscle damage after intense exercise
  2285. Capsicum annuum bioactive compounds: Health promotion perspectives
  2286. Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators
  2287. Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation
  2288. Cardioprotective and neuroprotective roles of oleuropein in olive
  2289. CARNOSINE: A POTENT MODULATOR FOR DIFFERENT DISEASES
  2290. Carotenoids of microalgae used in food industry and medicine
  2291. Carthamus, Salvia and Stachys species protect neuronal cells against oxidative stress-induced apoptosis
  2292. Castanea sativa Mill. Leaves as New Sources of Natural Antioxidant: An Electronic Spin Resonance Study
  2293. Catalpol: a potential therapeutic for Neurodegenerative diseases
  2294. Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats
  2295. Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway
  2296. Catharanthus roseus: Detoxification and Hepatic Protection of Aflatoxin B1
  2297. Cell aging: molecular mechanisms and implications for disease
  2298. Cell and Nanoparticle Tracking PET Imaging Study using Bioorthogonal F-18 Labeling Protocols.
  2299. Cell culture models of oxidative stress and injury in the central nervous system
  2300. Cell death and neuronal arborization upon quercetin treatment in rat neurons
  2301. Cell Protective Signaling Pathway of Activated Protein C
  2302. Cellular and mitochondrial effects of alcohol consumption
  2303. Cellular Antioxidant Defenses and Amelioration by Biopigments with Particular Focus on mRNA Oxidations
  2304. Cellular prion protein-dependent signaling pathway for proinflammatory cytokine-and β-amyloid-induced cofilin-actin rod formation, A
  2305. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, Neurodegenerative disorders and longevity
  2306. Centella asiatica (Gotu kola) as a neuroprotectant and its potential role in healthy ageing
  2307. Centella asiatica attenuates D-galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice
  2308. Centella asiatica, an Ayurvedic Medicinal Plant, Prevents the Major Neurodegenerative and Neurotoxic Mechanisms Associated with Cognitive Impairment
  2309. Centella asiatica: phytochemistry and mechanisms of neuroprotection and cognitive enhancement
  2310. Central additive effect of Ginkgo biloba and Rhodiola rosea on psychomotor vigilance task and short-term working memory accuracy
  2311. Central nervous system diseases and Scutellaria: a review of current mechanism studies
  2312. Cerebrovascular and neuronal cellular consequences of amyloid-βinduced nuclear factor-κB activation
  2313. Chaenomeles–health promoting benefits
  2314. Challenges on the processing of plant-based neuronutraceuticals and functional foods with emerging technologies: Extraction, encapsulation and therapeutic …
  2315. Chamomile: a herbal agent for treatment of diseases of the elderly
  2316. Changes & Directions of Education for Other Health Care Professionals: Medical & Dental Education in Korea
  2317. Changes in the Central Glutamatergic Nervous Activity Following Chronic Intracerebroventricular Administration of Nicotine in Rats
  2318. Changes of Anti-inflammatory Activity of Gardeniae Fructus by Processing
  2319. Changes of Catecholamine Secretion in the Perfused Adrenal Medulla of the Alloxan-Induced Diabetic Rats
  2320. CHANGES TO THE BRAIN FOUNDATION BOARD
  2321. Changing paradigm to target microglia in Neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation
  2322. Characteristcs of Pathogen-specific Memory T cells in the Liver during acute viral infection
  2323. Characteristics, Biological Properties and Analytical Methods of Trans-Resveratrol: A Review
  2324. Characteristics, composition, and antioxidant activities in vitro and in vivo of Gynostemma pentaphyllum (Thunb.) Makino seed oil
  2325. Characterization and bioavailability of neuroprotective grape seed extract in an animal model
  2326. Characterization of antimicrobial and antioxidant metabolites from Pinus gerardiana and Picea smithiana growing in North Western Himalayas
  2327. Characterization of Autophagic Cell Death Mechanism in Two Different Dopaminergic Neuronal Models
  2328. Characterization of Novel Regulators of Helper T Cell Proliferation
  2329. Characterization of Physicochemical Properties for ADME/PK Study and New Drug Discovery
  2330. Characterization of Tau Oligomeric Strains: Implications for Disease Phenotypes
  2331. Characterization of the neuroprotective potential of derivatives of the iron chelating drug deferiprone
  2332. Characterizing the inhibition of α‐synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP
  2333. Chemical analysis and antioxidant activities of bark extracts from four endemic species of Hyrcanian forests in Iran
  2334. Chemical analysis and neurobiological effects of Newfoundland wild blueberries
  2335. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals
  2336. Chemical characterization and antioxidant properties of a new coffee blend with cocoa, coffee silverskin and green coffee minimally processed
  2337. Chemical Composition and Antioxidant Activity of Aloe saponaria
  2338. Chemical composition and antioxidant, antibacterial and antifungal activities of the essential oils from Bidens pilosa Linn. var. Radiata
  2339. Chemical composition and biological activity of Capparis spinosa L. from Lipari Island
  2340. Chemical composition and in vitro antioxidative activity of a lemon balm (Melissa officinalis L.) extract
  2341. Chemical Composition Antioxidant and Antimicrobial Activities of the Essential Oils of Matricaria aurea Loefl. Growing in Tunisia
  2342. Chemical composition of the lipophilic fraction of Livistona australis R. Br. Mart.,(Arecaceae) fruit pulp and evaluation of its antioxidant and antihyperlipidemic …
  2343. Chemical composition of the perennial plant sorghum and fodder prepared and hay.
  2344. Chemical composition, antioxidant potential, macromolecule damage and neuroprotective activity of Convolvulus pluricaulis
  2345. Chemical constituents from the fruits of Citrus unshiu and their inhibitory effects on acetylcholinesterase
  2346. Chemical Constituents of Selected Herbal Medicines
  2347. Chemical Constituents of Soft Coral Lobophytum compactum in the Sea Vietnam and Cytotoxic and Antioxidant Activities of Some Diterpenes and Sterols
  2348. Chemical Constituents with Pancreatic Lipase Inhibitory Activity from the Rhizomes of Anemarrhena asphodeloides.
  2349. Chemical modification of the multitarget neuroprotective compound fisetin
  2350. Chemical modulators of protein misfolding and Neurodegenerative disease
  2351. Chemical profiling and in vitro biological effects of Cardiospermum halicacabum L. (Sapindaceae) aerial parts and seeds for applications in Neurodegenerative …
  2352. Chemical profiling, antioxidant, enzyme inhibitory and molecular modelling studies on the leaves and stem bark extracts of three African medicinal plants
  2353. Chemical standardization of some anti inflammatory rasayana plants used in Indian system of medicine
  2354. Chemical transformations and phytochemical studies of bioactive components from extracts of rosmarinus officinalis L.
  2355. Chemical, molecular pharmacology and neuroprotective properties of the essential oil derived from Aloysia citrodora Palau
  2356. Chemistry and Biochemistry of Terpenoids from Curcuma and Related Species
  2357. Chemistry and functional properties in prevention of Neurodegenerative disorders of five Cistus species essential oils
  2358. Chemistry and health effects of bioactive compounds in selected culinary aromatic herbs
  2359. Chemistry and pharmacological properties of some natural and synthetic antioxidants for heavy metal toxicity
  2360. Chemistry and pharmacology of naturally occurring bioactive compounds
  2361. Chemistry and pharmacology of Withania somnifera: An update
  2362. Chemistry of Advanced Materials 3 (2)(2018) 36-59 Antioxidant, Anti-inflammatory and neuroprotective Activities of a Plant Extract Derived from Traditional Chinese …
  2363. Chemistry of functional foods and their role in disease control
  2364. Chemo-botanical and neurological accounts of some ayurvedic plants useful in mental health
  2365. Chemoprevention of Inflammation-Associated Colorectal Carcinogenesis: Molecular Targets and Underlying Mechanisms
  2366. Cherry phytochemicals
  2367. Chicoric acid supplementation ameliorates cognitive impairment induced by oxidative stress via promotion of antioxidant defense system
  2368. Chinese Herbal Medicine Used Against Depression in China
  2369. Chinese Medicines in Neurological Diseases: Pharmacological Perspective
  2370. Chinical Application of Adult Stem Cell Therapy in Neurological Disorders; Present and Future
  2371. Chiral Self-Recognition of 3, 5-Dinitrobenzoylleucine Derivatives using Pirkle-type Chiral Stationary Phases
  2372. Chitooligosaccharide (CHOS) mediated regulation of intestinal inflammatory condition in colitis mice
  2373. Chloroquine inhibits glutamate‐induced death of a neuronal cell line by reducing reactive oxygen species through sigma‐1 receptor
  2374. Chocolate, air pollution and children’s neuroprotection: What cognition tools should be at hand to evaluate interventions?
  2375. Chocolate, air pollution and children’s neuroprotection: What cognition tools should be at hand to evaluate interventions?
  2376. Cholesterol, Statins and the Truth about Cardiovascular Health and Disease
  2377. Cholinesterase inhibition of selected 4-methylcoumarins in comparison to their antioxidant activity
  2378. Cholinesterase inhibitor (Altenuene) from an endophytic fungus Alternaria alternata: optimization, purification and characterization
  2379. Cholinesterase inhibitors from plants: possible treatment strategy for neurological disorders-a review
  2380. Cholinesterase inhibitory, anti-oxidant and anti-tyrosinase activities of three Iranian species of Dracocephalum
  2381. Cholinesterase, β-amyloid aggregation inhibitory and antioxidant capacities of Chinese medicinal plants
  2382. Chromatographic Fingerprint Analysis, Acetylcholinesterase Inhibitory Properties and Antioxidant Activities of Redflower Ragleaf (Crassocephalum Crepidioides) …
  2383. Chromolaena odorata (L.) RM King & H. Rob.(Asteraceae) in sub-Saharan Africa: A synthesis and review of its medicinal potential
  2384. Chronic administration of quercetin prevent spatial learning and memory deficits provoked by chronic stress in rats
  2385. Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress
  2386. Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity
  2387. Chrysophanol: a natural anthraquinone with multifaceted biotherapeutic potential
  2388. Cilostazol, a Phosphodiesterase Inhibitor Attenuates Endotoxin Shock and LPS-induced Inflammation by Independence of cAMP, MAPK, and NK-kappaB …
  2389. Cinnamon and chronic diseases
  2390. Cistanches Herba: a neuropharmacology review
  2391. Citrus: A Perspective for Developing Phytomedicines for Neurodegenerative Diseases
  2392. Clean Cuisine: An 8-Week Anti-Inflammatory Diet that Will Change the Way You Age, Look & Feel
  2393. Clinical aspects of functional foods and nutraceuticals
  2394. Clinical benefits and pharmacology of scutellarin: a comprehensive review
  2395. Clinical benefits of green tea consumption for cognitive dysfunction
  2396. Clinical natural medicine handbook
  2397. Clinical Pharmacological Aspects of Herb-drug Interaction
  2398. Clinical research on traditional chinese medicine compounds and their preparations for amyotrophic lateral sclerosis
  2399. Clinical trials of resveratrol
  2400. Clitoria ternatea ameliorated the intracerebroventricularly injected streptozotocin induced cognitive impairment in rats: behavioral and biochemical evidence
  2401. Cocoa and chocolate in human health and disease
  2402. Cocoa and chocolate: chemistry, biochemistry, and beneficial brain effects
  2403. Cocoa and health
  2404. Cocoa and human health: from head to foot—a review
  2405. Cocoa beans improve mitochondrial biogenesis via PPARγ/PGC1α dependent signalling pathway in MPP+ intoxicated human neuroblastoma cells (SH-SY5Y)
  2406. Cocoa phytochemicals: recent advances in molecular mechanisms on health
  2407. Coconut (Cocos nucifera) ethanolic leaf extract reduces Amyloid-β (1-42) aggregation and paralysis prevalence in transgenic Caenorhabditis elegans independently …
  2408. Coenzyme Q10: From bench to clinic in aging diseases, a translational review
  2409. Coffee and its active compounds are neuroprotective
  2410. Coffee Consumption and Chronic Diseases: Nutrigenomics Perspectives
  2411. Coffee Diterpene Kahweol Inhibits Metastasis via STAT3 Inactivation
  2412. Coffee intake can promote activity of antioxidant enzymes with increasing MDA level and decreasing HDL-cholesterol in physically trained rats
  2413. Coffee–Chemical Composition and Potential Impact on Health
  2414. Coffee–functional food and medicinal herb
  2415. Coffee, caffeine, chlorogenic acid, and the purinergic system
  2416. Coffee: A health fuel-blot popular drinking
  2417. Coffee: Consumption and Health Implications
  2418. Coffee: The revolutionary drink for pleasure and health
  2419. Cognitive and behavioral assessment in dogs and pet food market applications
  2420. Cognitive and cardiovascular aging: The effects of multivitamin supplementation
  2421. Cognitive and mood improvements following acute supplementation with purple grape juice in healthy young adults
  2422. Cognitive anxiolytics
  2423. Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice
  2424. Cognitive enhancement and neuroprotection by catechin‐rich oil palm leaf extract supplement
  2425. Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs
  2426. Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014
  2427. Cognitive Enhancing, Anti-Acetylcholinesterase and Antioxidant Properties of Tagetes erecta against Diazepam Induced Amnesia in Rodents
  2428. Cognitive function and tea consumption in community dwelling older Chinese in Singapore
  2429. Cognitive impairment in patients with type 2 diabetes mellitus: Perspectives and challenges
  2430. Cognitive impairments in type 2 diabetes, risk factors and preventive strategies
  2431. Cognitive Improving Effects by Highbush Blueberry (Vaccinium crymbosum L.) Vinegar on Scopolamine-Induced Amnesia Mice Model
  2432. Cognitive Nutrition
  2433. Cognitive short-and long-term effects of coffee cherry extract in older adults with mild cognitive decline
  2434. Combination Protocol of Surface Camouflage and Immunosuppressive Drugs for the Pancreatic Islet Transplantation
  2435. Committee on herbal medicinal products (HMPC)
  2436. Commonly used dietary supplements on coagulation function during surgery
  2437. Comparative analysis of synthetic and nutraceutical antioxidants as possible neuroprotective agents
  2438. Comparative approaches to understanding thyroid hormone regulation of neurogenesis
  2439. Comparative biophysical characterization: A screening tool for acetylcholinesterase inhibitors
  2440. Comparative effect of Camellia sinensis teas on object recognition test deficit and metabolic changes induced by cafeteria diet
  2441. Comparative evaluation of Prosopis cineraria (L.) druce and its ZnO nanoparticles on scopolamine induced amnesia
  2442. Comparative Evaluation of the Antioxidant Properties of Prunella vulgaris L. and Thymus vulgaris L.
  2443. Comparative qualitative and quantitative analysis of phytochemicals in five different herbal formulations of Bacopa monnieri
  2444. Comparative study on anti-oxidant and anti-inflammatory activities of Caesalpinia crista and Centella asiatica leaf extracts
  2445. Comparison between Hexane and Water Fractions from Equisetum hyemale L. for Antioxidant Activity
  2446. Comparison of Consumer Acceptance, Physico-chemical Properties, and Bioactive Delivery of Blueberry Extract and Whole Blueberry Powder Confections
  2447. Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice
  2448. Comparison of the inhibition of monoamine oxidase and butyrylcholinesterase activities by infusions from green tea and some citrus peels
  2449. Comparison of the neuroprotective and anti-inflammatory effects of the anthocyanin metabolites, protocatechuic acid and 4-hydroxybenzoic acid
  2450. Comparison of two analytical methods for assessing antioxidant capacity of rapeseed and olive oils
  2451. Comparison of α-synuclein fibril inhibition by four different amyloid inhibitors
  2452. Complementary and alternative medicine for the treatment of multiple sclerosis
  2453. Complementary and alternative medicines use against Neurodegenerative diseases
  2454. Complementary and Integrative Therapies for Psychiatric Disorders, An Issue of Psychiatric Clinics, E-Book
  2455. Comprehensive review on the interaction between natural compounds and brain receptors: Benefits and toxicity
  2456. Computational insight into the effect of natural compounds on the destabilization of preformed amyloid-β (1–40) fibrils
  2457. Computer aided drug design studies in the discovery of secondary metabolites targeted against age-related Neurodegenerative diseases
  2458. Conditional Knockdown of p70 S6 Kinase in Liver Protects against Hepatic Steatosis and Systemic Insulin Resistance
  2459. Conformation-Specific Chemical Probes for Amyloid
  2460. Conformation-Specific Chemical probes for Amyloid-Beta
  2461. Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in Neurodegenerative diseases
  2462. Considerations for evaluation of public health nutrition interventions in diverse communities
  2463. Constituents with DNA Topoisomerase I and II Inhibitory Activity and Cytotoxicities from Euonymus alatus III
  2464. Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice
  2465. Consumption Of Drugs For Peptic Ulcer And Gastroesophageal Reflux Disease: An Analysis Focusing On Drug Claims 2006 To 2011
  2466. Consumption of Nuts at Midlife and Healthy Aging in Women
  2467. Contribution of Receptors, Transcription Factors, and Genes in the Induction of Neuroinflammation
  2468. Contribution of Yeast and Plant Research for Improving Human Health
  2469. Convenient determination of methylsulfonylmethane for a commercially available dietary supplement formulations using gas chromatography-flame ionization …
  2470. Coordination complex formation and redox properties of kynurenic and xanthurenic acid can affect brain tissue homeodynamics
  2471. Copper and Zinc Binding to Amyloid‐β: Coordination, Dynamics, Aggregation, Reactivity and Metal‐Ion Transfer
  2472. Coriander (Coriandrum sativum): A promising functional food toward the well-being
  2473. Coriolus versicolor biomass increases dendritic arborization of newly-generated neurons in mouse hippocampal dentate gyrus
  2474. Correlation between antibutyrylcholinesterasic and antioxidant activities of three aqueous extracts from Tunisian Rhus pentaphyllum
  2475. Correlations Among Total Ash, Acid-Insoluble Ash, and Heavy Metals Contained in the Component Medicinal Herbs of “Ssanghwatang”, a Widely Used …
  2476. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
  2477. Coumarins and related compounds from the medicinal plants of Africa
  2478. Coumarins as Promising Scaffold for the Treatment of Age-related Diseases–An Overview of the Last Five Years
  2479. Coupling sea lavender (Limonium algarvense Erben) and green tea (Camellia sinensis (L.) Kuntze) to produce an innovative herbal beverage with enhanced …
  2480. Crepis foetida L. subsp. rhoeadifolia (Bieb.) Celak. as a source of multifunctional agents: Cytotoxic and phytochemical evaluation
  2481. Critical evaluation of ayurvedic plants for stimulating intrinsic antioxidant response
  2482. Cross Talk Between Impaired Brain Glucose Metabolism and Tau hyperphosphorylation
  2483. Cross-Talk for Health Care Providers Nutrition and Behavior as it Applies to Systemic and Ocular
  2484. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related Neurodegenerative disease: Etiologies and therapeutic strategies
  2485. Cu and Zn interactions with Aβ peptides: Consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers
  2486. Cudratricusxanthone L Suppresses Lipopolysaccharide-induced Activation of BV2 and Primary Rat Microglial Cells by Inhibiting JNK, p38 MAPK, and NF-κB …
  2487. Cultural and Natural Resources and Quality Control of Chinese Medicinal Materials
  2488. Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha‐Synuclein Fibrillation and Cytotoxicity
  2489. Curcuma longa L.: From Ethnomedicinal to Novel Biomedical Applications
  2490. Curcumin activates defensive genes and protects neurons against oxidative stress
  2491. Curcumin and health
  2492. Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain
  2493. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century
  2494. Curcumin and Neurodegenerative diseases: a perspective
  2495. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences
  2496. Curcumin counteracts the aluminium-induced ageing-related alterations in oxidative stress, Na+, K+ ATPase and protein kinase C in adult and old rat brain regions
  2497. Curcumin Impact on Multiple Sclerosis
  2498. Curcumin-Loaded Nanocapsules Reverses the Depressant-Like Behavior and oxidative stress Induced by β-Amyloid in Mice
  2499. Curcumin-supplemented diets improve antioxidant enzymes and alter acetylcholinesterase genes expression level in Drosophila melanogaster model
  2500. Curcumin—from molecule to biological function
  2501. Curcumin, an atoxic antioxidant and natural NFκB, cyclooxygenase‐2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic …
  2502. Curcumin, Hormesis and the Nervous System
  2503. Curcumin: Structure-activity relationship towards its role as a versatile multi-targeted therapeutics
  2504. Curcuminoids promote neurite outgrowth in PC12 cells through MAPK/ERK-and PKC-dependent pathways
  2505. Current and future treatment of amyloid diseases
  2506. Current evidence of Chinese herbal constituents with effects on NMDA receptor blockade
  2507. Current perspective in the discovery of anti-aging agents from natural products
  2508. Current perspectives on anti-aging interventions
  2509. Current State and Prospects of DNA Barcoding and DNA Fingerprinting in the Analysis of the Quality of Plant Raw Materials and Plant-Derived Drugs
  2510. Current Status and Perspective of R&D Promotion in Food, Agriculture, Forestry and Fisheries
  2511. Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery
  2512. Current Supporting System for New Drug Development in the R&D Program of Ministry of Health and Welfare
  2513. Current therapeutic molecules and targets in Neurodegenerative diseases based on in silico drug design
  2514. Current trends and future perspectives on functional foods and nutraceuticals
  2515. Current trends in glaucoma: what about neuroprotection?
  2516. Cuttlebone has anti-inflammatory activity via the suppression of NF-κB activation
  2517. Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases
  2518. Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells
  2519. Cytoprotective effect of methanolic extract of Nardostachys jatamansi against hydrogen peroxide induced oxidative damage in C6 glioma cells.
  2520. Cytoprotective effects of hesperetin and hesperidin against amyloid β‐induced impairment of glucose transport through downregulation of neuronal autophagy
  2521. Cytoprotective mechanism of baicalin against endothelial cell damage by peroxynitrite
  2522. Cytotoxic and antioxidant activity in aqueous fraction of Opuntia elatior extract
  2523. Cytotoxic Effects of Ginsenoside Rb1 and Ginsenoside Rh1 against HIV-1-Transduced Human Macrophages
  2524. Cytotoxicity Models of Huntington’s Disease and Relevance of Hormetic Mechanisms: A Critical Assessment of Experimental Approaches and Strategies
  2525. Daily consumption of antioxidants:-prevention of disease is better than cure
  2526. Dalbergia ecastaphyllum leaf extracts: in vitro inhibitory potential against enzymes related to metabolic syndrome, inflammation and Neurodegenerative diseases
  2527. Date palm (Phoenix dactylifera): novel findings and future directions for food and drug discovery
  2528. Daumone Fed Late in Life Ameliorates Renal Aging in Mice
  2529. Dealing with misfolded proteins: examining the neuroprotective role of molecular chaperones in neurodegeneration
  2530. Dealing with skin and blood-brain barriers: The unconventional challenges of mesoporous silica nanoparticles
  2531. Deciphering the enhanced inhibitory, disaggregating and cytoprotective potential of promethazine towards amyloid fibrillation
  2532. Deciphering the molecular signaling cascade in rotenone-mediated neuronal death
  2533. Decoding Longevity: Ending Aging as We Know It
  2534. Decreasing effect of mast cell of dung beetle extracts on a high-fat diet in Sprague-Dawley rats
  2535. Decursinol angelate isolated from Angelica Gigantis Radix potentiates pentobarbital-induced sleeping behaviors via GABAA-ergic systems.
  2536. Degenerative Diseases of Ageing: Causes and Preventions
  2537. Delivery of nanoformulated superoxide dismutase to the brain for the treatment of angiotensin II-mediated hypertension
  2538. Demyelinating diseases
  2539. Depressive symptoms and diet: their effects on prospective inflammation levels in the elderly
  2540. Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification
  2541. Desflurane Induces Cardioprotection Against Myocardial Infarct in vivo Through Activation of Adenosine-Monophosphate-activated Protein Kinase
  2542. Design of diarylheptanoid derivatives as dual inhibitors against class IIa histone deacetylase and β-amyloid aggregation
  2543. Design of pharmacophoric group containing 1, 4-dihydropyridine derivatives and determination of spectrum of pharmacological activities
  2544. Design, synthesis and in vitro biological evaluation of new transthyretin (TTR) amyloid fibril formation inhibitors
  2545. Design, synthesis, and in vitro evaluation of a novel probucol derivative: protective activity in neuronal cells through GPx upregulation
  2546. DESIGN, SYNTHESIS, ANTI-INFLAMMATORY ACTIVITY EVALUATION, AND STRUCTURE-ACTIVITY RELATIONSHIP (SAR) STUDY OF DIARYLPENTANOID …
  2547. Designing Bioactive Nanoparticles: The Era of Nutraceuticals
  2548. Designing drugs with multi-target activity: the next step in the treatment of Neurodegenerative disorders
  2549. Determinants of Pharmaceutical Expenditure in National Health Insurance: Policy Implication of the Analysis
  2550. Determination of aluminum and zinc in infusion tea cultivated in north of Iran
  2551. Determination of anti-inflammatory activities of standardised preparations of plant-and mushroom-based foods
  2552. Determination of Antioxidant and Antimicrobial Activity of Dichloromethane Extract of Garcinia cowa stem
  2553. Determination of antioxidant capacities of vegetable oils by ferric-ion spectrophotometric methods
  2554. Determination of antioxidant capacity of Chinese rice wine and Zhuyeqing Liquor using nanoparticle-based colorimetric methods
  2555. Determination of Globotriaosyl Sphingosine (Lyso-Gb3) by LC-negative Electrospary Ionization Tandem Mass Spectrometry for Fabry Disease as a Biomarker
  2556. Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies
  2557. Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic
  2558. Development and evaluation of polyherbal formulations for antidiabetic and antiphypertensive activities
  2559. Development of a neuroprotective potential algorithm for medicinal plants
  2560. Development of a New Adjuvant System for Vaccines against Infectious Diseases
  2561. Development of a novel gold nanoparticle-based method to determine antioxidant capacity of Brassica oilseeds, white flakes and meal
  2562. Development of Advance Extraction Methods for the Determination of Aluminum and Vanadium in Environmental, Biological and Pharmaceutical Samples
  2563. Development of Biosensors to Monitor the Interaction of Small Molecules with Amyloidogenic Proteins using Optical and Electrochemical Methods
  2564. Development of Chemical Modulators for Heat Shock Protein 70 (Hsp70): a Potential Therapeutic Target for Tauopathies.
  2565. Development of Medication Adherence Management Program for Chronic Diseases using National Health Insurance Database
  2566. Development of neuroprotective strategies utilizing selected spice actives
  2567. Development of novel delivery systems for nose-to-brain drug delivery
  2568. Development of Recombinant Protein Therapeutics for Immune and Metabolic Genetic Diseases
  2569. Development of Shinbaro, a New Herbal Medicine in the Treatment of Osteoarthritis
  2570. Development of Therapeutic Agent for Duchenne Muscular Dystrophy by Targeting NMD
  2571. Developmental neurotoxicity of the organophosphorus pesticide chloryprifos: from animal behavior to molecular mechanisms
  2572. DH504 inhibits endotoxin-induced inflammation in murine macrophages
  2573. Diabetes mellitus: channeling care through cellular discovery
  2574. Diagnostic and management challenges in chronic obstructive pulmonary disease and heart failure: the need for an interdisciplinary approach
  2575. Diazepam-induced Cognitive Enhancement is Associated with the Alteration of GABAA Receptor Subunit in Transient Forebrain Ischemia Mice Model
  2576. Dicarbonyl stress at the crossroads of healthy and unhealthy aging
  2577. Diet and brain aging: effects on cell and mitochondrial function and structure
  2578. Diet and cognition: interplay between cell metabolism and neuronal plasticity
  2579. Diet and exercise interventions to promote metabolic homeostasis in TBI pathology
  2580. Diet and herbal-derived medicines
  2581. Diet and inflammation
  2582. Diet and longevity: The effects of traditional eating habits on human lifespan extension
  2583. Diet quality and cognition among older adults from the NuAge study
  2584. Diet Science/Plant Medicine Research
  2585. Diet supplementation with hydroxytyrosol ameliorates brain pathology and restores cognitive functions in a mouse model of amyloid-β deposition
  2586. Diet, Exercise, and Chronic Disease: The Biological Basis of Prevention
  2587. Dietary advanced glycation end products and their role in health and disease
  2588. Dietary and Serum Level of Antioxidants in the Elderly with Mild Impaired and Normal Cognitive Function: A Case-Control Study
  2589. Dietary antioxidant for disease prevention corroborated by the Nrf2 pathway
  2590. Dietary antioxidants, peroxidation and cardiovascular risks
  2591. Dietary Berry Supplementation in Aging
  2592. Dietary Coumarins
  2593. Dietary Curcumin And Caloric Restriction As Interventions For The Reversal Of Age Associated Functional Decline
  2594. Dietary derived antioxidants: implications on health
  2595. Dietary effects on cardiovascular disease risk biomarkers
  2596. Dietary Factors in Geriatric Neurology
  2597. Dietary guidelines for Indians
  2598. Dietary impact on neuronal autophagy control and brain health
  2599. Dietary Intake of AGEs and ALEs and Inflammation—Nutritional Aspects
  2600. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging
  2601. Dietary intervention and prevention of cognitive-related outcomes in healthy older adults without cognitive dysfunction
  2602. Dietary Intervention of Utazi (Gongrenema Latifolium) Supplemented Diet Using Wistar Male Rat Animal Brain Model
  2603. Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China
  2604. Dietary Patterns and Cognitive Decline: key features for prevention
  2605. Dietary patterns and cognitive health in older adults: A systematic review
  2606. Dietary patterns and risk of self-reported activity limitation in older adults from the Three-City Bordeaux Study
  2607. DIETARY PATTERNS AND SUPPLEMENT INTAKE OF OLDER ADULTS IN
  2608. Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges
  2609. Dietary Phytochemicals in Neurodegenerative Disease
  2610. Dietary phytochemicals in neuroimmunoaging: a new therapeutic possibility for humans?
  2611. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice
  2612. Dietary sources, bioavailability and biological activities of naringenin and its derivatives
  2613. Dietary supplementation of Almond prevents oxidative stress by advocating antioxidants and attenuates impaired aversive memory in male rats
  2614. Dietary supplements and military divers: A synopsis for undersea medical officers
  2615. Dietary supplements and related products: a brief summary
  2616. Dietary supplements for cognitive impairment
  2617. Dietary supplements: current knowledge and future frontiers
  2618. Dietary Supplements/Antioxidants: Impact on Redox Status in Brain Diseases
  2619. Differential molecular targets for neuroprotective effect of chlorogenic acid and its related compounds against glutamate induced excitotoxicity and oxidative stress in …
  2620. Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats
  2621. Dihydrobenzofuran Neolignans Isolated from Euonymus alatus Attenuated Excessive Inflammatory Responses in the Activated RAW264. 7 Macrophage Cells
  2622. Dihydrochalcones: Methods of Acquisition and Pharmacological Properties—A First Systematic Review
  2623. Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity
  2624. Dihydropyrimidinones (DHPMs) Derivatives Suppress LPS-induced Nitric Oxide Productionin BV-2 Microglial Cells
  2625. Dimethyl-carbamic acid 2, 3-Bis-Dimethylcarbamoyloxy-6-(4-Ethyl-Piperazine-1-Carbonyl)-phenyl ester: A novel multi-target therapeutic approach to neuroprotection
  2626. Diminished brain resilience syndrome: a modern day neurological pathology of increased susceptibility to mild brain trauma, concussion, and downstream …
  2627. Diosmin is neuroprotective in a rat model of scopolamine-induced cognitive impairment
  2628. Discovering Coffee’s Unique Health Benefits
  2629. Discovery and Development of neuroprotective Agents from Natural Products
  2630. Discovery and Mechanisms of Small Molecule Amyloid Formation Inhibitors
  2631. Discovery of Hsp90 inhibitors form natural product and its analogues
  2632. Discovery of Leonuri and therapeutical applications: From bench to bedside
  2633. Discovery of Natural Product Analogs Against Ethanol-induced Cytotoxicity in Hippocampal Slice Cultures
  2634. Discovery of novel genes for depressant in restraint-stress-induced depression in Wistar Kyoto Rat
  2635. Discovery of Novel P2X7 Receptor Antagonists for Pain and Inflammatory Diseases
  2636. Discovery of Novel Therapeutic Agents using Molecular Diversity and Chemical Biology
  2637. Discovery of potential biomarkers in the prediction of diabetes acquisition
  2638. Disease Biomarker Discovery and Validation Using Mass Spectrometry
  2639. disease: A pharmacoinformatic approach, Informatics in Medicine Unlocked
  2640. Distinct Role of Hippocampus and Prefrontal Cortex in Recognition Memory
  2641. Diterpenes: advances in neurobiological drug research
  2642. DNA damage protection: an excellent application of bioactive compounds
  2643. Do Ganoderma lucidum and Salvia officinalis extracts exhibit synergistic antioxidant and antiNeurodegenerative effects?
  2644. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid‐β oligomers
  2645. Doenjang, A Korean Traditional Fermented Soybean Paste, Ameliorates Neuroinflammation and Neurodegeneration in Mice Fed a High-Fat Diet
  2646. DOES MEDITERRANEAN DIET CONFER NEUROPROTECTION AGAINST NEUROINFLAMMATION AND RELATED DISEASES? AN OVERVIEW
  2647. Does the addition of spices change the content of fluoride and antioxidants in black tea infusions?
  2648. Dopamine neurotoxicity, oxidative stress and schizophrenia-in vitro and in vivo studies of peroxisomal reactions to increased dopamine
  2649. Dopaminergic neurotoxicity by MPTP is enhanced in IL-32 transgenic mice
  2650. Dosage effects of EGb761 on hydrogen peroxide-induced cell death in SH-SY5Y cells
  2651. Dosage of Standard Herbal Decotion and Solid Extract
  2652. DPPIV Inhibitor as an Antidiabetic Agents: from LC15-0133 to LC15-0444 (Zemiglo)
  2653. Drosophila as a model system for studying lifespan and neuroprotective activities of plant-derived compounds
  2654. Drosophila as a Model System for the Identification of Pharmacological Therapies in Neurodegenerative Diseases
  2655. Drug Development for Neurodegenerative Diseases
  2656. Drug discovery and design for complex diseases through QSAR computational methods
  2657. Drug Discovery Approach on Tectona Grandis Linn Leaves Against Apicomplexan Plasmodium and Wound Links its Ethnopharmacological Validation and …
  2658. Drug discovery from traditional Chinese medicine for neurogenesis: implications for stroke and Neurodegenerative diseases
  2659. Drug treatment of cognitive impairment in the elderly
  2660. Drug-delivery nanocarriers to cross the blood–brain barrier
  2661. Drugs and dietary supplements with unproven effects in research and practice: Part 2
  2662. Drugs to Treat Age‐Related Neurodegenerative Problems The Final Frontier of Medical Science?
  2663. Dual Effects of AT1 Receptor Blocker on Catecholamine Release from the Rat Adrenal Medulla
  2664. Dual Inhibitors of ROCK I and NOX to Attenuate Neuroinflammation in Neurological Disorders High Throughput Virtual and Biological screening
  2665. Dual Therapeutic-imaging Nanoparticles for Triggered Tumor Delivery of Chemotherapeutic Adjuvant
  2666. Duality of antidepressants and neuroprotectants
  2667. Dysregulation of Heat Shock Proteins in Neurodegenerative Diseases: Restorative Roles of Small Molecules and Natural Compounds
  2668. Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies
  2669. Early neurophysiological diagnosis of true neurogenic «thoracic outlet syndrome»(TOS)
  2670. Eat This and Live: Simple Food Choices That Can Help You Feel Better, Look Younger, and Live Longer!
  2671. Echinacoside, an inestimable natural product in treatment of neurological and other disorders
  2672. Eco-Agri-Food Ecology and Human Health
  2673. Efectos saludables de la cúrcuma y de los curcuminoides
  2674. Effect EtOH ext. of Chaenomeles sinensis fruit on the metabolism of APP from APPswe overexpressing Neuro2a cell line
  2675. Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose
  2676. Effect of Acacia catechu (Lf) Willd. on oxidative stress with possible implications in alleviating selected cognitive disorders
  2677. Effect of alcoholic extracts of millet seed (Panicum miliaceum L.) on spatial memory in male mice
  2678. Effect of Amaranthus on advanced glycation end-products induced cytotoxicity and proinflammatory cytokine gene expression in SH-SY5Y cells
  2679. Effect of amyloid beta (25-35) peptide on mitochondrial respiratiory function in neuroral cells over expressing ape1
  2680. Effect of Andrographis paniculata and Phyllanthus amarus leaf extracts on selected biochemical indices in Drosophila melanogaster model of neurotoxicity
  2681. Effect of antioxidants supplementation on aging and longevity
  2682. EFFECT OF AQUEOUS AND ETHANOL LEAF EXTRACTS OF ERIOSEMA PSORALEOIDES ON SOME oxidative stress PARAMETERS IN ALLOXAN …
  2683. Effect of aqueous extract of ginger on acetylcholine in brain and it’sa possible role in learning and memory during ethanol withdrawal
  2684. Effect of Capparis spinosa L. on cognitive impairment induced by D-galactosein mice via inhibition of oxidative stress
  2685. Effect of chronic consumption of blackberry extract on high-fat induced obesity in rats and its correlation with metabolic and brain outcomes
  2686. Effect of Chronic Treatment with Conventional and Organic Purple Grape Juices (Vitis labrusca) on Rats Fed with High-Fat Diet
  2687. Effect of dietary interventions in mild cognitive impairment: a systematic review
  2688. Effect of dietary phytochemicals on metabolic syndrome and neurological disorders
  2689. Effect of Endocannabinoids on Soybean Lipoxygenase-1 Activity
  2690. Effect of Epigallocatechin Gallate and Catechin on Overexpression of GSK-3β and IR Genes Induced by Streptozotocin in Rat Brain. Caspian J Neurol Sci. 2019 …
  2691. Effect of Food on the Pharmacokinetics of Rosuvastatin Following Single Oral Administration in the Dog
  2692. Effect of Gallic acid on memory and pain of male diabetic rats
  2693. Effect of Ginkgo biloba Extract EGb 761 on Differential Gene Expression in the Brain
  2694. Effect of Ginsenoside Rg3 on the Phosphorylation and Expression of Endothelial Nitric Oxide Synthase: Essential Roles of Estrogen Receptor-dependent PI3 …
  2695. Effect of glycation inhibitors on aging and age-related diseases
  2696. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment …
  2697. Effect of lifestyle, aging, and phytochemicals on the onset of neurological disorders
  2698. Effect of Lipid on Physicochemical Properties of Paclitaxel Loaded-solid Lipid Nanoparticle
  2699. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide …
  2700. Effect of Manasamitra Vatakam against aluminium induced learning and memory impairment of apoptosis in rat’s hippocampus and cortex
  2701. Effect of Medicinal Herb Composites on Antioxidative and Cognition-Enhancing Activities in Rats
  2702. Effect of Methyl 3, 5-Dicaffeoyl Quinate on ROS Level, Mitochondrial Membrane Potential and the Release of Cytochrome C in HT-29 Cells
  2703. Effect of Microbiota on Neurodegenerative Diseases
  2704. Effect of myricetin, pyrogallol, and phloroglucinol on yeast resistance to oxidative stress
  2705. Effect of natural antioxidants on the aggregation and disaggregation of beta-amyloid
  2706. Effect of natural exogenous antioxidants on aging and on Neurodegenerative diseases
  2707. Effect of natural products on diabetes associated neurological disorders
  2708. Effect of nutrition on Neurodegenerative diseases. A systematic review
  2709. Effect of o-VA on mast cell-mediated allergic inflammation
  2710. Effect of Paullinia cupana Mart. Commercial Extract During the Aging of Middle Age Wistar Rats: Differential Effects on the Hippocampus and Striatum
  2711. Effect of PEGylation on the Cytotoxicity and Bioactivity of Pentapeptide
  2712. Effect of Physicochemical Properties of Drug and Pressure Sensitive Adhesives on Transdermal Drug Delivery
  2713. Effect of pineapple, orange and watermelon juices on phosphodiesterase, monoamine oxidase and angiotensin-I converting enzyme activities in rat heart and brain …
  2714. Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model
  2715. Effect of quercetin on learning and memory in STZ-induced diabetic rat.
  2716. Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats
  2717. Effect of Rosa rugosa (RR) flower on APPswe overexpressing Neuro2a cell line.
  2718. Effect of Salvia officinalis Hydroalcoholic Extract on Iron Oxide Nanoparticle Induced Memory Impairment in the Presence and Absence of Beta-Adrenergic …
  2719. Effect of Sub Lethal Concentration of Glyphosate Based Herbicide on Some Biochemical Parameters of Male Clarias Gariepinus
  2720. Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron …
  2721. Effect of the NU-AGE diet on cognitive functioning in older adults: a randomized controlled trial
  2722. Effect of TIMBD on Neurotoxicity Associated with HIV-1 Gp120 and Tat
  2723. Effect of Toasting on the Chemical Composition, Functional and Antioxidative Properties of Full Fat and Defatted Sesame (sesamum indicum L) Seed Flours
  2724. Effect of Trigonella foenum-graecum Linn. seeds methanol extract on learning and memory
  2725. Effect of vitamin D supplementation on CREB-TrkB-BDNF pathway in the hippocampus of diabetic rats
  2726. Effectiveness of Opuntia ficus indica L. inermis Seed Oil in the Protection and the Healing of Experimentally Induced Gastric Mucosa Ulcer
  2727. Effectiveness of Oriental Medicine Mainly Including Kudzu Root (Pueraria) for Controlling Blood Glucose in Patients with Diabetes
  2728. Effects against Mercury Chloride-Induced Nephrotoxicity by Activated Cultivated-Wild Ginseng in Rats
  2729. Effects and Mechanisms of Antioxidant-Rich Functional Beverages on Disease Prevention
  2730. Effects of 1, 2, 3, 4, 6-Penta-O-Galloyl-β-D-Glucose on the Metabolism of Amyloid Precursor Protein
  2731. Effects of 90 days of resveratrol supplementation on cognitive function in elders: a pilot study
  2732. Effects of a 1-Piperonylpiperazine Analog on the Metabolism of Amyloid Precursor Protein
  2733. Effects of a new nutraceutical combination on cognitive function in hypertensive patients
  2734. Effects of a Propolis Extract on the Viability of and Levels of Cytoskeletal and Regulatory Proteins in Rat Brain Astrocytes: an In Vitro Study
  2735. Effects of a Proprietary Standardized Orthosiphon stamineus Ethanolic Leaf Extract on Enhancing Memory in Sprague Dawley Rats Possibly via Blockade of …
  2736. Effects of Anthocyanins 10 on Neuronal and Cognitive Brain Functions
  2737. Effects of Anti-inflammatory Anthraquinones from Rhubarb on P-glycoprotein-mediated Drug Efflux in Caco-2 Cells.
  2738. Effects of anti-inflammatory bioactives on diabetes-induced changes in cognition-related gene expression in the hippocampus
  2739. Effects of Camellia Sinensis Extract on Passive Avoidance Learning and Hippocampal Neurogenesis in Rats
  2740. Effects of Chronic Alcohol Consumption on Expression Levels of APP and Aβ-Producing Enzymes
  2741. Effects of Chrysanthemum indicum Linne flowers on acetylcholinesterase activity and learning performance in mice
  2742. Effects of coffee consumption on serum uric acid: systematic review and meta-analysis
  2743. Effects of Constituents Identified in the Adults of Tenebrio molitor on Antioxidant and Anti-BACE-1 Activities
  2744. Effects of Cysteine on the Pharmacokinetics of Etoposide in Rats with Protein–calorie Malnutrition
  2745. Effects of Cysteine on the Pharmacokinetics of Tamoxifen in Rats with Protein-calorie Malnutrition: Enhanced Gastrointestinal Absorption by Cysteine
  2746. Effects of Dark Chocolate Intake on Brain Electrical Oscillations in Healthy People
  2747. Effects of DCM Leaf Extract of Gnidia glauca (Fresen) on Locomotor Activity, Anxiety, and Exploration-Like Behaviors in High-Fat Diet-Induced Obese Rats
  2748. Effects of DHA and EGCG on the alpha-secretase mediated processing of APP
  2749. Effects of dietary derived antioxidants on the central nervous system
  2750. Effects of Dietary Supplements and Nutraceuticals of Plant Origin on Central and Peripheral Nervous System Pathology
  2751. Effects of Distylium Recemosum on the Metabolism of Amyloid Precursor Protein
  2752. Effects of Energy and Macronutrient Intake on Cognitive Function Through the Lifespan
  2753. Effects of Enzogenol Extract on Regulating Blood Glucose and Lipid Metabolism in C57BL/KsJ-db/db Mice
  2754. Effects of epigallocatechin-3-gallate on behavioral impairments induced by psychological stress in rats
  2755. Effects of Eurycoma longifolia Jack on chronic cerebral hypoperfusion-induced oxidative damage and memory deficit in rats
  2756. Effects of excipients on the permeability of BCS IV classcompounds
  2757. Effects of Extra‐Virgin Olive Oil in Neurological Disorders
  2758. Effects of grape skin extract on age-related mitochondrial dysfunction, memory and life span in C57BL/6J mice
  2759. Effects of Gryllus bimaculatus (Gb) fractions on alcoholic hepatitis
  2760. Effects of Gryllus bimaculatus (Gb) fractions on viral hepatitis
  2761. Effects of Impurities on Stabilization of Amorphous Donepezil: Synthesis and Identification of Process-Induced Impurities of Donepezil.
  2762. Effects of intrinsic and extrinsic factors on aggregation of physiologically important intrinsically disordered proteins
  2763. Effects of Juglans sinensis Extract on the Metabolism of Amyloid Precursor Protein
  2764. Effects of Korean Red Ginseng Extract on Immune Modulation and Anti-oxidation in Human Keratinocytes
  2765. Effects of lotus-derived constituents on learning and memory activity of scopolamine-induced mice
  2766. Effects of Matricaria chamomilla extract on motor coordination impairment induced by scopolamine in rats
  2767. Effects of matricaria chamomilla extract on motor coordination impairment induced in rat and determination antioxidant properties of chamomile
  2768. Effects of Mediterranean diet components on Neurodegenerative diseases
  2769. Effects of methanolic extract of Bacopa
  2770. Effects of Moringa oleifera on Glycaemia and Insulin Levels: A Review of Animal and Human Studies
  2771. Effects of Moringa oleifera on the Acetylcholinesterase and Monoamine Oxidase Activities in the Streptozotocin-Induced Diabetic Rat Brains
  2772. Effects of Multi-Ingredient Dietary Supplementation and Tai Chi on Cognitive and Physical Function in Middle-Aged and Older Individuals
  2773. Effects of Nanomaterial Mixture on the Skin Corrosion and Irritation Tested by Alternative Method Using Reconstituted 3D Human Skin Model, KeraSkin™
  2774. Effects of Natural Antioxidants on Motor and Cognitive Deficits in an Animal Model of Aging and Obesity and Dopaminergic-Like SH-SY5Y Cell Line
  2775. Effects of natural products on sugar metabolism and digestive enzymes
  2776. Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid
  2777. Effects of Novel Benzofuran-2-carboxamide Derivatives on the Excitotoxic Neuronal Damage in Primary Cultured Rat Cortical Cells
  2778. Effects of nutritional supplementation on the progression of motor neuron degeneration in a murine model of amyotrophic lateral sclerosis
  2779. Effects of P-glycoprotein and CYP3A4 Inhibition by Amlodipine on the Pharmacokinetic Parameter of Warfarin
  2780. Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive …
  2781. Effects of phytochemicals on cellular signaling: reviewing their recent usage approaches
  2782. Effects of Proton Radiation and Pomegranates on Hippocampus and Behavior
  2783. Effects of Purple Coneflower (Echinacea purpurea) on CYP3A4 Metabolism and P-glycoprotein Mediated Transport in Vitro
  2784. Effects of Red Ginseng on Radical Scavenging Activity and Collagen Synthesis
  2785. Effects of Resveratrol on the Bioavailability and Pharmacokinetics of Losartan in Rats
  2786. Effects of rhynchophylline derived from Uncariae Ramulus et uncus on pentobarbital-induced sleep
  2787. Effects of Saffron (Crocus sativus L.) and its Active Constituent, Crocin, on Recognition and Spatial Memory after Chronic Cerebral Hypoperfusion in Rats
  2788. Effects of Salvia officinalis in the liver: relevance of glutathione levels
  2789. Effects of Side-Chain Length on Ring-Closing Metathesis to Form an All-Hydrocarbon Staple in α-Helical Peptides
  2790. Effects of silibinin on hair follicle stem cells differentiation to neural-like cells
  2791. Effects of Some Fractions Extracted from Korean Pine Needle on Catecholamine Release in the Rat Adrenal Gland
  2792. Effects of SP-8203 Combined with Thrombolytic Therapy in a Rat Embolic Stroke Model
  2793. Effects of the extract from the fruit hull of mangosteen (garainia mangostana l.) on learning memory and the central cholinergic system of male wistar rats
  2794. Effects of the Mediterranean Diet on Brain Function: Underlying mechanisms
  2795. Effects of the Methanolic Extract of Vitellaria paradoxa Stem Bark Against Scopolamine-Induced Cognitive Dysfunction and oxidative stress in the Rat Hippocampus
  2796. Effects of Vehicles and Enhancers on the In Vitro Permeability of Meloxicam (MX) through Hairless Mouse Skin
  2797. Effects of Vehicles and Enhancers on the In Vitro Permeation of Lornoxicam Across Excised Skin
  2798. Effects of Western, Mediterranean, Vegetarian, and Okinawan Diet Patterns on Human Brain
  2799. Efficacy and tolerability of phytomedicines in multiple sclerosis patients: a review
  2800. Efficacy of herbal combination of sedge, saffron, and Astragalus honey on major neurocognitive disorder
  2801. Efficacy of morin as a potential therapeutic phytocomponent: Insights into the mechanism of action
  2802. Efficacy of natural compounds in Neurodegenerative disorders
  2803. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP
  2804. EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’of α-Synuclein
  2805. Electrospinning of 3D poly (l-lactic acid) biodegradable scaffold containing tgf as potential for cartilage regeneration
  2806. Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-γ
  2807. Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration
  2808. Elucidating the inhibitory potential of designed peptides against amyloid fibrillation and amyloid associated cytotoxicity
  2809. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms
  2810. Emblica officinalis (Amla): A review of potential therapeutic applications
  2811. Embryonic Stem Cell as a Model System in Drug Discovery from Natural Products
  2812. Emergence of nutraceuticals as the alternative medications for pharmaceuticals
  2813. Emerging anti-aging strategies-scientific basis and efficacy
  2814. Emerging Bioresources with nutraceutical and pharmaceutical prospects
  2815. Emerging potential of natural products as an alternative strategy to pharmacological agents used against metabolic disorders
  2816. Emerging roles of Sonic Hedgehog in adult neurological diseases: neurogenesis and beyond
  2817. Emerging targets and latest proteomics based therapeutic approaches in Neurodegenerative diseases
  2818. Encapsulation of cinnamon essential oil in whey protein enhances the protective effect against single or combined sub-chronic toxicity of fumonisin B 1 and/or …
  2819. Encapsulation of Islets with Liposomal Clodronate in Matrigel in a Xenotransplantation Model
  2820. Encephalopathy: a vicious cascade following forebrain ischemia and hypoxia
  2821. Endocrine Disruptors: Mechanism of Action and Impacts on Health and Environment
  2822. Endogenous Catalase Plays a Role in Adipose Tissue Macrophage Polarization
  2823. Endogenous non-enzymatic antioxidants in the human body
  2824. Endophytic microbes: a novel source for biologically/pharmacologically active secondary metabolites
  2825. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?
  2826. Enhanced antioxidant capacity and anti-ageing biomarkers after diet micronutrient supplementation
  2827. Enhanced neuroprotective effects of combination therapy with bone marrow-derived mesenchymal stem cells and ginkgo biloba extract (EGb761) in a rat model of …
  2828. Enhanced neuroprotective Effects of Panax ginseng G115® and Ginkgo biloba GK501® Combinations In Vitro Models of Excitotoxicity
  2829. Enhancement of Functional Properties of Dairy Products by Date Fruits
  2830. Enhancement of immune response and intestinal motility by Undariapinnatifidamedia cultured L. plantarum.
  2831. Enhancement of the neuroprotective effect of fermented Spirulina maxima associated with antioxidant activities by ultrasonic extraction
  2832. Enhancing learning and memory in the aged: Interactions between dietary supplementation and exercise
  2833. ENTADA PHASEOLOIDES ATTENUATES SCOPOLAMINE INDUCED MEMORY IMPAIRMENT, NEURO-INFLAMMATION AND NEURO-DEGENERATION VIA …
  2834. Entrepreneurial Opportunities in Nutraceuticals developed from fish and fish wastes
  2835. Environmental effects of ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2017
  2836. Environmental Neurotoxic Metabolites: 2, 5-Hexanedione and 1, 2-Diacetylbenzene
  2837. Enzyme inhibitory and antioxidant activities of Viburnum tinus L. relevant to its neuroprotective potential
  2838. Enzyme inhibitory properties of black tea and its components
  2839. Epicatechin and catechin in cocoa inhibit amyloid β protein induced apoptosis
  2840. Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double‐blind, placebo‐controlled, crossover …
  2841. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe …
  2842. Epigallocatechin-3-gallate (EGCG): mechanisms and the combined applications
  2843. Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down’s …
  2844. Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties
  2845. Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?
  2846. Epigenetic modifications in neurological diseases: natural products as epigenetic modulators a treatment strategy
  2847. Epigenetics and cognitive disorders—translational aspects
  2848. Epigenetics of Brain Aging
  2849. Epigenome-based Mechanisms of Disease Pathogenesis and the Therapy
  2850. Equol, a dietary daidzein gut metabolite attenuates microglial activation and potentiates neuroprotection in vitro
  2851. Ergothioneine–a diet‐derived antioxidant with therapeutic potential
  2852. Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
  2853. Essential oils and Neurodegenerative diseases: current data and future perspectives
  2854. ESSENTIAL OILS AS MODIFIERS OF HUMAN BEHAVIOR
  2855. ESSENTIAL OILS AS POTENTIAL ANTIOXIDANT AGENTS IN THE TREATMENT OF OXIDATIVE STRESS-RELATED Neurodegenerative DISEASES …
  2856. Essential roles of natural products and gaseous mediators on neuronal cell death or survival
  2857. Establishing a Leaf Proteome Reference Map for Ginkgo biloba Provides Insight into Potential Ethnobotanical Uses
  2858. Establishment for Standardization of Herbal Medicines
  2859. Establishment of a comprehensive list of candidate antiaging medicinal herb used in Korean medicine by text mining of the classical Korean medical literature,“ …
  2860. Establishment of Analytical Methods and Monitoring for Marker Compounds of Herbal Medicines
  2861. Establishment of the Database of Herbal Formulas in the 10 EFKM (Established Formularies of Korean Medicine)
  2862. Estimation of UV-induced DNA Damages to Suppress Expression of Protein Using Reporter Gene Assay-Based Single Cell Cotransfection Imaging Cytometry
  2863. Estrogen activates protein kinase C in neurons: role in neuroprotection
  2864. Estrogen Receptor Beta inhibits HIF-1 Activity
  2865. Estrogen Receptor Related Receptor Gamma Promotes Dopaminergic Neuronal Differentiation Estrogen Receptor Related Receptor Gamma Promotes …
  2866. Estrogen Receptor β Regulates Brain Signaling Involved in Depression
  2867. Estrogen—Mystery Drug for the Brain?: The neuroprotective Activities of the Female Sex Hormone
  2868. Estrogenic and Antiestrogenic Effects of GBE on Uterus using Immature Rat Uterotrohpic Assay
  2869. Ethanol extract of a Korean medicinal prescription (SSY) including Rehmanniae Radix Preparata promote hair growth in an alopecia animal model
  2870. Ethanol Extract of Centipeda minima Exerts Antioxidant and neuroprotective Effects via Activation of the Nrf2 Signaling Pathway
  2871. Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice
  2872. Ethanol Induces oxidative stress via Up-Regulation of NADPH Oxidasederived ROS Generation in RAW264. 7 Macrophages
  2873. Ethanolic extract of O. stamineus improves memory in scopolamine-induced amnesia model 2
  2874. Ethanolic extract of Streblus asper leaves protects against glutamate-induced toxicity in HT22 hippocampal neuronal cells and extends lifespan of …
  2875. Ethnobotanical survey and biological screening of medicinal plants from Vanuatu
  2876. Ethnobotanical, Antioxidant And Toxicity Study Of Selected Medicinal Plants Used In Nyamira North Sub-county, Nyamira County
  2877. Ethnobotany, phytochemistry, toxicology and pharmacological properties of Terminalia sericea Burch. ex DC.(Combretaceae)–A review
  2878. Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status
  2879. Ethnopharmacological study of medicinal plants used in the treatment of CNS disorders in Sinai Peninsula, Egypt
  2880. Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Alpinia oxyphylla Miquel: A review
  2881. Ethyl acetate fraction from persimmon (Diospyros kaki) ameliorates cerebral neuronal loss and cognitive deficit via the JNK/Akt pathway in TMT-induced mice
  2882. Eugenol Alleviates Hepatic Steatosis through AMPK-SREBP1 Pathway
  2883. Evaluating the therapeutic efficiency and drug targeting ability of alkaloids present in Rauwolfia serpentina
  2884. Evaluation for Protective Effects of β-Ionone against Gastric Lesions
  2885. Evaluation of anti-amnesic effect of extracts of selected Ocimum species using in-vitro and in-vivo models
  2886. Evaluation of anti-ischemic therapy in coronary artery disease: a review
  2887. Evaluation of antiarthritic activity of Indigofera tinctoria L in Sprague-Dawley rats
  2888. Evaluation of Antidiabetic, Antihyperlipidemic, and Antiglycation Effect of Moringa stenopetala (Baker f) Cufodontis leaves
  2889. Evaluation of Antihyperlipidaemic and Antioxident Activity of Artocarpus Heterophyllus Stem Extract
  2890. Evaluation of antioxidant activity of Safflower florets (Carthamus tinctorius L.) as food coloring agents
  2891. Evaluation of antioxidant activity of Viscum articulatum (Burm. F)
  2892. Evaluation of Antioxidant and Acetyl Cholinesterase inhibitory activity of Peltophorum pterocarpum in Scopolamine treated rats
  2893. Evaluation of Antioxidant and Cholinesterase Inhibitory Activities of Hoya parasitica Variegata-An In-vitro Study
  2894. Evaluation Of Antioxidant And Cytotoxicity Properties Of Amygdalin Extracted From Prunus Dulcis
  2895. Evaluation of antioxidant and neuroprotective activities of Cassia fistula (L.) using the Caenorhabditis elegans model
  2896. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion
  2897. Evaluation of antioxidant nootropic and antidepressant properties of Litsea Floribunda BL gamble lauraceae
  2898. Evaluation of Antioxidant, Anti-cholinesterase, and Anti-inflammatory Effects of Culinary Mushroom Pleurotus pulmonarius
  2899. EVALUATION OF BARK EXTRACT OF SPATHODEA COMPANULATA P. BEAUV FOR ANTIOXIDANT AND neuroprotective ACTIVITY IN ALBINO RATS
  2900. Evaluation of bioactive compounds as acetylcholinesterase inhibitors from medicinal plants
  2901. Evaluation of Camellia Sinensis in the Alcohol Deprivation Effects in Rats Following Long-Term Voluntaty Alcohol Consumption
  2902. Evaluation of Citrus aurantifolia peel and leaves extracts for their chemical composition, antioxidant and anti‐cholinesterase activities
  2903. Evaluation Of Cytotoxic and Genotoxic Properties Of Sinapic Acid
  2904. Evaluation of Drug Delivery Profiles in Geometric Three-layered Tablets with Various Mechanical Properties, in vitro-in vivo Drug Release, and Raman …
  2905. Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on oxidative stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
  2906. Evaluation of Impact of CCL2 on Vital Signaling Cascades in Microglial Cells using BV2 Cell Line as a Model
  2907. Evaluation of In Vitro Anti-Oxidant Activity of Mentha arvensis Linn in Memory Enhancing Study
  2908. Evaluation of in vitro free Radical Scavenging Activity of Tribulus terrestris
  2909. EVALUATION OF IN VIVO ANTI-OXIDANT ACTIVITY OF MENTHA ARVENSIS LINN IN RAT BRAIN HOMOGENATES
  2910. Evaluation of neuroprotective effects of natural extracts obtained from portuguese agro-food residues
  2911. Evaluation of neuroprotective Properties of Ecchium Amoenum L. Ethanolic Extract
  2912. Evaluation of neuroprotective Properties of Ellagic Acid and Caffeic Acid Phenethylester
  2913. Evaluation of nootropic activity of Sida cordifolia in mice
  2914. Evaluation of possible in vitro neurobiological effects of two varieties of Cupressus sempervirens (Mediterranean cypress) through their antioxidant and enzyme …
  2915. Evaluation of Potential Central Protective Role of Ethanol Extract of Pedalium Murex Linn. In Acute and Chronic Unpredictable Stress (CUS) Induced Models in SD …
  2916. Evaluation of protective effect of rutin on lead acetate-induced testicular toxicity in Wistar rats
  2917. Evaluation of Safety and Efficacy of Carnosine, a neuroprotective Agent against Ischemic Sroke
  2918. Evaluation of selected Libyan medicinal plant extracts for their antioxidant and anticholinesterase activities
  2919. Evaluation of the antioxidant activity and antitumor activity of marine invertebrates extracts
  2920. Evaluation of the Antioxidant and Neuroprotectant Activities of New Asymmetrical 1, 3-Diketones
  2921. Evaluation of the Effects of Storage Conditions on the Stability of Porcine Placenta Extract-loaded Liposome Formulations
  2922. Evaluation of the neuroprotective and antioxidant effects of Dorema aucheri extract on cerebral ischaemia-reperfusion injury in rats
  2923. Evaluation of the nutritional profile and antioxidant and anti-cholinesterase activities of Padina gymnospora (Phaeophyceae)
  2924. Evaluation of the Remedy for Neuronal Diseases from Rhemannia glutinosa Liboschitz and Elucidation of their Underlying Mechanisms.
  2925. Evaluation of the traditional and well-established use of Hyperici herba
  2926. Evaluation on biological activity of triphenylpyridine derivatives
  2927. Evaluation on biological activity of triphenylpyridine derivatives
  2928. Every person’s guide to antioxidants
  2929. Evidence for health benefits of berries
  2930. Evidence of Anti-Obesity Effects of the Laminaria japonica Areshoung Ethanol Extract in High-Fat Diet Induced Obese Rat
  2931. Evidence-Based Therapeutic Effects of Anthocyanins from Foods
  2932. Exacerbation of MG132-induced Protein Accumulation in the Brain of LRRK2-G2019S Transgenic Mice
  2933. Excitotoxicity: bridge to various triggers in Neurodegenerative disorders
  2934. Exercise and the brain
  2935. Expectation and Introduction of Reformed National Health Personnel Licensing Examination
  2936. Experimental inhibition of fibrillogenesis and neurotoxicity by amyloid-beta (Aβ) and other disease-related peptides/proteins by plant extracts and herbal compounds
  2937. Experimental Studies on the Hair Growth Activity of Herbal Extracts in C57BL/6 Mice
  2938. Exploration of body weight regulation by polyunsaturated fatty acids in rat: potential association with hypothalamic neurogenesis
  2939. Exploring anti-prion glyco-based and aromatic scaffolds: a chemical strategy for the quality of life
  2940. Exploring cellular actions and interactions of SIRT1 that may counteract ageing
  2941. Exploring in vitro neurobiological effects and high-pressure liquid chromatography-assisted quantitation of chlorogenic acid in 18 Turkish coffee brands
  2942. Exploring Nanoformulations of Pomegranate as Promising Nutraceuticals
  2943. Exploring the Role of “Brahmi”(Bacopa monnieri and Centella asiatica) in Brain Function and Therapy
  2944. Exploring the role of genetic variability and lifestyle in oxidative stress response for healthy aging and longevity
  2945. Exploring the structural diversity in inhibitors of α-synuclein amyloidogenic folding, aggregation, and neurotoxicity
  2946. Expression of indoleamine 2, 3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons
  2947. Extra virgin olive oil modulates brain docosahexaenoic acid level and oxidative damage caused by 2, 4-Dichlorophenoxyacetic acid in rats
  2948. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases
  2949. Extraction and chromatography-mass spectrometric analysis of the active principles from selected Chinese herbs and other medicinal plants
  2950. Extracts from Quercus sp. acorns exhibit in vitro neuroprotective features through inhibition of cholinesterase and protection of the human dopaminergic cell line SH …
  2951. Extracts of Liriopsis tuber protect AMPA induced brain damage and improve memory with the activation of insulin receptor and ERK I/II
  2952. Extracts of Sideritis species as inhibitors of monoamine transporters: A pharmacological mechanism for efficacy in CNS disorders like depressive disorders and …
  2953. Extracts of Twigs of Actinodaphne lancifolia Cause Nrf2-mediated Induction of Quinone Reductase
  2954. FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced …
  2955. Factors that influence adult neurogenesis as potential therapy
  2956. FAG Inhibits Lipopolysaccharide Induced-iNOS Expression and Activity of NF-kB in Macrophage
  2957. Familial Amyloid-Beta and Non-Amyloid-Beta Amyloidosis: Insights into Oligomerization, Toxicity, and Potential Therapeutic Strategies
  2958. Fast access of some grape pigments to the brain
  2959. Fasting for Life
  2960. Fenugreek seed powder nullified aluminium chloride induced memory loss, biochemical changes, Aβ burden and apoptosis via regulating Akt/GSK3β …
  2961. Fermentation enhances Ginkgo biloba protective role on gamma-irradiation induced neuroinflammatory gene expression and stress hormones in rat brain
  2962. Fern to Pharma: Potential Neuroameliorative Properties of Pteridophytes
  2963. Ferritin oxidation and proteasomal degradation: protection by antioxidants
  2964. Ferulic acid ethyl ester as a potential therapy in Neurodegenerative disorders
  2965. Ferulic Acid: A Promising Therapeutic Phytochemical and Recent Patents Advances
  2966. First-in-Class Pan-Nox Inhibitor Targeting Diabetic Kidney Disease
  2967. Fisetin acts on multiple pathways to reduce the impact of age and disease on CNS function
  2968. Fisetin and its role in chronic diseases
  2969. Fisetin reduces the impact of aging on behavior and physiology in the rapidly aging SAMP8 mouse
  2970. Flammulina velutipes polysaccharides improve scopolamine-induced learning and memory impairment in mice by modulating gut microbiota composition
  2971. Food and nutrients in disease management
  2972. Food and nutrition controversies today: A reference guide
  2973. Food Bioscience
  2974. Food Choices
  2975. Food colour additives of natural origin
  2976. Food components with the potential to be used in the therapeutic approach of mental diseases
  2977. Food for thought: The neuroscience of nutrition to fuel cognitive performance
  2978. Food is Medicine
  2979. Food processing and the Mediterranean diet
  2980. Food Processing Technologies: Impact on Product Attributes
  2981. Food Science and Human Wellness
  2982. Foods and dietary supplements in the prevention and treatment of disease in older adults
  2983. Forever Young: The Science of Nutrigenomics for Glowing, Wrinkle-free Skin and Radiant Health at Every Age
  2984. Formation of Heterotypic Amyloids: α‐Synuclein in Co‐Aggregation
  2985. Formulated Chinese Medicine Shaoyao Gancao Tang reduces Tau aggregation and exerts neuroprotection through anti-oxidation and anti-inflammation
  2986. Forsythiaside, a constituent of the fruits of forsythia suspense, ameliorates scopolamine-induced memory impairment in mice
  2987. Fortification of Functional and Medicinal Beverages With Botanical Products and Their Analysis
  2988. FoxO proteins in the nervous system
  2989. Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions
  2990. free radical []: free radical is any stable chemical specimen that contains at least
  2991. Free Radical Scavenging Activity and Docking Studies of Diarylheptanoids Isolated from Alnus hirsuta
  2992. Free radical scavenging activity and protective ability of methanolic extract from Duchesnea indica against protein oxidation and DNA damage
  2993. Free radical scavenging activity of antitumour polysaccharide fractions isolated from Ganoderma lucidum (Fr.) P. Karst
  2994. Free radical scavenging activity of chloroform and ethyl acetate extracts of leaves of Piper betle Linn
  2995. Free Radical Scavenging and Anti-inflammatory Activities of Ethyl Acetate Fraction of Pine Bark
  2996. Free radical theory of ageing: applications
  2997. Free Radical Theory of Aging
  2998. Free radical theory of aging: an update: increasing the functional life span
  2999. Free radical tissue damage: protective role of antioxidant nutrients.
  3000. Free radicals and antioxidants in human health: current status and future prospects
  3001. Free radicals and antioxidants–quo vadis?
  3002. Free radicals and antioxidants: A review
  3003. Free radicals and dietary antioxidants: a potential review
  3004. Free radicals and other reactive species in disease
  3005. Free radicals and oxidative damage in biology and medicine: An
  3006. Free radicals and oxidative damage in biology and medicine: An introduction
  3007. Free radicals and oxidative stress in Neurodegenerative diseases: relevance of dietary antioxidants
  3008. Free radicals in brain pathophysiology
  3009. Free radicals in brain pathophysiology
  3010. Free Radicals in Oxidative Stress, Aging, and Neurodegenerative Disorders
  3011. Free radicals, antioxidants and disease
  3012. Free radicals, antioxidants in disease and health
  3013. Free Radicals, Diabetes, and Its Complexities
  3014. From folk medicine to functional food: a review on the bioactive components and pharmacological properties of citrus peels
  3015. From small to big molecules: how do we prevent and delay the progression of age-related neurodegeneration?
  3016. FRUITS, VEGETABLES, AND HERBS FOUND IN KYÄNI SUNRISE TM
  3017. FULL-SPECTRUM ANTIOXIDANT THERAPY.
  3018. Functional and Medicinal Beverages: Volume 11: The Science of Beverages
  3019. Functional Food and Nutrition for the Management of Autism Spectrum Disorders and Schizophrenia
  3020. Functional Food Consumption and Its Physiological Effects
  3021. Functional foods
  3022. Functional foods
  3023. Functional foods and cognition
  3024. Functional Foods and Men’s Health
  3025. Functional Foods and Nutraceuticals
  3026. Functional Foods and Nutraceuticals: An Overview of the Clinical Outcomes and Evidence-Based Archive
  3027. Functional foods and physical activities in health promotion of aging people
  3028. Functional Foods and Their Importance in Geriatric Nutrition
  3029. Functional Foods as Source of Bioactive Principles: Some Marked Examples
  3030. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging
  3031. Functional Foods, Herbs, and Aging
  3032. Functional foods, nutraceuticals, and degenerative disease prevention
  3033. Functional foods: genetics, metabolome, and engineering phytonutrient levels
  3034. Functional neurotoxicity of arsenic and manganese as environmental agents and the possible protective role of natural antioxidants
  3035. Functional properties of green leafy vegetables and changes during processing
  3036. Functional Role of Mixed Lineage Kinase 3 (MLK3) on Osteoclastogenesis
  3037. Functional role of walnuts and acai fruits on brain health
  3038. Functionality of anthocyanins as alternative medicine
  3039. Fundamentals and health benefits of xanthohumol, a natural product derived from hops and beer
  3040. Future Medicinal Chemistry
  3041. Fyn Inhibition by Cycloalkane-Fused 1, 2-Dithiole-3-thiones Exerts Antioxidant Effect and Protects Mitochondria from Oxidative Injury
  3042. Gamma-Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the NFêB-Bim Pathway in Ischemic stroke
  3043. Garcinia kola diet provides slight protection to mice hippocampal neurons against neurotoxins
  3044. Gastrodia elata modulates amyloid precursor protein cleavage and cognitive functions in mice
  3045. GC-MS analysis of the methanolic extracts of Smilax china and Salix alba and their antioxidant activity
  3046. Gene Networks Governing Cholinergic Neuronal Identity in Vertebrate CNS
  3047. Gene-coffee interactions and health
  3048. Genetic Switches To Treat Obesity And Diabetes
  3049. Genetically engineered resveratrol-enriched rice inhibits neuroinflammation in lipopolysaccharide-activated BV2 microglia via downregulating mitogen-activated …
  3050. Genistein ameliorates scopolamine-induced amnesia in mice through the regulation of the cholinergic neurotransmission, antioxidant system and the ERK …
  3051. Genomic and epigenomic insights into nutrition and brain disorders
  3052. Genomic and proteomic mechanisms and models in toxicity and safety evaluation of nutraceuticals
  3053. Genoprotective and neuroprotective effects of Daphne gnidium leaf methanol extract, tested on male mice
  3054. Genus Spondias: A phytochemical and pharmacological review
  3055. Geriatric nutrition
  3056. Gerontology & Geriatric Research
  3057. Get Smart: Samantha Heller’s Nutrition Prescription for Boosting Brain Power and Optimizing Total Body Health
  3058. Ginkgo biloba
  3059. Ginkgo biloba
  3060. Ginkgo biloba
  3061. Ginkgo biloba
  3062. Ginkgo biloba extract (EGb 761) and CNS functions basic studies and clinical applications
  3063. Ginkgo biloba extract (EGb 761) and CNS functions basic studies and clinical applications
  3064. Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma
  3065. Ginseng: a promising neuroprotective strategy in stroke
  3066. Ginsenosides from American ginseng: chemical and pharmacological diversity
  3067. Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions
  3068. Glabridin inhibits lipopolysaccharide‐induced activation of a microglial cell line, BV‐2, by blocking NF‐κB and AP‐1
  3069. Gladiolus dalenii lyophilisate reverses scopolamine-induced amnesia and reduces oxidative stress in rat brain
  3070. Glioprotective effects of lingonberry extract against altered cellular viability, acetylcholinesterase activity, and oxidative stress in lipopolysaccharide-treated astrocytes
  3071. Global Botanical Drug Development for Respiratory Disease
  3072. Global Botanical Drug Development Utilizing the Plant Stem Cell
  3073. Global Metabolomic Analysis for Finding Biomarker Candidates from Acute Myocardial Infarction Disease
  3074. Glucose‐mediated protein glycation: Contribution of methanolic extract of Ceratonia siliqua L. in protection and in vitro potential inhibition of acetylcholinesterase
  3075. Glutamine synthetase: role in neurological disorders
  3076. Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species
  3077. Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species
  3078. Glutathione, oxidative stress and neurodegeneration
  3079. Glutathione, oxidative stress and neurodegeneration
  3080. Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease
  3081. Glycogen Synthase Kinase 3 alpha (GSK3a) Phosphorylates and Regulates the Osteogenic Activity of Osterix
  3082. Glycosides: From biosynthesis to biological activity toward therapeutic application
  3083. Glycyrrhizic Acid Ameliorates Mitochondrial Function and Biogenesis Against Aluminum Toxicity in PC12 Cells
  3084. Glyphosate’s suppression of cytochrome P450 enzymes and amino acid biosynthesis by the gut microbiome: pathways to modern diseases
  3085. Grape powder consumption affects the expression of neurodegeneration-related brain proteins in rats chronically fed a high-fructose–high-fat diet
  3086. Grape seed and skin extract prevents high-fat diet-induced brain lipotoxicity in rat
  3087. Grape Seeds Extract as Brain Food: A Review
  3088. Grapes and the Brain
  3089. Grapevine stilbenes and their biological effects
  3090. Grapevine stilbenoids: Bioavailability and neuroprotection
  3091. Green Coffee Bean Extract in Human Health
  3092. Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington’s disease models
  3093. Green Tea (Camellia sinensis) and its antioxidant property: A review
  3094. Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans—A comprehensive review
  3095. GREEN TEA AND POTENTIAL HUMAN HEALTH EFFECTS
  3096. Green tea and vitamin C ameliorate some neuro-functional and biochemical signs of arsenic toxicity in rats
  3097. Green tea catechins as neuroprotective agents: system-atic review of the literature in animal pre-clinical trials
  3098. Green tea catechins change the aggregation behavior of proteins associated with Neurodegenerative disease
  3099. Green Tea Effects on Age-Related Neurodegeneration: A Focus on Neuronal Plasticity
  3100. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in …
  3101. Green tea extract and (–)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities
  3102. Green tea extract enhances parieto-frontal connectivity during working memory processing
  3103. Green Tea Extract, Epigallocatechin Gallate, Protect Against Methamphetamine-Induced Striatal Neurotoxicity in Mice
  3104. Green Tea Revealed: The Mind Blowing Truth Behind This Tea
  3105. Green tea: A boon for periodontal and general health
  3106. Growth inhibitory effects of SB365 in gefitinib-resistant HCC827 cells
  3107. Guidance for New Extended-Release Solid Dosage Forms
  3108. Guideline on Review of the Fixed-Dose Combination Products for Cardiovascular Disease
  3109. Gut microbiota as a positive potential therapeutic factor in carcinogenesis: an overview of microbiota-targeted therapy
  3110. Gut microbiota: a new angle for traditional herbal medicine research
  3111. Hanbang’Cosmetics Based on The Korea’s Traditional Herbal Medicine: The History and Current Trends in R&D
  3112. Handbook of nutraceuticals volume I: ingredients, formulations, and applications
  3113. Handbook of research on food science and technology: Volume 3: Functional foods and nutraceuticals
  3114. Harnessing the power of microbiome assessment tools as part of neuroprotective nutrition and lifestyle medicine interventions
  3115. Harnessing the Self‐Assembling Properties of Proteins in Spider Silk and Lung Surfactant
  3116. Hazelnut and neuroprotection: Improved memory and hindered anxiety in response to intra-hippocampal Aβ injection
  3117. HDAC inhibitors from natural and synthetic libraries: towards the development of biochemical probes
  3118. HDL and cognition in Neurodegenerative disorders
  3119. Heal Your Heart: The Positive Emotions Prescription to Prevent and Reverse Heart Disease
  3120. Health Benefits of Anthocyanins
  3121. Health benefits of black tea
  3122. Health Benefits of Functional Foods: Future Perspective
  3123. Health benefits of green tea
  3124. Health Benefits of Nut Consumption in Middle-Aged and Elderly Population
  3125. Health benefits of the mediterranean diet: metabolic and molecular mechanisms
  3126. Health benefits of wine and alcohol from neuroprotection to heart health
  3127. Health Care for an Ageing Population E-Book: Meeting the Challenge
  3128. HEALTH EFFECTS OF INDOLEAMINES IN THE PREVENTION OF COGNITIVE DECLINE ASSOCIATED WITH BRAIN AGING AND AGE-RELATED DISEASES
  3129. HEALTH EFFECTS OF SPICES
  3130. Health for Seniors
  3131. Health Related Enzyme Inhibiting Natural Products from Medicinal Plants
  3132. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition
  3133. HEALTHY AGING
  3134. Healthy Aging for the Brain
  3135. Healthy components of coffee processing by-products
  3136. Healthy foods: Fact versus fiction
  3137. Healthy Heart: Strengthen Your Cardiovascular System Naturally
  3138. Heme Oxygenase-1-Inducing Activity of 4-Methoxydalbergione and 4′-Hydroxy-4-methoxydalbergione from Dalbergia odorifera and Their Anti-inflammatory and …
  3139. Heme oxygenase-1-mediated anti-inflammatory effects of tussilagonone on RAW 264.7 macrophages
  3140. Heme stabilization of α-synuclein oligomers during amyloid fibril formation
  3141. Hepatoprotective Impact of Cinnamon Aqueous Extract تأثیر المستخلص المائى للقرفة على حمایة الکبد
  3142. Herb-drug Interaction by Inhibition and Induction of Cytochrome P450
  3143. Herba Cistanches: anti-aging
  3144. Herbal and nonherbal supplements in medical-psychiatric patient populations
  3145. Herbal Beverages and Brain Function in Health and Disease
  3146. Herbal Contraindications & Drug Interactions
  3147. Herbal Drugs
  3148. Herbal extract as potential modulator and drug for synaptic plasticity and Neurodegenerative disorders
  3149. Herbal extracts and cognition in adulthood and ageing
  3150. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function
  3151. Herbal Medications: An Evidence-Based Review
  3152. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature
  3153. Herbal medicine for sports: a review
  3154. Herbal medicine: biomolecular and clinical aspects
  3155. Herbal medicines as neuroprotective agent: A mechanistic approach
  3156. Herbal medicines in Neurodegenerative disorders: an evolutionary approach through novel drug delivery system
  3157. Herbal nanoparticles: A patent review
  3158. Herbal nootropic agents.
  3159. Herbal preparations prevent beta-amyloid peptide induced hippocampal cell damage
  3160. Herbal remedies for CNS disorders
  3161. Herbal supplement extends life span under some environmental conditions and boosts stress resistance
  3162. Herbal supplements and the brain: understanding their health benefits and hazards
  3163. Herbal Therapeutics
  3164. Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1‐dependent diseases and longevity
  3165. Herbal Treatment of Major Depression: Scientific Basis and Practical Use: Scientific Basis and Practical Use
  3166. Herbals in the control of ageing
  3167. Herbs for Diabetes and Neurological Disease Management: Research and Advancements
  3168. Herbs used for brain disorders
  3169. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence
  3170. Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction
  3171. Heterogeneity of microglia phenotypes: developmental, functional and some therapeutic considerations
  3172. Hibiscus sabdariffa L. extract prolongs lifespan and protects against amyloid-β toxicity in Caenorhabditis elegans: involvement of the FoxO and Nrf2 orthologues DAF …
Related Posts

Leydig Cell Steroidogenesis

P38mapk

Adipocyte Differentiation

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping